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1.1 Biological significance of mRNA sorting 
The compartmentalization of RNAs is an efficient and effective mechanism to concentrate 
specific proteins in defined subcellular compartments and represents an essential step during the 
development of polarized cells.  
 
The first evidence for a specific subcellular localization of messenger RNAs (mRNAs) was 
reported in a study demonstrating that the messenger RNA encoding actin was particularly 
concentrated in the myoplasm of the oocytes of the ascidian Styela placata (Jeffery et al, 1983). A 
growing body of experimental evidence has contributed to demonstrate that this phenomenon is 
actually widely diffused in several organisms, from plants, to fungi to mammals, suggesting its strong 
evolutionary conservation. Moreover, RNA localization is often coupled to local control of protein 
synthesis, resulting in a finely regulated mechanism for the spatial and temporal regulation of protein 
expression that has been adopted in many different cell types (Kloc et al, 2002).   
 
The biological significance of mRNA sorting has to be considered in view of the metabolic 
needs that highly polarized cells like oocytes and neurons have to face, and can be summarized in 
five points. First, in these cells it is necessary to avoid ectopic expression of proteins in cellular 
districts where their presence would be otherwise deleterious, like a mislocalization of nanos and 
oskar in Drosophila’s embryos leading to abnormal development, or  an incorrect presence of Myelin 
Basic Protein (MBP) mRNA in proximal compartments of oligodendrocytes (Gavis et al, 1996; Smith et 
al, 1992; St Johnston, 1995).  Second, thanks to a local accumulation of mRNA a cell can drive a local 
increase of a particular gene product in defined sudomains, as for β-actin in fibroblasts’ leading edge 
or bicoid in the anterior portion of Drosophila’s embryos (Berleth et al, 1988; Kloc & Etkin, 1995). 
Third, it has also been described a regional accumulation of cyclin B mRNA at mitotic spindle 
(Groisman et al, 2000), as an example of how transcripts can be segregated in particular organelles or 
subcellular structures. Forth, thanks to regulated RNA sorting, a cell can build up a gradient of one 
morphogenic substance and therefore influence the expression of several other proteins, as happens 
for bicoid in Drosophila’s oocytes (Kloc et al, 2002). Fifth, even a new cell lineage can be generated by 
sequestering transcripts in particular cellular compartments of future daughter cells, as seen during 
differentiation of neuroblasts or in Drosophila’s oocytes (Kloc et al, 2002). Moreover, RNA 
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localization can contribute directly to the establishment of the polarization within a cell: in fact, 
disruption of β-actin mRNA localization at fibroblasts’ leading edge results in the collapse of cellular 
lamellae and lost of asymmetry, even if the global levels of β-actin mRNA and protein are conserved 
(Kislauskis et al, 1994).  As a consequence, it is easy to imagine the importance of mRNA 
compartmentalization for the maintenance of polarity in highly specialized cells like neurons.  
 
RNA sorting is also an efficient way to save cellular energy, since synthesis of many proteins is 
surely a much more energy-consuming process than localization of one or few mRNA molecules that, 
potentially, may be translated several times (St Johnston, 1995). This is particularly relevant in distal 
compartments, where proteins need to be transported from hundreds to thousands of microns away 
from the cell soma. This phenomenon results to be highly energy consuming and quite inefficient 
since it could take a time longer than the protein half-life. It is therefore easier and more convenient 
for a neuron to target some transcripts to neurites, opening the possibility of a local regulation of 
translation. In fact, it is well known that mRNAs encoding for crucial elements involved in synaptic 
plasticity like CaMKIIα and MAP2 are actively transported in dendrites (Bruckenstein et al, 1990; 
Burgin et al, 1990; Garner et al, 1988; Kleiman et al, 1990) as well that ribosomes are present at the 
base and neck of dendritic spines, together with several other translational machinery elements 
(Steward & Banker, 1992; Steward & Levy, 1982). It is therefore intriguing to speculate that local 
synaptic transmission could independently modulate  protein expression at post-synaptic sites, 
resulting in a “molecular signature“ that confers a unique identity to each synapse depending on the 
set of mRNA represented and the experienced stimuli. 
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2  TRANSPORT OF MRNA IN DENDRITES 
 
2.1 First studies  
Before 80’s, one of the major dogmas of neurobiology was based on the assumption that  the  
protein synthesis machinery was present only at the level of cell soma, assuming that the proteins 
required in distal compartments like dendrites and axons would be first synthesized in the perykarion 
and from here transported at their final destinations (Peters et al, 1976). According to this view, the 
complex functions and morphological  features of such highly polarized cells were exclusively driven 
by an extremely finely regulated process of protein transport along the cytoskeleton. However, this 
concept cannot explain many of the key features of central nervous system (CNS) neurons. These 
cells are able to maintain extremely  polarized structures very far from the cell soma, to continuously  
modify the strength of their connections and respond in a very fast and efficient fashion to several 
environmental stimuli. If the somatic transport to distal subcellular domains would be the principal 
route to drive proteins in neurites, it is easy to imagine how this phenomenon wouldn’t meet the 
constant high metabolic need of neuronal cells. In fact, this would be a high energy consuming 
process, and, as previously discussed, inefficient,  because  the whole transport could take a time 
longer than the mean cargo half-life. Moreover, the very distal synapses would experience serious 
difficulties in signalling their metabolic need to the cell soma. For this reason, Steward and colleagues 
hypothesized that RNAs, instead of mature proteins, might be transported at synaptic sites and there 
locally translated upon demand. This theory was indeed supported by the discovery of 
polyribosomes under the base of dendritic spines of hippocampal granule cells (Steward & Levy, 
1982), followed by the demonstration of the presence of several mRNAs in dendrites of hippocampal 
neurons (Davis et al, 1987).  The relevance of this finding gained further importance a couple of years 
later, when Merlie and co-workers discovered the presence of the acetylcholine (Ach) receptor 
mRNA at the neuromuscular junction (Merlie & Sanes, 1985), followed  by the discovery of  dozens of 
other transcripts in distal subcellular domains, as the Microtubule Associated Protein2 (MAP2) mRNA 
in neuronal dendrites (Garner et al, 1988).  
 
Of particular relevance was the characterization of one of the first dendritic targeting elements 
(DTEs) found in Myelin Basic Protein (MBP) mRNA (Ainger et al, 1997). It has been demonstrated that 
a small segment of 21 nucleotides, termed hnRNPA2 response element (A2RE) was necessary and 
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sufficient to drive MPB RNA localization in the myelin compartment. Later, the minimal binding 
sequence for hnRNPA2 was restricted to an 11 nt  fragment, that is shared with many other localized 
mRNAs as myelin-oligodendrocyte basic protein or the  α subunit of Ca++ Calmodulin Kinase II 
(CaMKIIα), neurogranin (NG), Arc and PKMζ (Burgin et al, 1990; Gao, 1998; Gould et al, 1999; 
Muslimov et al, 2004). Later on, many other transcripts have been discovered in distal dendrites, as G 
protein γ subunit (Watson et al, 1994), InsP3 receptor (Furuichi et al, 1993), Brain Derived 
Neurotrophic Factor (BDNF) and its receptor Tropomyosin Related Kinase (TrKB) (Tongiorgi et al, 
1997), β-actin (Eom et al, 2003; Tiruchinapalli et al, 2003), vasopressin (Mohr et al, 2001b), the AMPA 
receptor subunit GluR2 (Ju et al, 2004) and many others. 
 
In the first pioneer studies on MBP localization in living oligodendrocytes, Ainger and 
colleagues found out that microinjected MBP mRNA  first appears in a dispersed form into the 
perykarion, before being packaged in RNA transport granules that anchor to the cytoskeleton to 
move towards the periphery of the cell (Ainger et al, 1993). In this compartment, however, RNAs 
appear to be again widely dispersed, probably because some of them maintain the granular structure 
whilst others unpack to be ready for translation. Moreover, it has been demonstrated that also 
endogenous MBP RNA is transported along the microtubule network in the form of RNA transporting 
granules that exhibit different movement velocities, depending on the subcellular compartment 
(Ainger et al, 1993). These observations where further confirmed in neuronal dendrites a couple of 
years later by Knowles and coworkers, where mRNA transport particles (mRNPs) were directly 
labelled through the membrane permeable dye SYTO14 (Knowles et al, 1996). Those particles were 
found to colocalize with poly(A
+
)mRNAs, the 60S ribosomal subunit and with eEF1α, suggesting that 
they actually could represent a potential translational unit. As seen in oligodendrocytes, neuronal 
RNA granules moved at different rates depending also on the age of the cells analyzed, displaying 
anterograde and retrograde movements  that were completely abolished after treatment with 
microtubule-disrupting drugs.  
 
The results obtained by Ainger, together with the evidence collected by Knowles and co-
workers strongly  supported the idea that RNAs might be localized in processes in a tightly regulated 
and ordered way, thanks to this cellular trafficking system. Many descriptions of RNA granules in 
neurons have been performed by in situ hybridization techniques, suggesting that many different 
RNAs could be present at the same time in the same structure (Blichenberg et al, 1999; Knowles et al, 
1996). RNA granules can be seen as discrete units in the dendritic compartment, but they are also 
present in the somata where are less distinguishable because of their high density. Furthermore, it 
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became increasingly clear that this transporting system is evolutionary conserved since it has been 
adopted by a very variety of cells, from oocytes (Kloc & Etkin, 1995), to fibroblasts (Sundell & Singer, 
1990), budding yeasts (Bertrand et al, 1998) and Drosophila embryos (Ferrandon et al, 1994). 
 
At this point, one crucial question has been raised: is it just a passive diffused transport or is 
there a specific mechanism to drive RNA localization in the periphery of the cell? Several lines of 
evidence supported the latter possibility. First, a growing body of evidence described the presence of 
dendritic targeting elements among many localized mRNA, as in the 3’UTR of CaMKIIα (Blichenberg 
et al, 2001; Blichenberg et al, 1999; Mori et al, 2000), MBP and MAP2 mRNA (Ainger et al, 1997; 
Blichenberg et al, 1999), β-actin mRNA (Kislauskis et al, 1994), the non coding BC1  (Muslimov et al, 
1997) or in the 5’UTR of VP mRNA (Mohr, 1999; Prakash et al, 1997). Second, synaptic activity and 
neurotrophin application have demonstrated to be able to modulate the transport  of mRNA 
containing particles (Knowles & Kosik, 1997; Righi et al, 2000; Steward et al, 1998). For example, 
induction of Long Term Potentiation (LTP) evoked a dramatic increase of CamKIIα transcript into the 
synaptic compartment (Thomas et al, 1994), as well as Arc mRNA and protein accumulation after 
local synaptic activation in hippocampal granule cells (Steward et al, 1998). Finally, mRNPs display 
heterogeneous velocities and directions of movement that are directly related to the activity of 
motor proteins (kinesins and dyneins) that govern the overall phenomenon of RNA transport along 
the cytoskeleton (Hirokawa et al, 1998; Hirokawa & Takemura, 2005; Kanai et al, 2004; Setou et al, 
2000; Severt et al, 1999). Starting from the first early studies up to the present observations, a 
complex framework has been put forward of how mRNAs are transported along neurites, involving a 
plethora of different elements, from RNAs, to trans-acting RNA binding proteins (RBPs), molecular 
motors and cytoskeletal elements. All these components are essential to guarantee an efficient and 
effective  mechanism for RNA delivery that is at the basis of the fine and fast adaptive neuronal 
responses  required to promote synaptic plasticity and indeed memory and learning.  
 
2.2 Cis-elements and trans-acting factors involved in mRNA trafficking 
2.2.1 Cis elements 
In many cell types and organisms, RNA localization is a regulated phenomenon mediated by 
the recognition of cis-targeting elements, present on RNAs, by trans-activating elements, i.e. RNA 
binding proteins. This interaction gives rise to the RNA transporting granules that anchor to the 
microtubules and are subsequently driven into specific subcellular compartments. Once granules 
have reached the final destination, they are either stored into translational silent units or are 
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promptly translated into proteins upon an adequate stimulus. In this section, the most important cis-
acting elements found up to now will be taken into consideration, with particular interest for 
neuronal targeting elements.  In most cases, cis-acting sequences, alternatively called “zipcodes”, 
localization or targeting elements, are found in the 3’UnTranslated Regions (UTRs). However, few 
important exceptions have demonstrated the presence of those signals even at the level of the 
coding region/Open Reading Frame (CDS/ORF) (Severt et al, 1999; Shan et al, 2003) or 5’UTRs 
(Muslimov et al, 2004; Muslimov et al, 1997; Steward & Banker, 1992). RNA localization elements 
(RLEs) are quite variable in terms of length, structure, position and type of cognate protein bound, 
resulting in a wide landscape of combinations that can lead to extremely specific pattern of RNA 
targeting. 
 
In chicken fibroblasts and myoblasts, β-actin mRNA is accumulated into the leading edge of the 
cell (Lawrence & Singer, 1986), a localization mediated by a 3’UTR 54nt long “zipcode “ later 
characterized by Kislauskis (Kislauskis et al, 1994) and known to be recognized by Zipcode Binding 
Protein 1 (ZBP1) (Ross et al, 1997). The same RLE is active in neuronal cells, where it mediates the 
distal localization of β-actin transcripts through the recognition of ZBP1 in immature chicken 
neuronal growth cones and mature rat neurons (Eom et al, 2003; Tiruchinapalli et al, 2003). The 
usage of same cis and trans acting factors between different cell types and organisms demonstrates 
how RNA localization is a widespread mechanisms that has been conserved during evolution, thus 
highlighting its biological importance. However, since  β-actin mRNA is restricted in the somata of 
avian retinal neurons but targeted in neurites of mammalian retinal cells, dendritic localization has to 
be considered as an evolutional “conquer” that might have been adopted later in evolution as the 
complexity of brain structures and functions (i.e learning and memory) were growing (Cristofanilli et 
al, 2004). 
 
A key molecule involved in synaptic plasticity is the α- subunit of Ca
++
-Calmodulin Kinase II that 
is highly enriched in post-synaptic domains, especially after local translation induced by intense 
neuronal activity (Bagni et al, 2000; Ouyang et al, 1999; Wu et al, 1998). The 3’UTR of its transcript is 
quite long and complex, and it has been found to contain several non-overlapping dendritic targeting 
elements (DTEs). Mori and co-workers found two signals, one in the first 28-56 nts of 3’UTR that 
promotes RNA dendritic sorting (also common to neurogranin mRNA, therefore called CNDLE, 
CaMKIIα Neurogranin Dendritic Localization Element) that in turn is counteracted by a downstream 
retention signal that blocks mRNA export in resting conditions, but is relieved after KCl induced 
depolarization (Mori et al, 2000). On the other hand, Blichenberg and co-workers have characterized 
  ANALYSIS OF THE MOLECULAR MECHANISMS OF BDNF MRNA  




a separate 1200nt long DTE that induces RNA dendritic sorting. Moreover, this complex transcript 
also contains two hexanucleotide Cytoplasmic Polyadenylation Elements (UUUUAU) (CPEs) that 
facilitate both mRNA transport and translational activation (Huang et al, 2003). Even if the UTRs 
contain several localization elements, it also possible to find them at the level of the open reading 
frame, as the ORF-3’UTR spanning vasopressin DTE (Prakash et al, 1997), or the Y element in  
CaMKIIα recognized by translin, a DNA/RNA binding protein (Severt et al, 1999). In protein kinase Mζ 
transcript, one DTE is positioned at the interface between 5’UTR and CDS, and mediates somatic 
export, while a second 42nt long  stem loop sequence is required for a full localization in neurites 
(Muslimov et al, 2004). The latter features a GA kink turn (K-turn) motif that has been described as a 
potential docking site for many RNA binding proteins (Klein et al, 2001). Another transcript that 
contains multiple targeting elements is MAP2, with one DTE recognized by MARTA1 and MARTA2 
trans-acting factors that promote mRNA sorting (Blichenberg et al, 1999; Rehbein et al, 2000; 
Rehbein et al, 2002), together with a CPE consensus site (Huang et al, 2003), both present in the 
3’UTR. However, like BDNF and CamKIIα, MAP2 mRNA displays a  sorting sequence in the CDS (A2RE, 
(Huang et al, 2003). In addition, also MBP mRNA features a bipartite DTE, consisting of a proximal 
dendritic targeting signal that is necessary and sufficient hnRNPA2 mediated targeting, and a highly 
structured downstream sequence that is required for mRNA anchoring and stabilization to the myelin 
compartment (Ainger et al, 1997). It is interesting to note that also the immediately early gene 
Arc/Arg3.1, that is strongly induced after neuronal activity (Link et al, 1995; Lyford et al, 1995), is 
predicted to be a hnRNPA2 target due to a homology A2RE sequence in its open reading frame 
(Huang et al, 2003). However, in a study performed by Kobayashi and colleagues, dendritic targeting 
of Arc mRNA in hippocampal neurons resulted to be mediated by two signals in its 3’UTR that 
displayed any sequence correlation to other known dendritic targeting signals (Kobayashi et al, 
2005). 
 
It is worth noting that the non coding BC1 RNA displays dendritic as well axonal localization 
thanks to a 62nt long targeting signal in its 5’UTR (Cheng et al, 1996; Muslimov et al, 1997; Tiedge et 
al, 1991). Even if much more attention has been paid to dendritically localized mRNAs, there are 
growing evidences demonstrating the presence in axons and axonal growth cones of few transcripts, 
like the ones encoding for κ-opioid receptor (KOR) (Bi et al, 2003), tau (Aranda-Abreu et al, 1999; 
Litman et al, 1993), neurofilament, enolase, olfactory marker protein, neuropeptides, tyrosine 
hydroxylase and oxitocyn (Jirikowski et al, 1990; Mohr et al, 1991; Mohr et al, 1992; Ressler et al, 
1994; Skutella et al, 1994). It is remarkable that those mRNAs are found during early developmental 
stages and in the axon hillock and growth cones of immature neurons, but are much rarer in mature 
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cells, suggesting their critical role in promoting and guaranteeing a proper development, maturation 
and differentiation of neurites (Bassell et al, 1998; Kindler et al, 2005; Mohr et al, 2001a). 
 
In conclusion, from the studies described above it emerges that mRNAs localized in neuronal 
processes might share common cis-acting elements that are recognized by a similar set of trans-
acting factors. On one side, this could represent a strategy to regulate at the same moment different 
transcripts that are necessary for common cellular functions, on the other, the combination of 
different targeting signals can exponentially increase the combination of trans-acting factors that can 
simultaneously bind to (or even compete for) the same transcript, increasing the complexity of 
subcellular regulation of mRNA transport and translation. 
 
2.2.2 Trans acting factors 
From their birth in the nucleus to their death, RNAs are constantly bound by a heterogeneous 
and dynamic set of proteins (trans acting factors) that regulate their metabolism including, 
maturation of the primary transcript (capping, splicing and polyadenylation), export into the 
cytoplasm and modulation of subcellular localization, control of mRNA stability/decay and regulation 
of translation. In this context, trans acting factors (TAFs) are defined  as proteins that support RNA 
metabolism through binding to cognate cis-acting sequences on RNAs (Kindler et al, 2005). 
 
hnRNPA2, among the “core” RBPS that accompany mRNAs from the nucleus to the cytoplasm, 
plays a leading role, especially in neuronal cells where localization of mRNAs represent a key 
mechanism to post-transcritpionally modulate the expression of  several gene product in response to 
a wide variety of extracellular stimuli. As already mentioned, hnRNPA2 modulates the subcellular 
targeting of several transcripts bearing a A2RE response elements, like CaMKIIα (Blichenberg et al, 
2001), MAP2 (Shan et al, 2003), Arc (Huang et al, 2003) in neurons, MBP in oligodendrocytes (Ainger 
et al, 1997; Huang et al, 2003; Munro et al, 1999) and GFAP in astrocytes (Carson et al, 2001; 
Medrano & Steward, 2001). hnRNPA2 binding to A2RE RNAs is necessary for their assembly in 
transporting granules and for exclusion of non-A2RE RNAs from those transport particles. In fact, a 
point mutation (A8G) on the cis recognition elements prevents A8G RNAs binding to hnRNPA2 and 
assembly into granules (Carson et al, 2001). Moreover, the homotypic interaction between hnRNPA2 
molecules could provide a driving force for granules assembly, bridging together different  mRNAs 
with common functions, providing a mean for a coordinate expression of gene products in the same 
subcellular compartment, as described above (Cartegni et al, 1996). 
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ZBP1, that interacts with β−actin mRNA, belongs to the family of RBPs that contains two RNA 
recognition domains (RRMs) and four hnRNPK domains (Bassell & Kelic, 2004; Yaniv & Yisraeli, 2002). 
Mutation of zipcode sequences disrupts neurotrophin induce targeting of β-actin mRNA at growth 
cones and reduces growth cone motility (Zhang et al, 1999) and reduced accumulation of transcripts 
at the leading edge of fibroblasts (Ross et al, 1997). The same effects are mimicked by 
downregulation of ZBP1 expression, while overexpression of ZBP1 target mRNAs leads to an increase 
density of filopodia in neuronal cells (Eom et al, 2003). 
 
MARTA1 and MARTA2 are two TAFs that bind with high affinity to the dendritic targeting 
element of  MAP2 mRNA (Rehbein et al, 2000; Rehbein et al, 2002), and belong to the FUSE binding 
protein family of RBPs (FBPs) (Duncan et al, 1994; Min et al, 1997; Rehbein et al, 2002). MARTA1 is 
the rodent ortholog of human KH-type splicing regulatory protein (KSRP) and belongs to a 
macromolecular complex involved in neuronal splicing regulation (Gu et al, 2002; Min et al, 
1997)(Min et al., 1997). On the other side, ZBP2, the avian ortholog of MARTA1 is involved in β−actin 
mRNA sorting in fibroblasts and neurons (Gu et al, 2002). Moreover, MARTA2/FBP3, in contrast to 
MARTA1/ZBP2, resides in the somatodendritic compartment and when overexpressed partially co-
localizes with recombinant zipcode containing RNAs, while a truncated form severely interferes with 
MAP2 mRNA dendritic localization (Kindler et al, 2005). 
 
Translin, also known as Testis-Brain RNA Binding Protein (TB-RBP) is a DNA/RNA binding 
protein able to bind the Y element found in some localized transcripts, like ligatin, CaMKIIα, 
protamine2 (Chiaruttini et al, 2009; Kwon & Hecht, 1991; Severt et al, 1999). Translin binds to 
microtubules and interacts in a specific manner with both ssDNA and RNA sequences (Han et al, 
1995; Kwon & Hecht, 1991). In testis, Translin is involved in maintenance of the translational 
suppression state of germ cell mRNAs (Kwon & Hecht, 1991; Kwon & Hecht, 1993) and in mRNA 
transport along the intracellular bridges of male germ cells (Hecht, 1998; Morales et al, 1998). 
Translin is therefore a multitasking protein exerting different functions depending on the cell type 
and the nucleotide sequence bound, resulting in either suppression of protein translation (Kwon & 
Hecht, 1993), RNA transport (Kobayashi et al, 1998; Severt et al, 1999) or even cell cycle regulation 
and DNA repair (Castro et al, 2000; Erdemir et al, 2002). 
 
Staufen, is a double strand RNA binding protein that has been identified as a MAP2 interacting 
factor (Monshausen et al, 2001). In Drosophila’s oocytes and neuroblasts, Staufen is essential for the 
localization of bicoid, prospero and oskar transcripts and the subsequent determination of body axis 
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(Bashirullah et al, 1998). Two Staufen homologs, Staufen1 and Staufen2 have been found in 
mammals, with the former expressed in most body tissues and the latter exhibiting a prominent 
neuronal expression. Both isoforms have been found in neuronal dendrites, associated with mRNA 
transporting granules and interacting with the microtubule network (Duncan et al, 1994; 
Monshausen et al, 2001). Even if the cis-element recognized by Staufen is still unknown, it seems to 
be able to bind any structured RNA in vitro, but its binding specificity in vivo seems to be quite 
remarkable (Mohr & Richter, 2003). Biochemical fractionation analyses led to the isolation of high 
density granules containing ribosomal aggregates (Krichevsky & Kosik, 2001) that were also positive 
for Staufen. A couple of years later,  Mallardo and colleagues have purified Staufen form two set of 
different mRNPs: one was enriched in ribosomes and endoplasmic reticulum markers, whilst the 
other was devoid of these structures and was enriched in kinesin heavy chain  and the non coding 
BC1 transcript, a known translational repressor (Mallardo et al, 2003). Therefore, it seems that 
Staufen is present in different RNA transporting granules with different translational competences. 
The driving force that promotes inclusion in these structures is still not understood, since it could be 
due to the identity of the mRNA bound by Staufen or its ability to interact with different sets of 
proteins that in turn characterize silent RNA transporting granules or translationally competent units. 
 
CPEB1-4,  or Cytoplasmic Polyadenylation Element Binding proteins 1, 2, 3, 4 constitute a 
family of 4 related proteins, involved in regulation of both mRNA transport and repression/activation 
of translation in many different cell types. All CPEBs, in both vertebrates and invertebrates, display a 
similar structure, mainly composed by two RNA Recognition Motifs (RRMs) and two zinc-finger 
domains in their carboxy-terminal ends (Huang et al, 2006). However, despite these similarities, a 
sequence comparison between the RNA-binding regions suggested that CPEB1 has different binding 
preferences and affinities than CPEB2-4 (Mendez & Richter, 2001). In fact, the canonical CPE is 
recognized by CPEB1 and not the other family members, that seem rather to bind to secondary U-
rich structures (Huang et al, 2006).  The CPE response element (UUUUAU), the cis-binding sequence 
for CPEB1, has been found in many dendritic transcripts (Huang et al, 2003; Wells et al, 2000; Wu et 
al, 1998) and in Xenopus’ oocytes transcripts as well (Groisman et al, 2000; Hake & Richter, 1994). In 
Xenopus, a single CPEB binds several mRNAs and contributes to keep them in a translationally 
dormant state and, together with other factors, becomes essential for the poly(A) tail elongation that 
is fundamental for translation initiation (Mendez & Richter, 2001). The induction of polyadenylation 
requires the site specific phosphorylation of CPEB, that in turn recruits the Cleavage and 
Polyadenylation Specificity Factor (CPSF) and PolyA polymerase (PAP) that finally mediates poly(A) 
tail elongation and activation of protein synthesis. Under resting conditions, Maskin interacts with 
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both CPEB and eukaryotic initiation factor 4E (eIF4E), inhibiting translation activation via blockade of 
eIF4E-eIF4G interaction. However, after CPEB phosphorylation and poly(A) elongation, Maskin 
dissociates from this complex allowing the small ribosomal subunit to bind to the mRNA and initiate 
protein synthesis (Mendez & Richter, 2001). A similar mechanisms operates in neurons, where 
CPEB1, the best known family member, regulates CaMKII translation induced by experience 
dependent synaptic activity, which triggers a net increase in CaMKIIα polyadenylation, promoting the 
local translation of this plasticity related transcript (Huang et al, 2002).  
 
PolyA binding protein (PAP) is necessary for poly(A) tail stabilization and binds in multiple 
copies to extended tails increasing translation efficiency through interaction with the initiation 
factors bound to the 5’ of mRNA (Preiss et al, 1998). Interestingly, PAP is able to bind also to 
sequences different than poly(A) tails, suggesting other function beyond poly(A) tail stabilization. In 
fact, PAP can exert translational repression on its own transcript by binding to the 5’UTR (Bag & Wu, 
1996; de Melo Neto et al, 1995) and also by recognition of an inhibitory element on viral HIV p17
gag
 
mRNA (Afonina et al, 1997).  
 
ELAV proteins are the orthologues of Drosophila Embryonic Lethal Abnormal Vision,  also 
known also as Hu paraneoplastic antigens in humans, and play fundamental roles in development, 
regulation of mRNA stability, splicing and translatability. This family of proteins consists in four 
members, HuR (ELAVL1), that is widely expressed in all tissues, and HuB (Hel-N1/ELAVL2), HuC 
(PLE21) and HuD that are all neuronal specific isoforms, with the exception of HuB that is present 
also in gonads (Dalmau et al, 1992). Each ELAV/Hu displays three classic RRMs, where RRMs 1 and 2 
bind to AREs while RRM3 contributes to increase binding affinity and is probably involved in poly(A) 
tail recognition or protein-protein interactions. In addition to the RRMs, each ELAV/Hu protein 
presents a unique hinge region that might mediate the back and forth shuttling form the cytoplasm 
to the nucleus. ELAV/Hus share an overall 90% of sequence identity among the different family 
members (Okano & Darnell, 1997). These proteins extensively bind to AU an U rich sequences often 
present in 3’UTRs,  preventing degradation and promoting mRNA stabilization (Chen et al, 2002; 
Chung et al, 1996; Levine et al, 1993; Ma et al, 1996; Myer et al, 1997), competing with many 
proteins for binding, like hnRNPD (or AUF1) (Barreau et al, 2005; Raineri et al, 2004; Zhang et al, 
1993), CUG-triplet RNA binding protein-1 (CUG-BP1) (Carballo et al, 1998; Vlasova et al, 2008), 
tristetraprolin (TTP) (Carballo et al, 1998). Besides a role into the cytoplasm, these proteins are 
known to control splicing and polyadenylation of several transcripts (Barreau et al, 2005; Zhu et al, 
2006). Moreover, they can regulate translation by direct binding to untranslated regions of  target 
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mRNAs like neurofilament M, Insulin Like Growth Factor I (IGF-IR), p27 and GLUT1 (Antic et al, 1999; 
Jain et al, 1997; Kullmann et al, 2002; Meng et al, 2005; Millard et al, 2000) or even by relieving the 
miRNA mediated repression of CAT-1 expression (Bhattacharyya et al, 2006). The broad spectrum of 
action of Hu proteins, together with their evolutionary conservation among organisms, suggest their 
prominent role in development and differentiation on nerve cells (Antic & Keene, 1997) so that they 
are considered among the earliest markers of neuronal differentiation (Marusich et al, 1994; 
Wakamatsu & Weston, 1997).  
 
FMRP (Fragile-X Mental Retardatin Protein) is a translational repressor whose misregulation 
can lead to a severe disorder, the Fragile X syndrome in which FMRP is no more expressed by virtue 
of an abnormal CGG triplet expansion in its 5’UTR that can lead to transcriptional gene silencing and 
loss of FMRP protein. The phenotype ranges from mild to severe mental retardation, autistic-like 
behavior and anxiety (Jacquemont & Taniguchi, 2007). In neurons, FMRP is present in somata, along 
dendrites and also at the base of dendritic spines as well as in growth cones and axons (Antar et al, 
2004; Antar et al, 2006; Feng et al, 1997; Ferrari et al, 2007; Price et al, 2006).  FMRP has been 
frequently found in RNA transporting granules, containing several other partner RBPs as well as non 
coding RNAs. As the majority of mRNPs, FMRP containing particles undergo to dynamic changes in 
their composition depending on the subcellular localization and activation state of the cell (Bagni & 
Greenough, 2005). In fact, FMRP can be detected either in large mRNPs cosedimenting with 
polysomes, or in small translationally silent units or even in stalled mRNP complexes (Ashley et al, 
1993; Brown et al, 2001). FMRP containing granules travel along dendrites by interaction with the 
microtubule network an kinesins motor proteins (Antar et al, 2004; Davidovic et al, 2007; Kanai et al, 
2004). Moreover, it has recently been demonstrated that FMRP-dependent mRNA transport is 
modulated by synaptic activity, at least for map1b, CaMKIIα and Sapap mRNA cargoes (Dictenberg et 
al, 2008). FMRP is able to bind to many neuronal transcripts (rewieved in(Bagni & Greenough, 2005) 
either  through recognition of a purine G-rich quartet (Darnell et al, 2001; Schaeffer et al, 2001), or 
the “kissing complex” (Darnell et al., 2005) or even U rich stretches (Chen et al, 2003). In addition, 
FMRP can indirectly bind to target transcripts through interaction with BC1 non coding RNA or 
microRNAs (Jin et al, 2004; Zalfa et al, 2005; Zalfa et al, 2003). It is now becoming widely accepted 
among the scientific community the fact that during transport most mRNAs are kept translationally 
dormant in order to avoid ectopic protein expression: it is therefore easy to understand why many 
RBPs involved in transport, like CPEB and FMRP are translational repressors as well. In particular, 
FMRP is thought to repress translation at multiple steps (i.e. initiation end elongation), since it is 
able, similarly to CPEB, to interact with an eIF4E binding protein, namely CYFIP1 (Cytoplasmic FMRP 
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Interacting Protein1) (Napoli et al, 2008). In resting conditions protein synthesis is repressed because 
of the inhibited interaction between eIF4E and eIF4G that is necessary to promote translation 
initiation. However, after synaptic activation, CYFIP1-FMRP complex dissociates from RNA and 
translation can eventually take place (Napoli et al, 2008). However, it has been recently 
demonstrated a positive role for FMRP in regulating Super Oxide Dismutase (SOD) mRNA translation 
via interaction with a novel RNA binding motiv called SoSLIP (Sod1 mRNA Stem Loops Interacting 
with FMRP). This motiv features an extremely complex secondary structure consisting in three stem 
loops that act as enhancers for FMRP dependent translation (Bechara et al, 2009). A recent study by 
Zalfa and colleagues reported a novel stabilizing function of FMRP with respect of PSD95 and MBP 
mRNAs (Zalfa et al, 2007; Zhang et al, 2007), that seems to counteract a parallel work of Zang and co-
workers, where FMRP was described as a negative modulator of Nfx1 transcript, promoting its decay 
(Zhang et al, 2007). 
 
From the complex scenery described above, it is evident that even if a cell expresses a limited 
number of cis-acting signals and trans-acting factors involved in RNA transport, the broad spectrum 
of signal  combinations coupled to the many different functions exerted by a single RBP contribute to 
create a unique scenario for a finely regulated mRNA localization and expression. 
 
2.3 RNA transporting granules: structure and functions 
As already mentioned, RNA transport in the periphery of the cell is mediated by mobile 
structures called RNA granules, initially discovered in hippocampal neurons through uridine 
radioactive labeling (Davis et al, 1987). Later, Knowles and colleagues deeply investigated this 
phenomenon by fluorescently labeling endogenous RNA transport particles in cultured neurons, 
showing their anterograde and retrograde movements that was consistent with the interaction with 
the microtubule network (Knowles et al, 1996). Moreover, they were described to contain 
translational machinery components such as elongation factors or ribosomes. A similar study was 
also performed in living oligodendrocytes where, through microinjection of fluorescently labeled 
MBP mRNA, dynamic RNA granules were observed, with heterogeneous sizes and movement 
behavior (Ainger et al, 1993). These observations strongly suggested that RNA granules are 
intermediate structures mediating RNA sorting in peripheral subcellular domains, and represented 
the cornerstone for subsequent studies focused on dissecting their molecular composition. A 
growing body of evidence supports the idea that RNAs are transported in heterogeneous structures 
with different compositions and functions: transport particles, RNA granules,  translating polysomes, 
stress granules, processing bodies (P bodies), microRNA/RNA silencing complex particles (Sossin & 
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DesGroseillers, 2006) (see table 1). In this paragraph we will only discuss the known differences 
between transport particles and RNA granules . 
 
• Transport particles: these structures transport mRNAs but are devoid of ribosomes, and 
contain (i) mRNAs, (ii) proteins required for translational suppression, (iii) specific RBPs, (iv) 
adaptors that connect RBPs with molecular motors. One of the best characterized transport 
particle is the one  mediating ASH1 mRNA localization in budding yeasts (Shepard et al, 2003). In 
neurons, the situation is less defined, since it has been only partially described the composition of  
RNA transporting particles. It is known that they may contain translational repressors like FMRP as 
well as many specific RNA binding proteins (Pur alpha, Staufen) and molecular motors (myosin Va, 
kinesins) (Mallardo et al, 2003; Ohashi et al, 2002). Conversely, many data are lacking about 
putative candidates for adaptors and anchoring molecules that would connect mRNPs to 
molecular motors. 
• RNA granules: RNA granules resemble to transport particles in their composition, except that 
they do contain ribosomes. In those structures mRNA are still translationally silent despite the 
presence of ribosomes, and are presumably blocked at the stage of elongation (Anderson & 
Kedersha, 2006). RNA granules have been first described in oligodendrocytes (Ainger et al, 1993; 
Barbarese et al, 1995), and later also in neurons, in the form of amorphous aggregates (Knowles & 
Kosik, 1997; Krichevsky & Kosik, 2001). The latter were found to contain ribosomal proteins and 
rRNAs and many elements of the translation machinery like arginyl-tRNA synthase, elongation and 
initiation factors (eEF1a, eEF2 and eIF2b) and many RNA binding proteins (Barbarese et al, 1995; 
Krichevsky & Kosik, 2001). Krichevsky and co-workers have furthermore demonstrated the 
absence of eIF4E and eIF4G, two fundamental elements to initiate protein synthesis, therefore 
corroborating the idea that RNA granules are translationally silent units. However, after KCl 
induced depolarization, RNA granules appear to open to release RNAs and translation factors for 
their subsequent association with polysomes engaged in protein translation (Krichevsky & Kosik, 
2001). Two extensive studies independently performed by Kanai ad Elvira have characterized the 
protein content of RNA granules based in the association with KIF5 kinesin and on subcellular 
fractionation from embryonic brain, respectively (Elvira et al, 2006; Kanai et al, 2004). Kanai and 
colleagues isolated large detergent-insensitive RNA complexes tightly associated with 
microtubules via KIF5 anchoring,  enriched in Arc and CaMKIIα mRNAs, together with at least 42 
different RNA binding proteins. Among these, particular attention has been paid to the most 
abundant ones, as Purα and Purβ, both involved in RNA transport (Kelm et al, 1997), Dead Box 
Helicases 1 and 3 (DDX1, DDX3) (Godbout & Squire, 1993; Sowden et al, 1995), NonO (Yang et al, 
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1993), PSF (polypyrimidine tract binding protein-associated splicing factor) (Chanas-Sacre et al, 
1999), TLS (Yang et al, 1998), SYNCRIP (Mizutani et al, 2000), ALY (Bruhn et al, 1997) and hnRNPU 
 
Table 1. Protein composition of the different RNA particles discussed (from Sossin and DesGroseillers, 2006) ND, not 
determined 
 
(Kiledjian & Dreyfuss, 1992). Moreover, those granules contained FMRPs, Staufen, eEF1a and two 
functionally unknown proteins, HSPC117 (Zhang et al, 2000) and CGI-99 (Lai et al, 2000). Systematic 
silencing induced by siRNAs allowed to  identify key components necessary for CamKIIα 
localization, i.e. Purα, hnRNPU, PSF and Satufen1 (Kanai et al, 2004). On the other hand, the studies 
of Elvira et al. (2006) and Kanai and colleagues (2004) described only  a partially overlapping set of 
proteins, that could be either due to the techniques adopted in the two studies or the fact that 
Elvira started from embryonic brain tissue while Kanai used mature cortex. The proteomic analysis 
made by Elvira led to the identification of many ribosomal (61 out of 64) and microtubule 
associated proteins, a large set of RNA binding proteins with a prominent enrichment in β-actin but 
not  CamKIIα mRNA. Notably, many of the identified proteins were previously described in RNA 
transporting granules, like hnRNPs (hnRNPA1, SYNCRIP, hnRNPD, hnRNPA2/B1) (Kanai et al, 2004; 
Shan et al, 2003), DDXs (Kanai et al, 2004) and other RNA binding proteins like Staufen, nucleolin 
and RNG105 (Kanai et al, 2004; Shiina et al, 2005). This study was groundbreaker also for the 
identification of novel RNA granule associated peptides, like hnRNPC, eIF4A, ZBP2,CYFIp2, ELAV-like 
proteins, PABP and many others (Elvira et al, 2006). It is noteworthy that two well-known granule 
components, like FMRP and Purα, have  not been purified in this second study, probably, as 
mentioned above, because of technical reasons. However, both studies showed the presence of a 
 P bodies Stress 
granules 




Staufen 1 Yes Yes ND Yes Yes Yes 
Staufen 2 ND Yes ND Yes Yes Yes 
Ddh1/Rckp54/DEAD box6 Yes Yes ND ND Yes ND 
Decapping enzymes Yes No ND No No ND 
G3BP No Yes ND Yes Yes ND 
EIF4E Yes Yes ND Yes No Yes 
CPEB Yes Yes ND ND ND Yes 
ZBP ND ND ND ND Yes Yes 
FMRP Yes Yes Yes Yes Yes Yes 
TIA-1/R Yes Yes No No No No 
Pumilio No Yes ND ND ND Yes 
Poly(A)-binding protein No Yes Yes Yes Yes Yes 
Small ribosomal proteins No Yes Maybe Yes Yes No 
Large ribosomal proteins No No Maybe Yes Yes No 
Argonaute ND Yes Yes ND ND ND 
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novel protein, CGI-99, whose function is still poorly understood but has been proposed as a 
candidate for being one of the adaptors necessary for the formation of RNA transporting units 
(Sossin & DesGroseillers, 2006). 
 
Several groups have studied the dynamics of transport of RNA containing granules in cultured 
neurons, especially through live imaging techniques (Dynes & Steward, 2007; Huang et al, 2003; 
Knowles et al, 1996; Tiruchinapalli et al, 2003; Zhang et al, 2001). It has emerged that granules are in 
most cases stationary, while a minor fraction displaying oscillatory movements, as well as 
anterograde and retrograde movements with very different velocities, with a mean of 4-6 µm/min 
(Knowles & Kosik, 1997; Knowles et al, 1996; Muslimov et al, 1997). This heterogeneity could be due 
to the set of proteins bound to the transcripts, as well as to the nature of molecular motor driving 
the subcellular translocation. In a study performed by Rook and coworkers, neuronal activity 
increased the transport of CaMKIIα mRNA, probably due by a shift from the oscillatory population of 
granules to the anterogradely moving ones (Rook et al, 2000). Moreover, also the translocation of 
ZBP1 containing particles in influenced by neuronal depolarization and NMDA receptor activation 
(Tiruchinapalli et al, 2003). As a general rule, microtubule and microfilaments represent a “railway”  
onto which RNA transporting particles are anchored and allow back and forth long range movements 
along neurites (Bassell et al, 1994), due to the mixed  polarity of microtubules in proximal dendrites 
(Baas, 1998). In distal dendritic compartment, at the opposite, the cytoskeleton is mainly composed 
by actin filaments and unipolar microtubules with their plus end directed away from the soma 
(Burton & Paige, 1981). This peculiar organization may serve to organize and regulate the dynamic 
short range transport processes that occur at synapses.  
 
Molecular motors employ the energy derived by ATP hydrolysis to drive macromolecular 
cargoes to and from the periphery of the cell. They can be divided into non conventional myosins, if 
binding to actin filaments, or in kinesins/dyneins if binding to microtubules. In general, kinesins 
promote plus end directed movements whilst minus ended transport is governed by dynein motors 
(Hirokawa & Takemura, 2005). All kinesins have in common a globular motor domain, a microtubule 
interacting domain and an ATP-binding pocket. Apart these conserved regions, the aminoacidic 
sequence between members is quite variable, thus explaining the ability of transporting different 
cargoes, also mediated by interaction with different adaptor proteins (Hirokawa & Takemura, 2005), 
fig.1).  
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Fig.1. Kinesin superfamily and cargoes for dendritic and axonal transport (reproduced from Hirokawa and Takemura, 2005). 
A) overview on microtubule network  and transport machinery organization. Axonal (a) and dendritic (b) specific KIFs and 
relative cargoes. 
 
In dendrites, Kinesin 17 (KIF17) mediates the anterograde transport of NR2B subunit of AMPA 
receptors. Interestingly, it has  been demonstrated that these two genes are contextually co-
regulated, and overexpression of KIF17 in mouse models increases episodic-like memory and spatial 
learning (Guillaud et al, 2003; Wong et al, 2002). On the other side, it seems that AMPA receptors 
steer KIF5A,B and C in dendrites through interaction with the adaptor protein GRIP (Setou et al, 
2002). The proteomic study performed by Kanai has also demonstrated that KIF5s are able to 
transport in dendrites huge ribonucleoparticles containing CamKIIα and Arc mRNA that actually 
represent RNA transporting granules (Gu et al, 2003; Kanai et al, 2004). We have also to remember 
that molecular motors play important roles not only in dendrites, but in axons as well, where many 
membranous organelles are sorted from the cell soma to the axonal periphery. These cargoes include 
ion channels (Garrido et al, 2001; Gu et al, 2003), adhesion molecules (Vogt et al, 1996), synaptic 
vesicles  and even mitochondria (Kanai et al, 2004; Nangaku et al, 1994) 
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3  mRNA TRANSLATION IN DENDRITES 
 
3.1 Dendritic localization of protein translation machinery 
   The first ideas about a possible local protein synthesis in neuronal dendrites came from 
studies performed by Bodian and colleagues describing the presence of ribosomes in distal dendrites 
(Bodian, 1965). Those findings were later confirmed by electron microscopy studies on central 
nervous system neurons, supporting the  existence of ribosomal aggregates under the base of 
dendritic spines (also known as SPRC, synapse-associated polyribosome complexes) (Palacios-Pru et 
al, 1981; Spacek, 1985; Steward & Levy, 1982). Polyribosomes have been found in more than 75% of 
visual cortical spines and at the base of spines of CA1 and dentate gyrus neurons, but less frequently 
in spine heads (Spacek, 1985; Steward & Levy, 1982). Further studies have also shown that most of 
the ribosomes beneath the base of spines are associated with membranous cisterns in a RER-like 
distribution, whilst the ones inside the spine head are barely associated with such structures 
(Steward & Reeves, 1988). This peculiar distribution is also dramatically pronounced during 
denervation-induced synaptogenesis (Steward, 1982; Steward & Fass, 1983) and could then 
represent a molecular marker for newborn synapses (Steward & Falk, 1986). On the other side, when 
considering  other synapses not associated to spines, either excitatory or inhibitory, ribosomes are 
often located beneath the post-synaptic membrane (Steward et al, 1996). From this scenario, 
independently form the specific neuron considered, it clearly emerges that ribosomes are an 
ubiquitous element of the post-synaptic cytoplasm. Further studies have characterized the synaptic 
micro-environment, finding also the presence of several other elements belonging to the protein-
translation machinery including, transfer RNAs (tRNAs), aminoacyl-tRNA-synthases, elongation and 
initiation factors (in particular, eEF2 and eIF2β), together with elements of the cotranslational 
protein sorting machinery like TRAP (a component of the translocation complex in RER membranes), 
the Signal Recognition Particle (SRP) (Tiedge & Brosius, 1996) and several other markers of rough 
endoplasmic reticulum like ribophorin I (Torre & Steward, 1996). In the latter work, Torre and 
Steward have elegantly demonstrated the existence of RER and Golgi Apparatus (GA) associated 
glycosil-transferase activities in severed dendrites, together with the presence of several RER and GA 
markers in proximal and distal neurites (Torre & Steward, 1996). Moreover, it has been shown that  
some membranous formations in proximal dendrites are enriched in α-mannosidase II and β-
galactosidase, two Golgi resident enzymes (Eckstein & Shur, 1989; Lopez et al, 1989; Moremen et al, 
1991).  
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A regional specialization of the endoplasmic reticulum is the spine apparatus (SA), a complex 
organelle composed of stacks of smooth endoplasmic reticulum (SER) tightly packed with densely 
stained material, almost localized into the spine neck. Even if its function is not fully understood, the 
spine apparatus seems to be involved in synaptic plasticity through the modulation of local calcium 
homeostasis and post-translational regulation of protein synthesis (Jedlicka et al, 2008). In fact, 
synaptopodin deficient mice lacking of a functional SA show deficits in spatial learning (Jedlicka et al, 
2008). Interestingly, the spine apparatus has been recently hypothesized to be involved in receptor 
synthesis and/or trafficking and, more generally, to be part of the secretory pathway for membrane 
bound proteins  (Deller et al, 2007; Steward & Schuman, 2001). Since both AMPA and NMDA 
receptors have been localized in the SA (Nusser et al, 1998; Racca et al, 2000) and since the latter is 
also a local reservoir/source of calcium, it is tempting to speculate its fundamental role in synaptic 
plasticity and therefore memory formation. 
 
An important progress in understanding the mechanisms of regulation of local protein 
synthesis has been made thanks to a molecular dissection of the putative transduction pathways 
associated to synaptic plasticity events, in particular the (i) MAPK-Mnk-eIF4E, (ii) p70S6K-S6 
ribosomal protein, (iii) PI3-kinase-PDK-Akt - mTOR- 4EBP and (iv) eEF2 kinase /CaMKIII-eEF2 
pathways (Asaki et al, 2003). All the proteins involved in these cascades have been detected in 
proximal and distal dendritic compartments, thus indicating that the very same pathways controlling 
somatic protein translation are also present in the periphery of the cell, that can be therefore fully 
considered as an independent cellular domain capable of autonomous protein synthesis .  
 
Researchers have been looking for a proof of local protein synthesis in dendrites since late 
‘70s, when radiolabelled leucine spots were identified in distal hippocampal dendrites after  
ventricular injection (Kiss, 1977) or with the documented increased rate of protein precursors 
inclusion during reinervation processes (Fass & Steward, 1983). Later on, (Torre & Steward, 1992) 
demonstrated the incorporation of 
3
H-leucine in dendrites that were severed from the cell body, in 
order to rule out any contaminating protein transport from the cell soma. Similarly, transfection of 
an in vitro transcribed RNA led to the expression of the reporter gene even in dissociated MAP2 
positive neurites (Crino & Eberwine, 1996), consistent with the elegant experiments carried by 
Aakalu and coworkers, showing that in the same situation a dendritically targeted GFP reporter could 
be expressed after treatment with growth factors (Aakalu et al, 2001). On the other side, several 
reports certificate that in vitro isolated synaptoneurosomes are able to synthesize proteins as well 
(Weiler & Greenough, 1991; Weiler & Greenough, 1993), as a proof that synaptic subcellular 
  ANALYSIS OF THE MOLECULAR MECHANISMS OF BDNF MRNA  




compartments do contain all the elements required to autonomously produce functional proteins on 
demand. This feature is fundamental for the induction and maintenance of long term forms of 
synaptic plasticity that differ from the short term ones relying only on post-translation  modification 
of pre-existing proteins (Richter & Lorenz, 2002).    
 
3.2 Translational control mechanisms 
The contemporary presence of many components of the translation apparatus and post-
translation modification machinery suggest that dendrites are actually equipped with key factors 
necessary to synthesize proteins independently from the cell soma, hence conferring long term 
translation regulatory competences to each single dendritic microdomain. The consolidation and 
maintenance of long term memories, but not short term ones, require synthesis of new 
macromolecules, particularly proteins (Bliss & Collingridge, 1993; Malenka & Nicoll, 1999). At the 
cellular level,  synaptic plasticity is defined as long term modifications in the strength of synaptic 
transmission in response to different extracellular and environmental stimuli (Gladding et al, 2009). 
Long Term Potentiation (LTP) and Long Term Depression (LTD) in vertebrates and Short and Long 
Term Facilitation (STF, LTF) in invertebrates are widely accepted models to measure the strength of 
synaptic changes that underlie synaptic plasticity (Malenka & Bear, 2004). In particular, LTP, that has 
been used as a paradigm of learning, shares some cellular and molecular mechanisms characteristic 
of memory formation (Lynch, 2004; Neves et al, 2008). For example, LTP can be temporarily 
subdivided into three distinct phases: Early LTP (E-LTP or LTP1) lasting 1-3 hours, that relies on post-
translational modification of pre-existing synaptic proteins and is protein synthesis independent, 
Intermediate LTP (I-LTP or LTP2) that is dependent on new protein but not mRNA production and 
lasts 1-3 hours. Finally, Late-LTP (L-LTP or LTP3) is the persistent form of LTP (from hours to weeks) 
and is dependent on both mRNA transcription and protein synthesis (Adams & Dudek, 2005; 
Raymond, 2007). Likewise, facilitation can be induced in Aplysia sensory neurons by serotonin 
application, evoking either post-translational modification of pre-existing proteins (STF) or new 
protein synthesis (LTF) (Kandel, 2001). From this scenario it is intuitive to understand how important 
is the local control of protein translation, that can deeply influence the strength of synaptic 
transmission through a regulated temporal and spatial modulation of protein expression. In 
eukaryotes translation takes place in three different steps: initiation, elongation and termination. 
Initiation is without any doubt the rate limiting step of the entire process involving at least 12 
different initiation factors, and is therefore one of the major targets for translational control. 
Translation initiation requires (i) formation of the 43S ternary complex, (ii) recognition of the target 
mRNA to the 43S complex and (iii) formation of the 80S ribosomal complex (fig.2). The first step in 
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turn needs the arrangement of the so-called ternary complex (eIF2-GTP-tRNAi
Met
) that further binds 
to the 40S ribosomal subunit to form the 43S preinitiation complex (i). The assembly of the ribosome 
on the mRNA (ii) requires either the recognition of the 5’ cap structure (m
7
GpppX) present on all 
nuclear transcribed mRNAs or of an internal ribosomal entry site (IRES), a structured element in the 













Fig.2. Assembly of the translational initiation complex in eukaryotes (reproduced from (Klann & Dever, 2004). For detailed 
explanation see text. 
 
 A key factor involved in cap-dependent translation is eIF4F, composed by eIF4A (an ATP-
dependent RNA helicase that unwinds secondary structures), eIF4E (the cap binding protein) and 
eIF4G (a large scaffold protein that bridges the mRNA to the 43S ribosomal subunit) (Gingras et al, 
1999). Once bound to the mRNA, the 43S subunit starts scanning the 5’UTR searching for the AUG 
initiation codon in a 5’-3’ direction, whose selection is affected by several factors (eIF1, eIF2 and 
eIF3) that prevent joining to the 60 subunit. eIF5, a GTPase activating protein (GAP) promotes eIF2 
release through stimulation of eIF2-bound GTP hydrolysis, thus allowing the 60S subunit to join to 
the small 40S complex (Pestova et al, 2008). At this point, the elongation factors are recruited for the 
peptide chain elongation. eEF1A is a GTPase needed for the  tRNA to entry in the ribosome, while 
eEF1B is a guanine nucleotide exchange factor (GEF) for eIF1A. eEF2 then promotes the translocation 
of the ribosome on the mRNA once the peptide bond has been formed. Finally, upon recognition of 
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the stop codon, termination factors catalyze the release of the polypeptide form the ribosome, 
allowing a new round of translation to take place. 
In general, global translational control mechanisms in most cases involve 5’UTRs whilst mRNA 
specific regulation requires  the recognition of specific cis acting sequences located in 3’UTRs (with 
some exceptions), as previously discussed. In the next sections we will give a  panoramic view of the 
possible mechanism of translation regulation acting at 3’UTR ends, with particular attention to 
synaptic implications. 
 
3.2.1  Translational control mechanisms acting at 3’UTR 
Many of the translational control mechanism acting at 3’untranslated regions involve the 
recognition of cis-acting sequences by specific trans-acting factors that can either promote or repress 
translation. Notably, many of these regulators are actually RNA binding proteins that, as discussed 
above, can exert a dual role in transporting and regulating mRNA expression through interaction with 
5’UTR binding factors.  
 
• RNA binding protein mediated translational control 
A well known mechanism of translational regulation is mediated by CPEB, a sequence specific 
RNA binding protein that governs both mRNA sorting in dendrites as well as translational repression 
of dormant mRNAs and activity dependent polyadenylation, that in turn promotes translational 
activation (Huang et al, 2003; Wu et al, 1998). Translational repression is exerted by the interaction 
of CPEB with Maskin (or its orthologue neuroguidin) that build a complex with two other additional 
proteins, the poly(A) polymerase Gld2 and the poly(A) ribonuclease PARN that are hold together with 
the scaffolding protein symplekin (Barnard et al, 2004). Maskin contains an eIF4E binding domain 
similar to the eIF4G binding pocket, and therefore acts as a mRNA specific 4EBP, thus inhibiting the 
assembly of the eIF4F complex and translational initiation (Stebbins-Boaz et al, 1999). Moreover, 
since in resting conditions the deadenylase is more active than GLd2, it contributes to translational 
repression by maintenance of a short poly(A) tail (Kim & Richter, 2006). Synaptic activation promotes 
Aurora A kinase- and CaMKIIα-dependent phosphorylation of CPEB, that in turn promotes the 
dissociation of maskin and PARN, recruits CPSF and PAP/Gld2 for poly(A) tail elongation and 
translational activation  (Atkins et al, 2004; Huang et al, 2002; Mendez & Richter, 2001). Another 
example of message specific 4EBP is Cup in Drosophila embryo. Here, Smaug binds to the 3’UTR of 
unlocalized Nanos mRNA and through interaction with Cup, that sequesters eIF4E, inhibits eIF4F 
complex formation (Nelson et al, 2004). A very similar mechanism involving Cup represses also oskar 
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mRNA translation in the anterior pole of Drosophila oocytes, by interaction with the RBP Bruno 
(Wilhelm et al, 2003).  
 
In neuronal cells, an important translational repressor is FMRP that is thought to regulate the 
expression of several target mRNAs (Laggerbauer et al, 2001; Li et al, 2001). The exact mechanism 
through which FMRP regulates protein synthesis is not fully understood, however several different 
models have been proposed. One posits that FMRP modulates their targets via interaction with the 
non coding RNA BC1 (Zalfa et al, 2003). This interaction may either increase FMRP affinity for its 
target  or enhance BC1 dependent eIF4A inhibition, repressing the expression of mRNAs carrying 
highly structured 5’UTRs (Lin et al, 2008; Wang et al, 2002). Furthermore, it has been recently 
proposed that FMRP dependent repression relies on the interaction with a novel neuronal 4EBP, 
CYFIP1/Sra-1 (Cytoplasmic  FMRP Interacting Protein 1) (Napoli et al, 2008). Similarly to CPEB/maskin, 
FMRP/CYFIP interaction blocks translation initiation by competition with eIF4G for eIF4E binding, 
even if through a non canonical 4E binding domain. CYFIP repression can be relieved after activation 
of signaling cascades mediated by BDNF or DHPG (Dihydroxyphenylglycine), a phenomenon related 
to initiation of protein synthesis (Napoli et al, 2008). On the other side, an additional model has been 
proposed, in which FMRP interferes at post-initiation steps, since it has been found to be associated 
with functional polyribosomes (Stefani et al, 2004). In particular, phosphorylated FMRP is found in 
stalled ribosomal fraction, whilst the nonphoshorylated version is tightly associated with actively 
translating polyribosomes (Ceman et al, 2003). FMRP can be modified by S6K1 on a conserved serine 
residue that is fundamental for mRNA binding (Narayanan et al, 2008). In both FMRP and S6K1 
knock-out mice the levels of SAPAP3, a FMRP target, are increased, suggesting that S6K1 mediated 
phosphorylation of FMRP is necessary for its inhibitory activity. Many other RBPs seem to be involved 
in translation repression of transported mRNAs. Among these, the repressor RNG105 helps 
maintaining transcripts translationally silent during mRNA sorting (Shiina et al, 2005). In addition, 
hnRNPK and E1 have been described to block protein translation at post-initiation steps. In detail, 
they bind the differentiation control element (DICE) in the 15-lipoxygenase (LOX) mRNA 3’UTR. This 
cis acting sequence consist in several tandem repeats of the CU dinucleotide, that, when bound to 
hnRNPK and E1, prevents the assembly of the 80S ribosomal complex, possibly through interference 
with some still unidentified initiation factors (Ostareck et al, 2001). Moreover, hnRNPE1 mediates 
translational silencing also interacting with the hnRNPA2 partner. As already discussed, A2RE 
containing RNAs are transported in oligodendrocytes and in neuronal dendrites. In order to prevent 
ectopic protein expression, mRNAs are kept translationally silent during transport. It has recently 
been discovered that hnRNPA2 can also cooperate with its partner hnRNPE1, inhibiting synthesis of 
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A2RE RNAs (Kosturko et al, 2006). An intriguing translational control mechanism has been recently 
reported to involve the large ribosomal subunit protein L13a. Ceruloplasmin synthesis was known to 
be inhibited after interferon γ treatment through binding of a stem loop structure in its 3’UTR 
(Mazumder & Fox, 1999). Later, L13a has been identified as the trans-acting factor mediating 
translational repression (Mazumder et al, 2003). Actually, L13a phosphorylation leads to its 
dissociation from the ribosome, without affecting global translation rates, but strongly inhibiting the 
expression of ceruloplasmin mRNA. Even if the exact molecular mechanism is not understood, it has 
been proposed that circularization of the mRNA through eIF4G-PABP is necessary to bring L13a 
binding site on 3’UTR  in close proximity to the 5’UTR, therefore mediating translational repression 
(Mazumder et al, 2003). 
• Repression by deadenylation: another efficient mechanism to repress mRNA translation is 
the destabilization and removal of the poly(A) tail. As discussed earlier, CPEB is a key element 
regulating protein synthesis  through activity dependent modulation of polyadenylation. PABP, 
similarly to eIF4E, binds to eIF4G, and stimulates translation initiation. A current model posits that 
Pumilio, another repressor, binds to specific cis acting sequences in 3’UTRs and forms protein 
complexes that in turn promote deadenylation and translational silencing (de Moor et al, 2005).  
• Non sense mediated decay (NMD): an elegant way to tightly control local protein 
abundance, especially at synaptic sites is the regulation of mRNA turnover. A well known pathway of 
mRNA stability control is the non sense mediated decay (NMD). Thanks to this quality control 
mechanism, aberrant transcripts bearing premature stop codons, and therefore potentially 
dangerous for the production of truncated protein,  are rapidly destroyed (Isken & Maquat, 2007). 
However, NMD seems to be also used for the modulation of protein expression in a context of wild 
type mRNAs (Giorgi et al, 2007; Wittmann et al, 2006). NMD is triggered by the recognition of 
premature stop codons upstream of a splice site, where the exon-junction complex (EJC) is 
deposited. This complex is composed by a tetrameric protein core (eIF4AIII, Y14, MAGOH and 
MLN51) and is normally displaced after the first “pioneer” round of protein translation. When a 
premature stop codon is present, the key NMD factor, UPF1, rapidly leads to the degradation of the 
transcript (Maquat, 2004). However, any transcript bearing introns in its 3’UTR becomes a natural 
target for NMD, because the natural stop codon is then recognized as an aberrant stop.  Recent work 
of Giorgi and colleagues has demonstrated that Arc is a natural target for NMD, because of the 
presence of two introns in its 3’UTR (Giorgi et al, 2007). In cortical dendrites, Arc colocalizes with 
eIF4AIII, FMRP and Staufen, suggesting that most of the dendritically localized Arc mRNA has not yet 
undergone the first round of translation. It has been estimated that the mean Arc mRNA half life in 
cultured neurons is 47 minutes (Hutvagner & Zamore, 2002; Rao et al, 2006; Zeng et al, 2003). The 
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translation dependent degradation of Arc is an extreme but efficient way for regulating local protein 
abundance, allowing a fine spatio-temporal regulation of mRNA translation.  This evidence perfectly 
fits with the requirement of a sustained Arc mRNA synthesis during LTP consolidation.  
 
3.2.2  Translational control by microRNAs 
MicroRNAs (miRNAs) are a family of small, 21-22 nucleotide long RNAs that regulate protein 
expression by binding to 3’UTR of at least 50% of the expressed genes (Bushati & Cohen, 2007). Since 
the same miRNA can bind to multiple transcripts and because each mRNA can be targeted by several 
miRNAs, the scenario of possible regulatory combination sis extremely huge.  
 
Mammalian miRNAs are encoded by both mono- and polycistronic gene clusters, often found 
in intronic regions. They are transcribed in the nucleus by RNA polymerase II in the form of long pri-
miRNAs that are further processed by the nuclear RNAse Drosha, to generate a 70nt long stem-loop 
pre-miRNA. Pre-miRNAs are subsequently exported into the cytoplasm where are further cleaved by 
DICER into 21nt long ds miRNAs. Following cleavage, the guide strand is incorporated in the RNA 
induced silencing complex (RISC) that guides target recognition and therefore gene silencing. The 
imperfect base pairing between miRNAs and target transcripts represses translation and does not 
induce target degradation, that is instead triggered by the prefect seed matching of siRNAs 
(Hutvagner & Zamore, 2002; Zeng et al, 2003). The molecular mechanism by which miRNAs promote 
translational silencing  are multiple: (i) inhibition of translation initiation, (ii) inhibition of translation 
elongation, (iii) ribosome drop-off, (iv) cotranslational protein degradation and in some cases (v) 
mRNA degradation (Filipowicz et al, 2008; Jackson & Standart, 2007). miRNAs are widely expressed in 
many brain regions (Kosik, 2006) and have demonstrated to be critical for normal brain function and 
development (Davis et al, 2008; Kim et al, 2007; Schaefer et al, 2007). In mammalian hippocampal 
neurons, it has been recently demonstrated the leading role of miRNA 134 in regulating 
dendritogenesis and spine development (Schratt et al, 2006). This brain enriched miRNA negatively 
regulates the expression of Limk1, a protein kinase involved in spine growth and maintenance. BDNF 
application relieves miRNA 134 mediated repression, promoting Limk1 expression and spine 
morphogenesis (Schratt et al, 2006). Interestingly, it has been shown that also miRNA132 is a direct 
target of BDNF regulation through CREB mediated transcription. The authors have identified 
p250GAP as major target transcript for this miRNA, whose BDNF-dependent expression 
downregulates p250GAP protein levels, to promote neurite outgrowth (Vo et al, 2005). 
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miRNA mediated regulation of neuronal functions has been widely conserved during evolution, 
since also in Drosophila’s  neuronal cells a local increase in CaMKIIα expression is triggered by a 
parallel decrease in miRNA mediated repression (Ashraf & Kunes, 2006). This phenomenon seems to 
be related to a concomitant proteolysis of a RISC complex component, that in turn downregulates 
the miRNA mediated inhibition on CaMKIIα expression. As discussed above, miRNAs can be stored 
and transported in dendrites in special transport particles called miRNPs. However, it is not 
completely clear whether or not miRNAs are already associated to their targets during transport or 
subsequently bind to the mRNPs once they have reached their final subcellular destination. 
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4 ROLE OF DENDRITIC MRNAS 
 
4.1 What is the biological significance of mRNA localization and 
regulated local translation? 
As already discussed, learning and memory formation require long lasting synaptic changes 
that in turn rely on a fine modulation of the protein content of each synapse, depending on the type 
and number of stimulations experienced. The first theories elaborated to justify how synapse 
plasticity is generated during learning posed the ability of synapses to send retrograde messages to 
cell body, so that the somatically synthesized proteins would be transported specifically to the 
peripheral compartments. According to this view, the “synaptic tagging” theory has been elaborated, 
assuming that activated synapses are marked with molecular tags that in turn attract new proteins 
from the soma (Frey & Morris, 1997; Frey & Morris, 1998). As previously mentioned, a process based 
exclusively on protein transport would not meet the rapid changes needed for a fast neuronal 
response. Indeed, without excluding the ability of synapses to send retrograde signals as well as the 
tag theory, it could rather be that the latter also serves as an address for mRNAs to be synaptically 
targeted. In view of that, the experiments carried out by Schuman and coworkers have strongly 
supported this idea, demonstrating that lesioned hippocampal slices, where dendrites had been 
severed from their cell bodies, are still able to express a form of LTP that is induced by BDNF. 
Moreover, the authors have demonstrated that this event is dependent on local protein synthesis 
since it is completely abolished after pharmacological treatment with translation inhibitors, 
suggesting that BDNF acts locally inducing synaptic potentiation through activation of local protein 
synthesis processes (Kang & Schuman, 1996). On the same line, Huber and colleagues have shown 
that activation of mGlu receptors induced LTD in severed CA1 stratum radiatum, and that LTD  is 
blocked by protein translation antagonists, confirming the importance of newly synthesized proteins 
for the establishment of neuronal plasticity (Huber et al, 2000).  
 
Notably, local protein synthesis is essential not only for the induction and maintenance of LTP 
and LTD, but also for the formation of new spines, that in turn could be a downstream effect of long 
term neuronal plasticity  (Engert & Bonhoeffer, 1999; Trommald et al, 1996). In fact, observations 
collected by (Steward & Falk, 1986) have reported a significant accumulation of polyribosomes under 
the base of developing synapses. Accordingly, also after denervation it has been observed a local 
ribosomal enrichment at the level of newborn synapses (Steward & Fass, 1983).  
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A putative protein involved in shaping and formation of new spines in FMRP, since in animal 
models lacking of this   protein many developmental abnormalities have been reported, including 
long, thin and immature spines (Weiler & Greenough, 1999). Another essential actor involved in 
synaptogenesis and structural changes related to plasticity phenomena is Arc, whose induction is 
spatially and temporally regulated. In the next section we will deeply discuss about  the structural 
and functional implications of Arc expression with respect to LTP and spine stability. Finally, to 
support the role of local protein synthesis during LTD, we will provide an example of the 
consequences of the misregulated expression of FMRP that results in exaggerated hippocampal 
depression. 
 
4.2 Arc/Arg3.1 , actin and LTP consolidation 
Among the immediately early genes induced by LTP, a pivotal role is played Arc. Indeed, 
animals lacking of this important gene show strong deficits in long term potentiation maintenance 
(Plath et al, 2006). The leading role of Arc during synaptic plasticity can be deduced also by the fact 
that Arc is rapidly induced in many regions of the brain after stimulation. Newly expressed Arc mRNA 
is rapidly targeted to dendrites and accumulates nearby to activated synapses (Steward et al, 1998). 
Moreover, high frequency stimulation induces an enrichment of Arc protein at synapses of dentate 
granule cells and its localization to the post synaptic density of excitatory synapses (Bramham et al, 
2008). In a recent study by (Messaoudi et al, 2007), a time course Arc ODNs injection has 
demonstrated a specific time window in which Arc expression is required for proper LTP 
maintenance, in between 2-4 hours after synaptic stimulation. After 2 hours of LTP induction, ODNs 
injection rapidly reduced Arc mRNA an protein levels, promoted cofilin dephosphorylation and loss of 
F-actin (Messaoudi et al, 2007). The same treatment at 15 minutes post stimulation did only induce a 
rapid but reversible inhibition of LTP, accompanied by the same blockade and recovery of Arc 
expression. This transient effect is consistent with the key feature of early LTP, i.e. protein synthesis 
mRNA transcription independence. In vivo, an Arc knock out animal model showed severe deficits in 
LTP consolidation in the dentate gyrus as well as in CA1 region of acute hippocampal slices in vitro 
(Plath et al, 2006). Taken together, these results support a central role for Arc in LTP: its early 
expression contributes to LTP induction, while a sustained Arc protein synthesis is necessary for 
proper LTP consolidation and memory storage.  
 
BDNF-induced LTP in dentate gyrus has been associated with strong upregulation of Arc mRNA and 
has been shown to be dependent on new mRNA transcription (Messaoudi et al, 2002). Indeed, it has 
been shown that Arc ODN injection prevents BDNF dependent LTP induction together with cofilin 
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inhibition of phosphorilation, that, as earlier discussed, promotes F-actin depolimerization and spine 
shrinkage (Rex et al, 2007). As depicted in figure 3, BDNF signaling is essential to support protein 
translation. In fact, BDNF can promote mRNA release form transporting granules as well as activation 
of crucial signaling pathways involved in protein translation, as the PI3K/Akt/mTOR pathway. In this 
way,  BDNF can either promote phosphorylation of inhibitory 4EBPs, or activation of p70S6 kinases, 
phosphorylation of eIF4E and eEF2K, with a general promotion of mRNA translation. During LTP 
consolidation, a sustained Arc synthesis is indeed necessary for local actin polymerization and cofilin 
phosphorylation that result in the well known spine enlargement associated with late phase LTP. 
Moreover, a prominent role of BDNF in supporting spine remodeling is given by its ability to relief the 
miRNA134 repression of LIM kinase-1, the major cofilin kinase, that results in an increased 
phosphorylation of cofilin and subsequent F- actin stabilization (Meng et al, 2002; Schratt et al, 
2006). Intriguingly, BDNF might be related also to LTD processes and more generally to homeostatic 
regulation of synaptic activity, since it promotes Arc expression that has recently been described to 
be involved in mGluRI dependent LTD AMPAR endocytosis (Waung et al, 2008). 
 
 
Fig. 3 Model of Arc dependent consolidation in the dentate gyrus (see (Bramham & Wells, 2007)). 
 
Interestingly, Arc is not only essential during LTP related spine remodeling, but also during 
mGluR dependent LTD. In fact, Guzowski and coworkers have shown that inhibition of Arc protein 
expression through antisense oligodeoxynucleotide (ODN) injection before LTD induction impairs the 
maintenance of long term potentiation and the consolidation of long term memory (Guzowski et al, 
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2000). Moreover, it has recently been demonstrated that Arc promotes LTD through increased AMPA 
receptor exocytosis via interaction with dynamin and endophilin 2/3 (Chowdhury et al, 2006; Waung 
et al, 2008) and its expression is under the control of both eEF2 and FMRP proteins (Park et al, 2008). 
In particular, there is compelling evidence that Arc translational control relies on eEF2, since in eEF2 
kinase knock out slices both Arc expression and mGluR LTD are inhibited. Wild type conditions can be 
however restored with application of low concentrations of cycloheximide, known to induce eEF2 
phosphorylation. Moreover, mGluR activation leads to fast FMRP dephosphorylation, relieving its 
inhibitory effect on Arc mRNA translation (Antar et al, 2004; Narayanan et al, 2007). Lack of FMRP 
occurring  in Fragile-X syndrome and related animal models,  causes a constitutively deregulated Arc 
overexpression that may, at least in part, account for the exaggerated protein synthesis independent 
LTD (Park et al, 2008). 
 
4.3 mGluR LTD, FMRP and regulation of protein translation 
It is widely accepted that BDNF is a key modulator of LTP consolidation and memory formation 
(Bramham & Messaoudi, 2005). As will be further discussed in greater detail, BDNF is 
postsynaptically released from or near glutamatergic synapses and locally activates TrkB receptors on 
both pre and post synaptic membranes.  
 
By definition, LTD is a long lasting decrease in the efficacy of synaptic transmission (Gladding et 
al, 2009). This phenomenon was first described as heterosynaptic depression, in which 
depotentiation was observed in a non stimulated pathway after induction of LTP in a separate 
hippocampal CA1 pathway (Lynch et al, 1977). The same phenomenon was also observed by 
(Steward & Levy, 1982) in the dentate gyrus, indicating that heterosynaptic LTD may occur in 
different brain areas. Like LTP, also LTD can be locally evoked in a protein synthesis dependent 
manner, since it could be still elicited in CA1 dendrites that have been severed from their cell bodies 
(Huber et al, 2000).  
 
Among the proteins induced by mGluRI activation, a leading role is played by FMRP. It is worth 
noting that the same kind of stimulation promotes the translation of other dendritically FMRP-
interacting mRNAs, like PSD-95, amyloid precursor protein (APP), MAP1B, elongation factor 1a 
(eEF1a)  and Arc  (Davidkova & Carroll, 2007; Huang et al, 2005; Park et al, 2008; Todd et al, 2003; 
Waung et al, 2008; Westmark & Malter, 2007). As a consequence, any alteration of FMRP function 
would be reflected in synaptic anomalies, as seen for enhanced mGluR dependent LTD and spine 
structure abnormalities  in Fmr1KO mice. Additionally, in these mice the M1 muscarinic acetylcholine 
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(mAch) receptor and mGluR-dependent forms of LTD are enhanced and persist in an independent 
manner form new protein synthesis (Hou et al, 2006; Nosyreva & Huber, 2006). Based on these 
results, it has been hypothesized that FMRP normally inhibits the expression of the LTD related 
proteins, and this inhibition is relieved after mGluR activation that in turn leads to activation of  
protein synthesis. Therefore, genetic deletion of FMRP leads to a chronic, constitutively active 
expression of such LTD proteins, resulting in an exaggerated depression which is independent form 
new protein synthesis. At a molecular level, mGluR activation promotes a decrease in the number of 
surface AMPA receptors, in particular of GlR1 and GluR2 subunits (Snyder et al, 2001). New protein 
translation is not required to initiate the process of internalization, but instead is necessary for a long 
term DHPG dependent decrease in the density of surface AMPARs, indicating the requirement of 
new “LTD-related” proteins that are involved in AMPARs trafficking and endocytosis (Snyder et al, 
2001; Waung et al, 2008). Moreover, in order to maintain a steady state level of surface AMPARs, 
even if globally reduced, there must be a compensatory mechanism leading to increased exocytosis 
of GluR subunits, accordingly to a more rapid recycling of AMPARs seen during mGluR dependent 
LTD (Waung et al, 2008).  
 
Many LTD proteins have been discovered to be regulated at the mRNA level by FMRP. As 
previously mentioned, Arc is one of the major candidates in both LTP and LTD processes. With 
respect to the latter, Arc is known to promote AMPAR endocytosis via interaction with the endocytic 
proteins endophilin 2/3 and dynamin (Chowdhury et al, 2006). Accordingly, Arc KO neurons display a 
marked impairment in LTD processes and long term decrease of surface mGluR1 and AMPARs (Park 
et al, 2008; Waung et al, 2008). Interestingly, DHPG-induced mGluR activation led also to specific 
translation of the striatal-enriched protein tyrosine phosphatases (STEP) that has been implied in LTD 
related AMPAR endocytosis (Zhang et al, 2008). Inhibition of STEP activity, either by genetic deletion 
or pharmacological treatments increased AMPAR surface expression and prevented 
dephosphorylation of GluR2 that in turn would promote its internalization. This second LTD protein 
may cooperate with Arc in maintaining a sustained AMPAR internalization via Tyr dephosphorylation. 
However, evidence of altered STEP levels in Fmr1 KO models is still lacking. 
 
A third LTD protein is microtubule associated protein 1B (MAP1B), whose mRNA is a well 
known FMRP target . MAP1B is actively involved in LTD processes, since DHPG treatment increased 
its levels in neuronal dendrites, whilst  knock down of MAP1B prevented AMPAR internalization 
(Davidkova & Carroll, 2007). MAP1B has been described to interact with GRIP1, a scaffolding and 
GluR2 interacting protein  (Davidkova & Carroll, 2007; Seog, 2004). It has been therefore proposed 
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that increased MAP1B levels seen after DHPG stimulation might lead to an increased association with 
GRIP1, therefore destabilizing the surface GluR2 expression and therefore promoting their 
internalization. Moreover, NMDA activation promotes MAP1B expression as well, therefore 
contributing to the NMDAR dependent LTD  and AMPAR endocytosis (Waung & Huber, 2009).  
 
Stimulation of mGluR promotes translation by activating two main downstream signaling 
cascades, the ERK-MAP andPI3K-mTOR pathways, that in turn lead to the activation of key protein 
kinases as earlier discussed. In addition to these general stimulation of translation, mGluRs provide 
also a means for mRNA specific regulation of translation through FMRP. Upon synaptic stimulation, 
CYFIP1, a cytoplasmic FMRP interacting protein that inhibits translation by sequestering eIF4E, 
dissociates from its partner allowing the formation of eIF4F complex that in turn promotes 
translational of target mRNAs like Arc and MAP1B (fig.4). Accordingly, reduced levels of CYFIP1 would 














Fig.4. Proposed model for FMRP/CYFIP translational repression (reproduced from (Napoli et al, 2008)). The CYFIP/FMRP or 
CYFIP/FMRP/BC1 complexes are transported in the form of translationally silent mRNPs. The CYFIP/eIF4E interaction 
prevents translation initiation. However, synaptic stimulation, possibly leading to FMRP and/or CYFIP modifications, relieves 
FMRP/CYFIP inhibition promoting translation initiation. 
 
Additionally, dephosphorylation of FMRP has been linked to increased association with 
translating polysomes (Ceman et al, 2003) and rapid translation of some target transcripts like 
SAPAP3 (Narayanan et al, 2007). It has been proposed that rapid, mGluR induced dephosphorylation 
of FMRP might facilitate the movement of ribosomes along mRNA, as well as rapid ubiquitination of 
FMRP leading to its immediate degradation, in order to relief any translational suppression (Bassell & 
Warren, 2008; Hou et al, 2006). 
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Summarizing, it emerges how mGluR signaling supports the coordinated expression of 
functionally related proteins that together act in promoting GluR1 and 2 internalization to reduce 
surface AMPAR expression. In particular, a pivotal role is covered by Arc, since it seems to be 
sufficient for the induction of LTD even in the absence of new STEP and MAP1b expression (Waung et 
al, 2008; Zhang et al, 2008). Moreover, enhanced LTD in Fmr1 KO mice strongly relies on Arc activity, 
since crossing of Arc KO with Fmr1 KO mouse strains leads to a less marked LTD (Park et al, 2008). In 
a similar way, Fmr1 KO animals backcrossed with GluR5 
+/-
 animals show a less pronounced 
exaggeration of mGluR LTD, sustaining the so called “mGluR” theory stating that mGluR5 signaling 
that promotes AMPAR internalization is abnormally enhanced in Fmr1 KO mice (Dolen et al, 2007; 
Huber et al, 2002). 
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5 BDNF mRNA LOCALIZATION AND FUNCTIONS 
 
Neurotrophins (NTs) are small secreted proteins that play important roles in the development 
of the nervous system in vertebrates (Chao et al, 2006), whose  first member, Nerve Growth Factor 
(NGF), was discovered during early ’50s by Levi Montalcini and Hamburger (Levi-Montalcini et al, 
1954). Twenty years later, studies carried by Barde and colleagues led to the isolation and 
characterization of a second member, called Brain-derived Neurotrophic Factor (BDNF) (Barde et al, 
1982). Since then, four other additional neurotrophins have been identified, i.e. neurotrophin-3 (NT-
3), neurotrophin-4/5 (NT-4/5), neurotrophin-6 (NT-6) and neurotrophin-7 (NT-7). The latter two have 
been found only in fish (Carballo et al, 1998; Gotz et al, 1994; Lai et al, 1998). Once secreted, NTs can 
bind to two types of cell surface receptors, the Trk tyrosine kinases and the p75 neurotrophin 
receptor (p75NTR). Each Trk receptor (Trk A, Trk B and Trk C) is preferentially activated by one or 
more NTs and is responsible for mediating most cellular responses.  More specifically TrkA is 










Fig. 5. NTs binding to their receptors. 
 
Binding of the NT initiates Trk dimerization, transphosphorylation of tyrosine residues in its 
cytoplasmic domain and kinase activation (see figure 5). The phosphotyrosine residues function as 
binding sites for recruiting specific cytoplasmic signalling proteins. These proteins may in turn be 
activated by phosphorylation. Contrarily to Trk receptors, p75NTR can be activated by the binding 
with all the four neurotrophins with approximately equal affinity, even if it is lower than Trk 
receptors. While Trk receptors transmit positive signals, p75NTR transmits both positive and negative 
signals. The signals generated by the two neurotrophin receptors can either augment or oppose each 
  ANALYSIS OF THE MOLECULAR MECHANISMS OF BDNF MRNA  




other, regulating almost all aspects of neuronal development and function, including precursor 
proliferation and commitment, cell survival, axon and dendrite growth, membrane trafficking, 
synapse formation and function, as well as glial differentiation and interactions with neurons. 
Moreover, recent studies have revealed a diversity of roles for these factors outside the nervous 
system, most notably in cardiac development, neovascularisation and immune system function 
(Donovan et al, 2000; Kermani et al, 2005). Activated Trk receptors control three major signaling 
pathways: the MAP kinase signaling cascade, which promotes neuronal differentiation; the 
phosphatidylinositol 3-kinase pathway, that promotes survival and growth of neurons and other 
cells; the phospholipase C-γ pathways that promotes synaptic plasticity (Reichardt, 2006).       
                            
5.1 BDNF  signaling and gene structure 
BDNF protein structure and sequence have been highly conserved during evolution among 
several species, suggesting its fundamental role in regulating many different cellular functions (Hofer 
et al, 1990; Rosenthal et al, 1991). BDNF is widely expressed in the central nervous system, especially 
in cerebral cortex, hippocampus formation and amygdaloidal complex (Ernfors et al, 1990a; Ernfors 
et al, 1990b; Hofer et al, 1990; Phillips et al, 1990; Wetmore et al, 1990), and its expression increases 
during development until it reaches a maximal level after birth (Friedman et al, 1991a; Friedman et 
al, 1991b; Maisonpierre et al, 1990; Schecterson & Bothwell, 1992). Then, the expression of BDNF 
seems not to decline with age (Katoh-Semba et al, 1998; Lapchak et al, 1993; Narisawa-Saito & Nawa, 
1996). However, BDNF has not only been found in the central nervous system, but its mRNA has 
been observed in numerous other tissues and cell types as colon, intestine, leukocytes, ovary, spleen, 
thymus, testis, pancreas and blood (Liu et al, 2005; Pruunsild et al, 2007; Rosenfeld et al, 1995). The 
widespread distribution of BDNF among tissues underlines its importance in a large number of 
different cellular processes, especially for what concerns neuronal functions. BDNF like the other 
neurotrophins is a morphoregulatory molecule that supports cell proliferation, cell survival/cell 
death, differentiation and phenotype maintenance. New evidence indicates that BDNF is also 
involved in dendritogenesis and axonogenesis (McAllister, 1999), spine formation and maturation, 
synaptogenesis and moreover neuronal homeostasis, brain plasticity-related process such as 
memory and learning (Tyler et al, 2002; Yamada et al, 2002) and drug addiction (Ghitza et al, 2009). 
The regulation of synaptic transmission and plasticity, peculiar for NT-3 and especially BDNF, was 
reported in a study carried by Lohof and co-workers, demonstrating how such neurotrophins are able 
to potentiate synaptic transmission in developing neuromuscular junctions (Lohof et al, 1993). 
Alterations in BDNF expression in specific neuronal subpopulations contribute to the onset of various 
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pathologies, including depression, epilepsy, and Alzheimer’s-, Huntington’s- and Parkinson’s diseases 
(Bibel & Barde, 2000; Binder, 2004; Castren, 2004; Cattaneo et al, 2005; Gottschalk et al, 1998; Lu & 
Chow, 1999; Murer et al, 2001; Russo-Neustadt & Chen, 2005). 
 
BDNF plays a pivotal role in LTP, because of its capability to act at both pre- and post-synaptic 
level through the interaction with its receptor TrKB (Xu et al, 2000). In fact, when BDNF is released 
into the inter-synaptic compartment, it induces the release of glutamate from  pre-synaptic neurons 
on one hand, and inhibits the release of the inhibitory neurotransmitter GABA (Frerking et al, 1998; 
Tanaka et al, 1997) on the other. Moreover, pre-synaptic activation of TrkB receptor seems to 
contribute to  LTP through retrograde nuclear signaling, leading to transcriptional activation in pre-
synaptic cell bodies (Gooney et al, 2004). At post-synaptic level, BDNF modulates the sensitivity of  
NMDA receptors and promotes new protein synthesis of synapse-targeted transcripts and appears to 
be directly associated with up-regulation, dendritic transport and local protein synthesis of Arc mRNA 
(Messaoudi et al, 2002; Rodriguez et al, 2005). From a molecular point of view, BDNF induces the 
dimerization of TrkB, promoting the trans-phosphorilation of specific residues in the intracellular 
domain of the receptor (Huang & Reichardt, 2003). This event induces the activation of three 
different signaling cascades, i.e., the MAP Kinase (Mitogen Activated Protein Kinase), PI3 Kinase 
(Inositol-3 Phosphate Kinase) pathways and the activation of Phospholipase Cγ (PLCγ) (Kaplan & 
Miller, 2000) (fig.6). The phosphorylated tyrosine residues provide a docking site for adaptor proteins 
such as Shc and Frs2, which induce Ras activation. The latter initiates MAP kinase-signaling cascade, 
having as final target eIF4E that in the phosphorylated form is able to initiate the translation of target 
transcripts (Bramham & Wells, 2007).  
 
At pre-synaptic level, BDNF-induced activation of MAPK leads to an increase in the release of 
glutamate, because of the phosphorilation of synapsin, a vesicular protein required for the fusion of 
vesicles with plasma membrane (Takei et al, 1997; Yamada et al, 2002). On the other hand, the 
activation of PI3 kinase pathway prevents the phenomenon of “synaptic fatigue”, i.e. the depletion of 
neurotransmitter-containing vesicles, seen especially after  repeated series of high frequency action 
potentials (Gottschalk et al, 1999). Moreover, a downstream postsynaptic target of PI3K is Akt, a 
crucial kinase able to phosphorylate mTOR (mammalian Target Of Rapamycin), whose transduction 
pathway is involved in the regulation of CAP-dependent mRNA translation (Kang & Schuman, 1996; 
Takei et al, 2001) and represents the principal mechanism through which BDNF is able to induce local 
protein synthesis (LPS). In fact, even if for the maintenance of LTP new mRNA transcription is 
required, during the induction phase only protein synthesis form pre-existing mRNAs is needed. 
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Fig.6. Schematic representation of BDNF signaling and activation of three main cascades, PLCg, PI3-kinase and MAP-kinase. 
For detailed description see text 
 
It is thought that this is the critic phase in which de novo synthesis of synaptic proteins is 
regulated by BDNF signaling, achieving the long term modifications  characteristic of synaptic 
plasticity (Kang & Schuman, 1996; Yin et al, 2002). The last intracellular pathway initiated by BDNF is 
the PLCγ cascade, that leads to the post-synaptic phosphorilation of B2 subunit of NMDA receptor  
(Frerking et al, 1998; Yamada & Nabeshima, 2003) via CaMKIIα. This kinase is then responsible for 
the BDNF-induced E-LTP that, we remember, requires exclusively post-translational modifications of 
synaptic proteins (Minichiello et al, 2002). The increase of intracellular Ca
++ 
mediated by PLCγ 
signaling is able to induce also the activation of CaMKIV and subsequently to the transcription factor 
CREB (cAMP Responsive Element Binding Protein), thus allowing the transcription of new genes that 
are required during the consolidation phase of L-LTP (Minichiello et al, 2002). In conclusion, we can 
state that PLCγ pathway is involved in both BDNF-dependent E-LTP induction (through CaMKIIα) and 
consolidation of L-LTP through de novo mRNA synthesis under the control of CREB.   
 
All genes encoding neurotrophins have a basically similar structure, but among all discovered 
neurotrophins the genomic structure of the BDNF gene is unusually complex. Despite the fact that 
the gene organization and regulation of human and rodent BDNF gene expression have received 
close attention during the last decade, knowledge of the structural organization of mouse, rat and 
human BDNF gene has been well characterized only in the last years (Liu et al, 2005; Pruunsild et al, 
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2007). Each BDNF transcript is composed by multiple alternatively non coding exons spliced 
upstream of a common 3’ exon that encompasses the whole coding sequence and the 3’untransleted 
regions (3’UTRs). The detailed characterization of the rodents and human BDNF gene has revealed 
the existence of four exon clusters, each of them regulated by different promoters located upstream 
of these alternatively spliced exons. These promoters enable a precise regulation of BDNF expression 
in different cell types or in response to different stimuli. The biological meaning of this complexity 
has been extensively investigated in our lab in the past years, focusing on a possible spatio-temporal 
fingerprint for the regulation of BDNF synthesis and localization, as will be discussed in the next 
paragraphs. 
 
5.2 In vitro and in vivo studies of BDNF mRNA localization 
Early in vitro experiments carried out by Crino and Eberwine revealed the presence of BDNF 
mRNA in dendritic growth cones of developing neurons after 24hours in culture, whilst TrkB mRNA 
has been detected only after 48 hours (Crino & Eberwine, 1996). The presence of BDNF and TrkB 
mRNA in mature dendrites was demonstrated by Tongiorgi et al. (1997) using cultured hippocampal 
neurons. This study showed that TrkB and BDNF mRNAs are targeted to distal dendrites in an activity 
dependent manner ((Tongiorgi et al, 1997), see fig.7), demonstrating that does not rely on new 
mRNA synthesis, but rather depends on an accumulation in dendrites of pore-existing mRNAs. 
Moreover, calcium signalling revealed to be essential for promoting BDNF and TrkB mRNA sorting in 
dendrites, since application BAPTA-AM and EGTA, two Ca
++
 chelators, significantly inhibited dendritic 
localization of these two mRNAs. Similarly, blockade of voltage gated L-type Ca
++
 channels by 










Fig.7 High potassium increases the dendritic localization of BDNF mRNA in cultured hippocampal neurons (modified from 
(Tongiorgi et al, 1997). A, Whole-cell patch-clamp recordings, under current-clamp conditions, after depolarization with 10 
mM KCl. B, In situ hybridization on cultured hippocampal neurons with BDNF riboprobe in resting conditions. C, 
Depolarization with 10 mM KCl for 3 hr increases the dendritic localization of BDNF mRNA. 
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During those years, studies suggesting that BDNF might be rapidly synthesized and released in 
an activity dependent manner (Goodman et al, 1996; Tongiorgi et al, 1997), together with evidence 
supporting a role for NT-3 in promoting RNA sorting (Knowles & Kosik, 1997), prompted to 
investigate whether or not BDNF itself might also stimulate its own mRNA transport into dendrites. It 
was found that BDNF is able to promote the peripheral sorting of its own mRNA in a feedback 
autocrine-paracrine autoregulatory loop (Righi et al, 2000). Even if the proteins directly involved in 
this process remain still unknown, it was shown that the PI3K signalling pathway is crucial to promote 
BDNF mediated mRNA sorting, whilst MAP/ERK and CaMKII activation did not result to be essential 
(Righi et al, 2000). These results perfectly fit with the notion that BDNF plays a prominent role in 
potentiating synaptic transmission at both pre- and post synaptic levels. However, an abnormal 
accumulation of this transcript might be related to pathological disturbances like epilepsy (Binder et 
al, 2001). Indeed, in vivo animal models of epilepsy displayed a dramatic accumulation of BDNF 
mRNA in the stratum radiatum of CA1 and CA3 neurons after administration of pro-epileptogenic 
stimuli like pilocarpine and kainic acid (Tongiorgi et al, 2004). Importantly, acute, intense seizures per 
se are not sufficient to induce distal BDNF sorting, that is instead triggered by stimulation paradigms 
able to induce the cellular cascades underlying  epileptogenesis. The same stimulation paradigm was 
applied to study the relative distribution of the five most abundant BDNF splice variants, namely 
those containing exons I, IIB, IIC, IV and VI (Aid et al, 2007; Chiaruttini et al, 2008; Liu et al, 2006). The 
finding that after 3 hours of pilocarpine administration only exon IIB/C and VI containing splice 
variants were present at dendritic level, whilst the other two were still confined in the cell soma 
suggested the hypothesis that the different splice variants can represent a spatial code and can be 
expressed in a regulated manner to locally modulate BDNF availability (Chiaruttini et al, 2008). To 
support this hypothesis, very recent submitted data revealed that some mRNAs are implicated in cell 
survival, whilst other splice variants are involved in the regional regulation of dendritogenesis and 
spinogenesis (Baj & Tongiorgi, 2009); Baj and Tongiorgi, personal communication). BDNF mRNA 
sorting in vivo occurs also during most physiological stimuli, like during developmental plasticity 
induced by visual experience (Pattabiraman et al, 2005).  
 
Despite this huge body of experimental evidence, however, the molecular mechanism 
underlying the selective localization of the different splice variants is still poorly understood. Very 
recently, two important advances have been made for understanding the dynamics if this complex 
phenomenon. Firstly, An and colleagues demonstrated that the long 3’UTR of BDNF mRNA, but not 
the short one, is necessary and sufficient for mRNA dendritic targeting, and its truncation completely 
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abolishes BDNF mRNA targeting in vivo (An et al, 2008). Moreover, the importance of this splice 
variant has been highlighted by finding that TG mice carrying a constitutive deletion if the long 3’UTR 
display severe depletion of dendritic BDNF protein that in turn can account for the LTP deficits and 
spine abnormalities seen in adult, but not young animals (An et al, 2008). However, these authors did 
not consider the effect of the short 3’UTR nor the potential consequences of neuronal activity 
regarding the subcellular distribution of BDNF mRNA. In this doctoral thesis, I will show and discuss 
data supporting a functional role in vitro and in vivo for both short and long 3’UTRs, paying particular 
attention to the different effects induced by different extracellular stimulation paradigms. In 
addition, we recently demonstrated that BDNF’s CDS contains an unexpected but essential dendritic 
targeting element for the correct activity dependent sorting of the transcript in hippocampal 
dendrites (Chiaruttini et al, 2009). This element, conserved in humans and rodents, is recognized 
translin, a DNA/RNA binding protein. A frequent human SNP, G196A (or Val66Met) has been 
frequently associated with neuropsychiatric diseases, possibly because if an impaired activity-
dependent secretion of BDNFMet (Chen et al, 2004; Egan et al, 2003). We also proposed that such 
mutation additionally disrupts the BNDF mRNA:translin interaction, depleting dendrites not only of 
the protein, but also of the  fraction of dendritic BDNF mRNA addressed to local translation.  
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The subcellular compartmentalization of transcripts represents a milestone for the local 
regulation of mRNA availability that guarantees a fine spatio-temporal regulation of protein 
expression fundamental for the development and maintenance of highly polarized cells. In particular, 
in neuronal cells this phenomenon has gained a broader significance, since it seems to be at the basis 
of synapse-specific delivery of new mRNAs. This regulated sorting allows the local synthesis of new 
proteins that are required during plasticity related phenomena, therefore significantly contributing 
to higher brain functions like memory and learning (Steward & Schuman, 2001). 
 
A growing body of evidence indicates that dendritic sorting of BDNF mRNA represents a crucial 
event regulating synaptic plasticity (Soule et al, 2006; Tongiorgi et al, 1997). However, little is known 
about the molecular mechanisms regulating the selective, activity-dependent sorting of BDNF mRNA 
in dendrites (Righi et al, 2000; Tongiorgi et al, 1997) and how it could effectively influence synaptic 
activity. In recent studies performed in our and other laboratories it has been demonstrated that 
some BDNF splice variants differ in their subcellular localization (An et al, 2008; Baj & Tongiorgi, 
2009; Chiaruttini et al, 2008; Pattabiraman et al, 2005), indicating that they could actually represent 
a spatial code to preferentially regulate BDNF expression and consequently to modulate the 
metabolism of restricted subcellular domains.  
 
To help define the mechanism underlying the regulation of activity-dependent BDNF mRNA 
subcellular localization and the biological meaning of having two 3’UTRs , we separately investigated 
the role of the different transcript’s regions searching for specific localization signals and 
translational regulatory elements. In particular, with both in vitro and in vivo approaches we 
analyzed: 
- the role of 5’UTRs and coding region respect to mRNA traffic regulation; 
- the role of both 3’UTR short and long in mRNA sorting; 
- the translational regulation exerted by BDNF short and long  3’UTRs. 
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7 MATERIALS AND METHODS 
 
7.1 Cell cultures 
7.1.1 SK-N-BE and PC12 cell lines 
SK-N-BE human adrenal neuroblastoma cells were cultured in Dulbecco’s modified Eagle’s 
medium (D-MEM, Euroclone), 10% fetal bovine serum (FBS, Euroclone), 2 mM L-glutamine, penicillin 
100 U/mL, streptomycin 100 µg/mL (Euroclone) at 37°C in a 5% CO2-humified incubator. Likewise, 
rat pheochromocytoma cells (PC12) were cultured in RPMI medium (Euroclone) supplemented with 
10%FBS, 5% donor horse serum (DHS, Euroclone), 20mM HEPES, 2 mM L-glutamine, penicillin 100 
U/mL, streptomycin 100 µg/mL (Euroclone) at 37°C in a 5% CO2-humified incubator. Undifferentiated 
cells were plated onto 6 multiwell plates at 55% of confluence for subsequent transfection assays. 
7.1.2 Primary rat hippocampal neurons cultures 
Primary hippocampal from postnatal Sprague–Dawley rats were made according to the 
method of Malgaroli and Tsien (Malgaroli & Tsien, 1992) with slight modifications (Tongiorgi et al, 
1997). Hippocampi  were dissected from 0 to 1-day-old animals (P0-P1). All the dissections were 
performed in cold Hank’s balanced salt solution (NaHCO3 4.2 mM (Sigma), Hank’s salt powder 
0.952% (Sigma), Hepes 12 mM (Sigma), D-glucose 33 mM (Sigma), Kinurenic acid 2 mM, streptomycin 
100 µg/mL (Euroclone)); the dissected tissue was maintained in ice until the end of the extraction. 
Hippocampi were then digested with 500 μL of 0.25%, tripsin in native MEM (Minimum Essential 
Medium + Earle’s salts + glutaMAX
TM
I (Euroclone)), for 7 minutes at 37°C, shaking periodically and 
gently the tube. The digestion was blocked with 4 mL of D-MEM supplemented with 10% heat 
inactivated Fetal Bovine Serum (FBS, Gibco) and the dissected tissue was centrifuged at 800 rpm for 5 
minutes at 8°C. The pellet was resuspended in 5 mL of fresh Neurobasal supplemented with 2% B27 
(invitrogen). To isolate single cells, pellets were dissected by mechanically pipetting the suspension in 
order to get a homogeneous solution. Cells were slowly filtered using a cell strainer (40 μm pore 
diameter, Sarstedt) to remove impurities and cellular debris. Cells were counted at the microscope 
using the vital dye Trypan Blue. Cells were seeded onto 12 mm glass coverslips treated with poly-L-
ornithyne  (100 μg/mL) (Sigma) and  MatrigelTM (BD Biosciences, diluted 1:50 in Hank’s solution) at 
the concentration of 100.000 cells per well. After 4-5 hours the medium was replaced with fresh 
Neurobasal supplemented with 2% B27 (Invitrogen) supplemented with 1mM L-gluatmine, penicillin 
100 U/mL, streptomycin 100 µg/mL (Euroclone). Medium was changed every two days, and from the 
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second day in culture additioned of 5 μM cytosine arabinofuranoside (ARA-C, Sigma) to prevent the 
proliferation of non-neuronal cells. Cells were cultured for 6 days at 37°C in a 5% CO2-humified 
incubator. 
7.2 Animal treatments 
Procedures involving animals and their care were carried out in accordance with national 
(Decreto Legge N116, Gazzetta Ufficiale, suppl 40, 18-2-1992) and international laws and policies 
(European Community Council Directive 86/609,Oja L 358, 1, December 12, 1987; National Institutes 
of Health Guide for the Care and Use of Laboratory Animals, US National Research Council, 1996). All 
efforts were made to minimize animal suffering and to reduce the number of animals. For 
pilocarpine experiments, animals were treated with 300mg/kg i.p pilocarpine for 3hours (for in situ 
hybridization, ISH) or 6hours (for immunohistochemistry (IHC) analyses) under urethane anaesthesia 
(100mg/Kg i.p.). Mice were transcardially perfused under anaesthesia with ice-cold 2% (for IHC) or 
4% paraformaldeyde (PFA, Sigma) in phosphate buffered saline (PBS, 137mM NaCl, 2.7mM KCl, 
8.1mM NaH2PO4, 1.47mM KH2PO4, pH 7.4). After extraction, brains were left in PFA for other 2 hours, 
and afterwards cryoprotected in 2% or 4% PFA/20% sucrose at 4°C up to 6 months. Brains were 
quickly frozen with CO2 and cut in serial 40µm tick coronal sections with the Histoslide 200R 
cryomicrotome (Leica). Free floating sections were either processed for non-radioactive fluorescent 
ISH (FISH) after one week of post-fixation in 4%PFA in PBS or stored at -20°C in antifreeze solution 
(30% glycerol, 20% PEG supplemented with  0.1% sodium azide) for IHC experiments. 
7.3 Chimaeric BDNF-GFP  and RSV-MS2hairpin CDS constructs 
Total RNA was extracted from whole rat brain using TriZol Reagent (Invitrogen). 1mg of total 
RNA was then heat denaturated and reverse-transcribed into cDNA with a mix containing 100ng 
random primers (Roche Diagnostics), 5X first strand buffer (250mM Tris-HCl pH8.3, 375mM KCl, 
15mM MgCl2), 10mM DTT (Invitrogen), 2U/mL RNase inhibitor (Roche Diagnostics), 500mM dNTPs 
(Promega) and 200U Superscript III (Invitrogen). The reaction was carried out at 42°C for 50 minutes 
followed by SupercriptIII inactivation for 15 minutes at 70°C. For CDS-GFP chimaera cloning refer to 
Chiaruttini et al., 2008 (supplementary methods). PCR protocol was 5 min at 95 °C; 35 cycles of the 
progression- 1 min 95 °C, 1 min 55 °C, 2 min 72 °C-, 10min at 72°C. For GFP- 3’UTR short, GFP-3’UTR 
short mut ELAVup, GFP-3’UTR long, GFP-3’UTR mid and GFP-3’UTR end cloning, PCR were performed 
with 0.02 U/µL of Phusion Hi-Fidelity DNA polymerase (Finnzymes), 1 µg cDNA, 5X Reaction Buffer, 
1.5mM MgCl2, 200µM dNTPs (Promega) and 500nM of each specific forward and reverse primer 
(MWG biotech) (see Table2 for details).  PCR protocol was 30 sec at 98 °C; 31 cycles of the 
progression- 10 sec at 98°C, 20sec at 56 °C, 30sec (1.5 min for 3’UTR long amplification) at 72 °C,  
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10min at 72°C. For GFP-3’UTR short mutCPE and GFP-3’UTR short mutELAvdw cloning, an assembly 
PCR  strategy was adopted. Briefly, a first round of PCR was carried out as above described using the 
following protocol and primer pairs: 30 sec at 98 °C; 31 cycles of the progression- 10 sec at 98°C, 
2min at 57.5 °C, 30sec at 72°C. For CPE mutation: Fw 3’short 1-65 and Rev 3’short mut CPE; for 
ELAvdw mutation:  Fw 3’sh 1-65 and Rev ELAVdw mut (see table XXX for sequence details). A second 
round of PCR (30 sec at 98 °C; 31cycles of the progression- 10 sec at 98°C, 2min at 58 °C, 30sec at 
72°C) was performed using 2 µl of CPE and ELAVdw mutant fragments (as forward “megaprimers”) 
with 3’UTRsh Rev primer, to obtain mutated full length 3’UTR short sequence. PCR fragments were 
then purified (PCR Cleanup kit, Sigma) and digested with XhoI/SacII (New England Biolabs)(for BDNF 




5’- GGGCGGCCGCTGGATTTATGTTGTATAG -3' 




















5’- GTCAGTTAACTTTATTATCAATTCACAATTAAAGC -3’ 

















5’- GTCA AGATCTATGACCATCCTTTTCCTTAC -3’ 
5’- GTCAGCGGCCGCTCCCCTTTTAATGGTCAGTG -3’ 
Table 2.  Primer sequences used for reporter cloning. 
 
For RSV-MS2 hairpin CDS chimaera cloning, we used the same standard procedure above adopted, 
using 500nM of each specific primer pair (see table 2). PCR protocol was 30 sec at 98 °C; 31 cycles of 
the progression- 10 sec at 98°C, 20sec at 56 °C, 30sec at 72°C and final extension at 72°C for 10min. 
PCR fragments were purified (PCR Cleanup kit, Sigma) and digested with BglII/NotI restriction 
enzymes (New England Biolabs). 
For each clone, digested fragments were gel purified (Gen Elute gel extraction kit, Sigma)and ligated 
with 300U of T4DNA ligase (New England Biolabs) overnight at 16°C with properly digested pEGFPN1 
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vector for GFP chimaeras (Clontech) or RSV-MS2 hairpin vector (kind gift of professor K.Kosik, UCSB, 
California, USA) . Ligase products were then transformed into chemically competent DH5αF’ E.coli 
bacterial strain. Colonies were screened by PCR and positive clones have been further confirmed by 
sequencing. Already available clones have been used in this study, in particular ratCDS-GFP and 
rat∆(1-202)CDS-GFP and GFP-3’UTR short (cloned by dr.C.Chiaruttini), rat∆(68-212)CDS-GFP (cloned 
by dr.G.Baj), human Val66CDS-GFP and Met66CDS-GFP (kind gift of dr.B.Lu, NIH, Bethesda), 
humanG177A-, human G178A- and human G177A/G196A-CDS-GFP (cloned by dr.Z.Li, JHU, 
Baltimore), MS2-NLS-GFP by dr.Li-Na Wei (UMMS, Minnesota). 
7.4 siRNA production 
The target regions of interest were amplified from whole rat brain/testis cDNA, using T7 
promoter sequence-containing primers. Each PCR reaction was performed with 200 ng of cDNA, 
500nM of  each specific fw and rev primer (see table 3 for sequence details), 0.2 µM of dNTPs mix 
(Promega),  2.5 mM MgCl2 , 10X reaction Buffer, 0.05U/ µL of High Fidelity Taq DNA polimerase 
(Invitrogen). The PCR protocol was 5min at 95 °C; 31 cycles of the progression- 1min at 95°C, 1min at 
56 °C, 2min at 72°C- and final extension at 72°C for 10min.  




CPEB1  Fw T7 5’-GCGTAATACGACTCACTATAGGGtcagttgccagacttccagg-3' 
414 
 RevT7 5’-GCGTAATACGACTCACTATAGGGtgagtcagaggggctgctag-3' 
CPEB2 Fw T7 5’-GCGTAATACGACTCACTATAGGGtggggagcaatgcatggcagag-3' ~ 400 
 RevT7 5’-GCGTAATACGACTCACTATAGGGaacagattgtcggttcctgg-3' ~ 500 
CPEB 3 Fw T7 5’-GCGTAATACGACTCACTATAGGG tcctgcgcaaaccatgcagg-3’ 
494 
 RevT7 5’-GCGTAATACGACTCACTATAGGGtgcctccgaagaccgggttgac-3’ 
CPEB 4 Fw T7 5’-GCGTAATACGACTCACTATAGGG agtggaacggtattcccgcaagg -3’ 
471 
 RevT7 5’-GCGTAATACGACTCACTATAGGG agacgcctccatacagccggtc-3’ 
ELAV2 Fw T7 5’-GCGTAATACGACTCACTATAGGGttgtcgaccaggtcactggc-3’ 
275 
 RevT7 5’-GCGTAATACGACTCACTATAGGGtgctgagctagcggtcctgg-3’ 
ELAV3 Fw T7 5’-GCGTAATACGACTCACTATAGGGagccactgacgacagcaagacc-3’ 
364 
 RevT7 5’-GCGTAATACGACTCACTATAGGGctggctcatggtcttggggag-3’ 
ELAV4 Fw T7 5’-GCGTAATACGACTCACTATAGGGtcaggagtctctttgggagcattgg-3 
456 
 RevT7 5’-GCGTAATACGACTCACTATAGGGtgggcttctggccattcagc-3’ 
Translin Fw T7 5’-GCGTAATACGACTCACTATAGGG tgagcactggaggtttgtgc-3’ 324 
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 RevT7 5’-GCGTAATACGACTCACTATAGGGcgtagcgtttcctcagggag-3’ 
hnRNPA2/B1 Fw T7 5’-GCGTAATACGACTCACTATAGGGgaagatactgaggaacatcacc-3’ 
347 
 RevT7 5’-GCGTAATACGACTCACTATAGGGcctggtccgaaatttccaccgcca-3’ 
luciferase Fw T7 5’-GCGTAATACGACTCACTATAGGGcggccatgattggggtgcttg 
356 
 RevT7 5’-GCGTAATACGACTCACTATAGGGactaacgggatttcacgaggcca 
FMR1 duplex #1 GGUUUAUUCCAGAGCAAAUtt,       #2 GCAUGUGAUGCUACGUAUAtt 23 
FXR2P duplex #1 GCUACUAAGCACCUAGAGAtt        #2 GCUACCUUGAAUUUUCCGAtt 23 
 
Table 3. Sequences of the primers used for in vitro dsRNA production. Underlined, T7 promoter sequence. 
 
dsRNA synthesis was performed using the commercial kit Silencer™ siRNA Cocktail (RNase III) 
(Ambion) adding, in the following order, 1 µg of purified T7 PCR product, 2 µL of transcription buffer 
10X (Roche), 2 µL of ribonucleoside triphosphate mix 100 mM (ATP, CTP, GTP, UTP) (Roche), 2 µL of 
T7 RNA polymerase (Roche) and H2O DEPC up to the final volume of  20 µL. The reaction was carried 
out at 37°C for 2 hours and stopped adding the stop solution (20 µL of H2O DEPC, 8 µL of sodium 
acetate 1.5 M pH 5.2 and 80 µL of 96% cold ethanol).  PCR products were precipitated at -20°C and  
then centrifuged at 14000 rpm for 15 minutes at 8°C. The pellet was washed with of 80% ethanol and 
incubated for 10 minutes at room temperature. Subsequently, samples were centrifuged (14000 rpm 
for 5 minutes at 8°C) and resupsended in 50 µL of DEPC-treated H2O. The long dsRNAs were digested 
for 1 hour at 37°C with RNase III, to obtain pool of short siRNA (1µg of dsRNAs, 5 µL of buffer 10X 
(Ambion), 1 µL of RNase III (Ambion) and H2O DEPC up to the final volume of 50 µL). The reaction 
was stopped as previously explained for in vitro transcription. This methodology allows the 
production of pools of 12–30 bp double-stranded RNAs. The siRNAs were purified by EtOH 
precipitation and resuspended in 20 µL of H2O DEPC. The siRNAs were checked on 2% agarose gel 
and quantified using the spectrophotometer.  
For FMR1 and FXR2P , specific duplexes were kindly provided by Dr.Maja Castrén (Orionpharma, 
Helsinki). The efficiency of gene silencing was evaluated by western blotting analysis on siRNA 
transfected rat PC12 cells. 
7.5 Lipofectamine transfection 
The different vectors and siRNAs were transfected into primary neurons, PC12 or SK-N-BE cells, 
using lipofectamine 2000
(TM)
 (Invitrogen). The relative quantity of DNA to lipofectamine was 1μg of 
DNA (and, if it is the case, 19 nM of each siRNA) to 2μL of lipofectamine for each well of a 24 
multiwell slide The culture medium was replaced 3-6 hours before the transfection with fresh 
Neaurobasal supplemented with 2%B27. The conditioned medium was filtered (through 0.2 μm pore 
diameter filters) and diluted 1:1 with fresh neuron medium. The DNA (1 μg) was mixed with 50 μL of 
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native MEM medium (EUroclone) without serum nor antibiotics and incubated for 5 minutes at room 
temperature. At the same time, 2 μL of 1mg/mL lipofectamine were mixed with 50 μL of native MEM 
and incubated at room temperature for 5 minutes. The two solutions were then mixed and incubated 
for 20 minutes at room temperature, added to the cells and incubated for 1 hour at 37°C, 5% CO2. 
One hour after transfection the medium was removed and replaced with fresh filtered conditioned 
medium. For cell lines transfections on 6 well plates, a ratio of 4µg (or 19nM siRNAs) to 10µL of 
lipofectamine were used in 250µL of native MEM. The protocol was followed as described above 
except that the mixture was kept in culture until lysate preparation. 
7.6 Western blot analysis 
After transfection the cells were carefully washed twice in PBS. Cells were trypsinized and 
collected in lysis buffer  (25mM TrisHCl (pH 7.5),1mM EDTA, 1mM Spermidin, 1mM PMSF, 1mM 
iodoacetamide (IAA), 4μg/ml (1mM) Soy Bean Trypsin inhibitor (SBTI), 10μg/ml Turkey Egg White 
inhibitor (TEWI), 0.75% NP-40). Lysates were centrifuged at 10000 rpm for 15 minutes at 10°C to 
remove cellular debris, followed by Bradford assay to determine protein concentration. Sample were 
then boiled and analyzed on 12% polyacrylamide gel electrophoresis (10µg for SK-N-BE and 20µg for 
PC12 extracts). Proteins were then  electroblotted for 1 hour onto  nitrocellulose membrane 
(Schleicher & Schuell). Membranes were saturated for 40 minutes with a solution containing 5% non 
fat milk in PBST (PBS+0.1% Tween 20) before an overnight incubation at 4°C with either mouse 
monoclonal anti-GFP (1:4000 in 5% milk/PBST, Sigma), mouse anti-tubulin alpha (Sigma, 1:20000), 
rabbit anti CPEB-1,-2,-3,-4 (1:500, 1:400, 1:700 and 1:500 respectively, Abcam), rabbit antiELAV-1, -2, 
mouse anti ELAV-4 (1:500, 1:500, 1:1000 respectively, Abcam), goat anti ELAV-3 (1:1000, Santa Cruz), 
rabbit anti FMRP (1:1000, Abcam), rabbit anti FXR2 (1:700, Abcam), mouse anti hnRNPA2/B1 (1:1000, 
Abcam) and rabbit anti translin (1:2000). Membranes were then washed 3X5 minutes in 5% non fat 
milk in PBST and incubated for 1h at RT with the respective secondary antibody (anti rabbit 
HRP,1:10000 (Jackson); anti mouse HRP 1:10000 (Pierce); anti goat HRP 1:10000 (Dako); anti mouse 
AP 1:1500 (Jackson)). For alkaline phosphatase development, membranes were equilibrated in 
100mM Tris-HCl, pH 9.5, 50mM MgCl2, 100mM NaCl in presence of 70mg/ml NBT and 50mg/ml BCIP. 
For HRP development, membranes were incubated for 5 minutes with chemiluminescent substrate 
(GE Healthcare) before exposure to X-ray films (Kodak). 
7.7 Non radioactive in situ hybridization 
Non radioactive in situ hybridization on wild-type (WT), BDNF
Klox
 (courtesy of K.Jones, 
University of Colorado, Boulder, USA) and G196A knoxk in mice (courtesy of F.Lee, Cornell-Weill 
School of Medicine, New York, USA) brain sections was made according to the method described by 
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Tongiorgi et al. (Tongiorgi et al, 1998) with slight modifications. According to this method, free-
floating slices were washed twice in PBS/0,1% Tween20 (PBST) at room temperature (RT) for 5 min, 
quickly washed in H2O, then permeabilized with 2,3% sodium meta-periodate (Sigma) in H2O at RT 
for 5 min and quickly washed again in H2O. After these steps, the sections were incubated in 1% 
sodium borohydride (Sigma) in 100mM Tris-HCl buffer pH 7,5 at RT for 10 min, washed twice in PBST 
at RT for 5 min. Then the slices were digested with 8µg/ml proteinase K (Roche Diagnostics), for a 
time empirically determined with each set of slices, generally between 12min, and washed twice in 
PBST at RT for 5 min. After digestion the tissue sections were fixed in 4% PFA/PBST at RT for 5 min 
and washed two times in PBST at RT for 10 min. For in situ hybridization on cell cultures, the cells 
were fixed 15 min at RT in 4% PFA/PBS, washed in PBST, and permeabilized at -20°C in ethanol 
absolute for 20 min. To remove the ethanol, cells were rehydrateted for 3 min at RT with respectively 
a solution 50% ethanol/50% PBST, 30% ethanol/70% PBST and finally PBST alone. After 
rehydratation, both slices and cells were prehybridized at 55°C for 90 min in the hybridization mix 
containing: 20mM Tris-HCl, pH 7.5, 1mM EDTA (Sigma), 1x Denhardt’s solution, 300mM NaCl, 
100mM dithiothreitol (DTT, Fluka), 0.5mg/ml salmon sperm DNA (Labtek Eurobio), 0.5mg/ml 
polyadenylic acid (Sigma), and 50% formamide (Sigma). In situ hybridization was performed 
overnight at 55°C in the hybridization mix with 10% dextrane sulphate (Sigma) and the digoxigenin 
riboprobe (50-100ng/ml). High-stringency washes were performed in 2X saline sodium citrate buffer 
(SSC, 150mM NaCl, 15mM C6H5Na3O7⋅2H2O, pH 7.0) 0.1% Tween20 (SSCT)/50% deionised formamide 
at 55°C for 30 min, 20 min in 2X SSCT at 55°C and twice in 0,1X SSCT at 60°C for 30 min. Cells 
hybridized with digoxigenin riboprobe were processed for immunodetection with an anti-DIG Fab 
fragments coupled to alkaline phosphatase (Roche Diagnostics). Sections were instead  incubated 
overnight at 4°C in presence of the antibody diluted 1:1000 in PBST/10% fetal calf serum (FCS); while 
cells were incubated at RT in presence of the antibody diluted 1:500 in PBST/10% FCS for 3 hours 
only. After four washes in PBST for 10 min, in situ staining has been developed at RT with 4-nitroblue 
tetrazolium 70mg/ml (NBT; Labtek Eurobio) and 5-bromo-4-chloro-3-indolyl-phosphate 50mg/ml 
(BCIP; Labtek Eurobio) in 100mM Tris-HCl, pH 9.5, 50mM MgCl2, 100mM NaCl and 1mM Levamisol 
(Sigma). The time of incubation was empirically determined, generally for slices the reaction was 
carried out for at maximum 5 hours at room temperature, while cells were developed for about 45 to 
60 min at room temperature because of the strong expression of the GFP-chimeras. For fluorescent 
in situ hybridization, brain sections were stained with fluorescent anti-DIG enhancer set (Roche 
diagnostics) following manufacturer’s instructions. Sections were then mounted in anti fade 
mounting solution (Invitrogen) and stored at 4°C in dark. 
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7.8 GFP and CDS antisense probes preparation 
To produce anti-sense probes, 1µg of BamHI-linearized pBSKS-GFP or pGEM ratBDNF CDS were 
incubated with  2 μL of Transcription Buffer 10x (Roche), 2 μL of  DIG-UTP labelling mix (Roche), 2 μL 
of T7 RNA polymerase (for GFP antisense probes) or SP6 RNA polymerase (for rat BDNF CDS) (Roche), 
2U/μL of Rnase inhibitor (Roche) and H2O DEPC up to 20 μL. Reaction was blocked after 2 hours with 
2 μL of EDTA 0.5 M, 2 μL of LiCl 4 M, 75 μL of cold  EtOH 100%  and precipitated at -20°C. RNA probes 
were centrifuged at 13000 rpm for 20 minutes at 8 °C. The pellet was resuspended in 50 μL of H2O 
DEPC. Alkaline hydrolysis of the probes was performed in order to increase the specificity of ISH and 
reduce the background signal. One volume of the probes and one of the sodium bicarbonate buffer 
(40 mM NaHCO3/ 60 mM Na2CO3 pH 10.2) were mixed and incubated for 7 minutes at 60 °C. The 
reaction was neutralized and stopped adding half volume of HCl 0.1 M. RNA probe quality and 
integrity was tested through northern blot on nylon membranes before use. 
7.9 Immunohistochemistry on brain sections 
BDNF immunohistochemistry on wt and BDNF
Klox
 brain sections were performed on 2% PFA 
perfused brains cut at 40µm thick coronal sections. Briefly, slices were washed 3X5min in Tris 
buffered saline (TBS, 20mM Tris pH 7.5, 150mM NaCl), followed by incubation in 0.3% H2O2 in TBS to 
block the endogenous peroxidase activity. Sections were then washed 3X5 min in TBS before 30min 
of blocking in 10% FBS in Tris-X (0.75% Bovine Serum Albumin (BSA), 0.3% Triton X-100). After 
blocking, slices were washed again 3X5 min in Tris-X and incubated with polyclonal anti-BDNF 
antibody (Santa Cruz, 1:100) for 48hours at 4°C. To remove unspecific primary antibody binding, 3X5 
min washes in Tris-Y (0.25%BSA, 0.05% Triton X-100 in TBS) were performed, followed by incubation 
with anti rabbit HRP secondary antibody (Dako, 1:400) diluted in Tris-Y, for 1hour at room 
temperature. Slices were the washed 3X5 min in Tris-Y and again 3X5min in TBS before. Slices were 
finally developed through Nickel-enhanced diamminobenzidine (DAB) chromogenic reaction (one 
DAB tablet dissolved in 25mL TBS with 50mg D-glucose with 0.2% Nickel ammonium sulphate) for 
about 20-30 min at room temperature in dark. All passages, except development, were performed in 
gentle shaking. 
7.10 Polyadenylation assay (PAT) 
For polyadenylation assay (Salles et al, 1999), 1µg of total RNA was transcribed in cDNA as 
previously described, except that 200ng of  oligo(dT) anchor primer have been used instead of 
random primers. Subsequently, 100ng of retrotranscribed single stranded cDNA have been used in a 
second round of PCR to detect the poly(A) tail extension. The PCR program was 5min at 95 °C; 30 
cycles of the progression- 45sec at 95°C, 45sec at 59.5 °C, 1min and 30sec at 72°C and a final 
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extension at 72°C for 10 min. For 3’UTR short the following pair of primers have been used: Fw 3’UTR 
short 5’- GGGCGGCCGCTGGATTTATGTTGTATAG -3', Rev oligo(dT) anchor 5’-
GCGAGCTCCGCGGCCGCG-T12; for 3’UTR long the following primers have been used: Fw 3’long PAT 
2585 T5’-CATGCATGGCAGCAGGCCT-3’, Rev oligo(dT) anchor 5’-GCGAGCTCCGCGGCCGCG-T12. 
7.11  Live cell imaging 
For live cell imaging of RNA trafficking, we took advantage of the MS2 hairpin/MS2-GFP 
imaging system. Briefly, the RNA of interest was fused to an eight tandem repeat MS2 stem–loop 
sequence contained in the RSV vector that in turn had to be recognized by the MS2-NLS-GFP 
chimaeric protein. Primary rat hippocampal neurons at 5 DIV were co-transfected with a GFP-NLS-
MS2 vector (kind gift of professor Li-Na Wei, UMMS, Minneapolis, Minnesota) and a RSV-rBDNF CDS 
vector or a control RSV empty vector (a kind gift of Professor Kenneth Kosik, UCSB, Santa Barbara, 
California) to a 1:3 ratio. 24 hours after transfection, neurons were observed by live cell imaging 
using a camera (NIKON AXM 1200). Photos were taken every 20 seconds for 30 minutes, both in 
control condition and after application of 10mM of KCl to elicit neuronal activity. Images were 
elaborated and assembled with the stack builder plug-in of Image J 1.34 software (NIH). 
7.12  Sequence analysis and RNA folding 
An “in silico” analysis was performed on both BDNF coding region and 3’UTR using different 
alignment annotation softwares  and computer predictions starting from known cis-acting elements. 
Sequences obtained from NCBI (http://www.ncbi.nlm.nih.gov) were analyzed using BioEdit nucleic 
acid annotation (www.mbio.ncsu.edu/BioEdit/bioedit.html) and Primer Premier software with the 
support of ClustalW multiple alignment output (www.ch.embnet.org/software/ClustalW.html). Only 
conserved sites among different species have been taken in consideration in order to minimize false 
positives.Computer prediction of RNA 3’UTR short and long secondary folding structures was 
performed using the RNA structure 4.5 software based on the algorithm developed by M. Zuker 
(Zuker, 2003). Folding predictions were made by using parameters at default settings. Selection of 
the secondary structures has been carried out based on the most frequent observed ones that 
displayed the lowest  free energy. 
7.13 Quantitative imaging and statistic analysis 
Non radioactive in situ hybridization was analyzed by viewing stained cultures under bright-
field illumination. The positive neurons were acquired by a Nikon AXM1200 digital camera on a Nikon 
E800 Microscope with interference contrast-equipped lens (60x magnification) and then analyzed 
with the image analysis program ImageProPlus (Media Cybernetics, Silver Spring, MD). The function 
“Trace” was used to measure, starting from the base of the dendrites, the maximal distance of 
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dendritic labeling (MDDL) as done before (Tongiorgi et al, 1997). Dendrites were traced, in a 
conservative manner, up to the point at which the in situ labeling was clearly distinguishable from 
the background. The quantitative analysis refers to at least 4 different experiments in which about 
150 dendrites were measured in total. The mean of all the measurements are represented in bar 
graphs (see results) with corresponding standard errors (SE). Statistical data analysis was performed 
with the Sigma Stat 3.2 software (Systat Software, Inc.). Graph elaborations were done with Sigma 
Plot 11 software (Systat Software, Inc.). Statistical significance among groups was evaluated 
performing Kruskal-Wallis one-way ANOVA on ranks, followed by a multiple comparison procedure 
with Dunn’s method. Images in the thesis were captured with a 40X magnifications for the CA1, CA3 
and dentate gyrus (DG), cultured cells images were captured with a 60x objective (oil immersion). 
Densitometries on positively stained neurons were performed with the “Straighten” plugin of ImageJ 
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8.1 Activity dependent targeting of endogenous BDNF mRNA 
Several lines of evidence indicate that targeting of BDNF mRNA to dendrites plays a key role in 
mediating synaptic plasticity (An et al, 2008; Soule et al, 2006; Tongiorgi et al, 1997). As previously 
discussed, the studies carried by Tongiorgi, Righi and Cattaneo (1997, 2000) demonstrated that 
synaptic activity, elicited by BDNF signaling  and neuronal depolarization, represents the main event 
leading to increased dendritic sorting of the mRNAs encoding BDNF and its receptor TrkB . These 
studies have represented the starting point of the present study, focused on understanding the 
molecular mechanism as well as the stimuli underlying the activity dependent localization of BDNF 
mRNA in neuronal dendrites.  
In a first set of experiments, we sought for other possible stimuli able to induce BDNF mRNA 
translocation in neurites. To this aim, we used primary rat hippocampal neurons at 6 days in vitro 
(DIV) treated for three hours with 10mM KCl or 50ng/mL of each neurotrophin (NGF, BDNF, NT-3 and 
NT-4). After fixation, neurons were subjected to non radioactive in situ hybridization (ISH) (Tongiorgi 
et al, 1998) using a DIG-labeled antisense riboprobe against the coding region of BDNF mRNA to 
detect all possible BDNF splice variants. As reported in figure 8, panel A, BDNF mRNA is restricted in 
the proximal dendritic compartment in resting conditions, but a dramatic accumulation in distal 
dendrites is seen after 3 hours of  depolarization with 10mM KCl. We found that BDNF itself, even at 
a lesser extent, was able to promote the dendritic delivery of its own mRNA, confirming the data 
published in 2000 by Righi, Tongiorgi and Cattaneo.  Additionally, we found that a dendritic BDNF 
mRNA localization can be induced also by NT-3, but not NT-4 nor NGF. It was previously reported 
that NT-3 may promote the extrasomatic transport of RNA granules but the identity of the 
transported mRNAs was not discovered (Knowles & Kosik, 1997). Hence, BDNF appears to be the first 
known mRNA whose localization is influenced by NT-3 signaling.  
Data have been quantified by manually tracing the Maximal Distance of Dendritic Labeling 
(MDDL), that is the maximal distance starting from the base of the dendrite at which a signal above 
the mean background was detected. Only apical dendrites of bona-fide pyramidal neurons identified 
by morphological criteria, were measured. For each case, more than 100 cells were analyzed. Then, 
this measure has been normalized to the mean MDDL of BDNF mRNA in control conditions to obtain 
the “fold increase”. The specificity of the in situ hybridization technique was assessed using a sense 
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DIG-labeled riboprobe that, as expected, generated only a negligible background signal (fig.8 panel 
A). We found that KCl induces an increase in the distance reached by BDNF mRNA in dendrites of 
about 2.83±0.17 fold increase with respect to control conditions, while BDNF and NT-3 induce an 
increase of 1.59±0.11 and 1.49±0.10 folds, respectively. NGF and NT-4 did not significantly alter BDNF 
mRNA distribution. In further confirmation of the strict dependence of BDNF mRNA sorting on BDNF 
and NT-3 signaling, we found that blocking the Trk receptors activity with 30nM of K252a, either 30 
minutes before stimulation and throughout the stimulation period completely abolished the activity 
dependent sorting of BDNF transcripts (fig.8, panel C). As observed previously, inhibition of Trk 
signaling by K252a depressed significantly also BDNF mRNA KCl-dependent dendritic targeting, 















Fig.8. Activity dependent targeting of endogenous BDNF mRNA in primary hippocampal neurons. A) representative in situ 
hybridizations showing strong dendritic labeling after KCl, BDNF and NT-3 application. Lower panel, control in situ 
hybridization using CDS sense probe.  Scale bar 10µm; B) quantification of BDNF mRNA half life in cultures treated with the 
transcription inhibitor actinomycin D (5mg/mL) in control and stimulated conditions; C) quantification of the fold increase 
of BDNF mRNA in dendrites shows a strong upregulation after KCl, BDNF and NT-3 treatment (***, P<0.001, Kruskal-Wallis 
One Way Anova on Ranks followed by a multiple comparison procedure with Dunn’s method).   
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To rule out the possibility that the increased dendritic localization seen after stimulation was 
due to increased mRNA stability rather than enhanced transport, we performed semi-quantitative 
RT-PCRs on total BDNF mRNA extracted from stimulated and unstimulated control neurons treated 
with the transcription inhibitor actinomycinD.  As reported in fig.8 panel B, there is no statistical 
difference between BDNF mRNA stability in control and stimulated conditions at all the time points 
considered, arguing for a specific transport dependent mechanism initiated by KCl, BDNF and NT-3. 
To confirm the biological activity of the neurotrophins used throughout this study,  c-fos 
immunostaining on neuroblastoma SK-N-BE cells was performed. The strong nuclear c-fos labeling 
seen after KCl and NTs application was indicative of their active biological role, ruling out the 













Fig.9.  c-fos immunostaining on stimulated SK-N-BE to demonstrate the biological activity of  KCl and neurotrophins. Strong 
nuclear signaling is detected in most of the labeled cells. Scale bar, 10µm. 
 
8.2 Analysis of BDNF mRNA localization signals 
Given the high complexity of BDNF gene structure leading to the expression of up to 22 
different splice variants, one goal of this PhD study was to dissect the role of each different UTRs 
with respect to the regulation of BDNF mRNA subcellular localization. Previous studies carried by 
Cristina Chiaruttini in our laboratory demonstrated that chimaeric rat BDNF-GFP constructs display a 
different localization in neurons. In particular, rEx1-CDS-GFP and rEx4-CDS-GFP constructs were 
localized within the first 30% of the dendritic compartment whilst labeling for rEx2B-CDS-GFP, rEx2C-
CDS-GFP and rEx6-CDS-GFP extended into distal dendrites. Remarkably, the localization of these 
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constructs was not affected by extracellular stimuli like 10mM KCl and paralleled that of the 
corresponding endogenous transcripts in vivo even though they lacked the BDNF 3’ UTR (Chiaruttini 
et al, 2008). Thus, these findings are consistent with the presence of dendritic targeting signals in 
exons 2 and 6. Surprisingly, rCDS-GFP alone showed a comparable distal localization expressed as 
relative dendritic filling (RDF). The relative dendritic filling index (RDF) was determined by the MDDL 
normalized to the length of the dendrites as determined by MAP2 immunostaining . For the rat CDS, 
the RDF has resulted to be 69.97±2.38 (P<0.001 vs. GFP). Control constructs had the expected 
localization and consisted of GFP alone (RDF 32.95±1.60, proximal dendritic localization), GFP-
α tubulin (RDF 15.26±1.31, somatic localization) and GFP-α subunit of Ca2
++
calmodulin-dependent 
protein kinase II (RDF 82.49±6.69,  activity-dependent targeting to dendrites) (Mori et al, 2000). This 
unexpected finding indicates that, conversely, the CDS contains a dendritic targeting signal that is 
suppressed by exons 1 and 4, and seems to be constitutively active since it is not sensitive, like the 
exon containing chimaeras, to KCl stimulation . In addition, using the MS2 RNA-time lapse imaging 
system (for details, see materials and methods), we confirmed in living neurons that the dendritic 
trafficking of rCDS labeled granules is not affected by KCl treatment (fig. 10). Most MS2-rCDS 
granules (75%) had anterograde or retrograde movements with average velocity 0.12µm/s ±0.018 
(max 0.26 µm/s; min. 0.07 µm/s), while the remaining 25% oscillated around a fixed position. 
Conversely, MS2-control granules did not display extrasomatic localization, since the control vector 
did not encode for a dendritic targeting element. 
 
Fig.10 Video time-lapse analysis 
of living neurons shows no 
effect of KCl treatment on 
dendritic trafficking of MS2-GFP-
labeled rCDS RNA granules. The 
plasmid encoding the MS2-
binding protein fused with GFP, 
or the GFP alone (GFP), has a 
nuclear localization (GFP/MS2), 
but diffuses in the soma and 
dendrites cytoplasm when co-
transfected with a 6_MS2-BDNF 
CDS construct (GFP/MS2-CDS). 
MS2-BDNF CDS (MS-CDS) 
moving granules (75% of total 
granules) recorded over 10 min, 
move at the same speed as 
those under 10mMKCl 
depolarization. Oscillatory 
granules (25% total granules) do 
not change behavior during 
10mindepolarization with 10 
mM KCl. 
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8.2.1 The coding region contains a constitutive dendritic targeting 
signal 
To help identifying the dendritic targeting signal(s) present in the coding region, the rat and 
human sequences were scanned with BIOEDIT and ClustalW software to search for conserved 
recognition sequences for RNA binding proteins involved in dendritic RNA targeting. This sequence 
analysis revealed the presence of a strikingly conserved, bipartite recognition site (rBDNF CDS 
nucleotides 173–181 and 193–205; Fig. 11A), for the single stranded DNA/RNA binding protein 
translin, also known as testis brain-RNA binding protein (TB-RBP) (Kwon & Hecht, 1993; Li et al, 
2008).  These two elements are 70% and 80% identical to the rat Protamine-2 Y’ and H’ elements, 
respectively. Of note, the position of the H element within the human BDNF sequence overlaps the 
location of the G196A (Val66Met) mutation (Freudenberg-Hua et al, 2003) (arrow in Fig. 11A), which 
has been shown to impair dendritic localization of BDNF and is associated with cognitive impairment 
and neuropsychiatric disorders (Egan et al, 2003). To determine whether this region is required for 
dendritic trafficking of the CDS-GFP chimaeric construct, we tested in primary neurons two deletion 
chimaeras: ∆(68–212)-rCDS-GFP and ∆(1–202)-rCDS-GFP. Both constructs had somatic expression 
levels that did not differ from that of GFP and displayed RDF values lower than that of the intact 
rCDS-GFP sequence (fig. 11), suggesting that these deletions disrupt the constitutive dendritic 
targeting signal present in the CDS. 
 
Fig.11. Analysis of the effects on BDNF mRNA targeting of deletions in the 
region containing the putative translin binding site. (a) Schematic 
representation of rCDS-GFP chimaera,_(68–212)- and_(1–202)-rCDS-GFP 
deletion mutants lacking nucleotides 68–212 and 1–202, respectively. (b) 
Relative dendritic filling (RDF) values of rCDS-GFP, ∆(68–212)- and ∆ (1–
202)-rCDS-GFP chimaeras. The decrease in the RDF values was significant 





Based on these encouraging observations, we proceeded to assess the involvement of translin 
in dendritic targeting of BDNF mRNA by using an siRNA ‘‘cocktail’’ against translin (si translin), 
generated by digestion of a 300-bp fragment of translin (Fig. 12B). Si-translin produced 72% down-
regulation of endogenous translin mRNA and 73% reduction of translin protein in hippocampal 
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cultures without interfering with control GAPDH RNA or tubulin protein expression (Fig. 13A and B). 
Dendritic targeting of both rat and human BDNF CDS-GFP constructs was significantly reduced by si-
translin (P<0.001; Fig. 12B) leading to RDF values close to that of GFP alone (GFP RDF 32.06±3.12). 
Similar effects on dendritic targeting of transfected BDNF rCDS-GFP, were obtained by silencing 
translin with two defined siRNA oligo sequences used either alone or in combination (si690, si744; 























Fig. 12. Role of translin in BDNF mRNA targeting. (A) Conserved translin binding Y and H elements in human and rat BDNF 
and mouse Protamine2. (B) Inhibition of the rat and human CDS-GFP RDF values with an siRNA translin mixture (rat ***, P 
< 0.001; human δδδ, P < 0.001 vs. control), or two siRNA oligos used either alone or in combination (si690, si744), 
mutated si744 (si744M) had no effect. Inhibition of CDS-GFP dendritic targeting by si690 and si744 was rescued by co-
transfection with siRNA-insensitive human translin. (C) Endogenous BDNF mRNA dendritic targeting up-regulation by KCl 
(***,P< 0.001 Crtl_KCl vs. Crtl), is inhibited by translin siRNA (###, P < 0.001 si-translin KCl vs. Crtl_KCl), or si690 and si744, 
but not by scrambled siRNA (NS, not significant). (D) GFP-3_ UTRlong displays an activity-dependent targeting to 
dendrites in response to 3 h 10 mM KCl that is not affected by si-translin. (E) (Upper) trax antibody immunoprecipitates 
Translin (arrowhead).Coprecipitation of translin is blocked by omission of Trax antibody or preincubation with its antigen 
peptide. (Lower) RT-PCR analysis of the immunoprecipitated RNA:protein complexes. BDNF mRNA was detected only in 
the ‘‘offered’’ sample and the IP pellet containing translin. (F) A radiolabelled segment of the human CDS region 
containing the Y and H elements (nucleotides 176–211) forms two gel-shift bands after incubation with rat brain extracts. 
  ANALYSIS OF THE MOLECULAR MECHANISMS OF BDNF MRNA  




The lower band (arrowhead ‘‘Translin’’) is ‘‘supershifted’’ with Trax antibody (marked with *). Upper band (small arrow) 
reflects binding of thisprobe with an unrelated complex. 
In contrast, a scrambled siRNA oligo generated by inserting multiple mismatches into si744 si744M) 
had no effect on BDNF rCDS-GFP dendritic targeting (Fig. 12B). As human translin contains multiple 
mismatches with both si690 and si744, we assessed whether it would reverse their inhibitory 
effects. As expected, cotransfection of human translin with si690 and si744 rescued the constitutive 
dendritic targeting of the BDNF rCDS-GFP construct (Fig. 12B), confirming that the inhibitory effect 
of these siRNA oligos is due to silencing endogenous translin. 
Fig. 13. Analysis of efficacy and specificity of 
siRNA- and shRNA-mediated translin knockdown. 
(a) Semiquantitive RT-PCR showed that siRNA to 
translin downregulated translin mRNA by 72% 
while the signal for the housekeeping gene 
GAPDH was unaffected. (b) Western blot analysis 
of hippocampal neurons transfected with si-
translin showed a 73% down-regulation of translin 
protein. (c) The ability of defined shRNA 
sequences to decrease endogenous expression of 
translin was tested in primary cortical cultures 
following infection with lentiviral constructs 
containing shRNA inserts. Immunoblots show that 
two sequences, called 690 and 744, reduce 
translin protein expression. Of note, deletion of 
translin also reduces trax protein levels. β-actin 
blot shown as a normalizing  control. In contrast, 
the sequence generated by inserting multiple 
mismatches into 744, called 744M, did not 
decrease either translin or trax protein levels. For 
the values presented in the bar graph, the 
intensity of the translin bands was adjusted for 
changes in β -actin levels. Translin levels in 
cultures treated with either 690 or 744 were 
significantly reduced (*, P < 0.05) 
 
Taken together, these studies demonstrate that translin mediates a constitutive dendritic 
targeting signal located in the CDS and this targeting mechanism is conserved in rat and human 
mRNAs. As the constitutive targeting signal was identified with an artificial truncated BDNF construct, 
its physiological relevance was still unclear. Accordingly, we examined translin’s role in dendritic 
targeting of endogenous, full-length BDNF mRNA. To this end, primary hippocampal cell cultures 
were transfected with si translin or a control, scrambled, siRNA and then depolarized with 10mMKCl 
for 3 h. In accordance with previous studies (Tongiorgi et al, 1997), depolarization induced a strong 
RDF increase for endogenous full-length BDNF mRNA (from CTRL  29.18 ± 0.74 , to 85.37±2.18 for 
10mMKCl; P<0.001). However, in the presence of si-translin and KCl, the RDF only increased to 40.85 
±1.6 (P <0.001 with respect to KCl alone), while a scrambled siRNA had no significant effect (Fig. 12C). 
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Similarly, activity-induced dendritic targeting of endogenous BDNF mRNA was abolished by 
transfecting neurons with si690 and si744 either alone or in combination (Fig. 12C) Of note, si-
translin did not block the ability of KCl to induce dendritic trafficking of the long 3’ UTR fragment of 
BDNF mRNA that encodes an electrical activity dependent targeting signal (see paragraph 8.3) (Fig. 
12D). Taken together, these results suggest that the constitutive dendritic targeting signal located in 
the CDS, which depends on translin, also plays a critical role in mediating the inducible targeting of 
full-length BDNF mRNA into distal dendrites.  
In collaboration with prof. Baraban at Johns Hopkins School of Medicine (Baltimore, USA), we 
were able to demonstrate through co-immunoprecipitation and supershift experiments that translin 
effectively interacts in vivo with BDNF mRNA together with its partner Trax (Translin associated 
factor X) (fig. 12E and F). Omission of trax antibody or its preincubation with the antigen peptide 
blocked immunoprecipitation of both translin and BDNF mRNA. Thus, these results indicate that 
BDNF mRNA is associated with the translin complex in vivo. To check whether translin binds to the 
segment of the CDS containing adjacent Y- and H-like elements, gel-shift studies employing forebrain 
homogenates using this recognition element  as probe confirmed that endogenous translin/trax 
complex binds to this sequence on BDNF mRNA. Moreover, in collaboration with dr.Braiuca and 
prof.Gardossi at the Department of Pharmacological sciences at the University of Trieste, we created 
an in silico 3D interaction model between two translin monomers and a 48nt long RNA stretch 









Fig.14. Three-dimensional modeling of translin dimer binding to human BDNF mRNA. (A) Minimal consensus RNA sequence 
for binding to the translin complex with two critical G residues separated by a poly U spacer of variable length. In human 
BDNF, spacing of the relevant G residues (G178 and G196, in bold) is constrained by formation of a stem-loop. (B and C) 
Interaction of G178 and G196 and position of the stem-loop on BDNF mRNA with a translin dimer (monomers in two 
different brown shades). (D) Modeling of the eight BDNF mRNA nucleotides interacting with a translin dimer. (E) Translin 
amino acids His-90, Arg-21, Glu-89 form three hydrogen bonds with G196 (normal BDNF) but only one with A196 (mutated 
BDNF, in F). (G) Summary of the nucleotide:amino acid selectivity for each of the four binding sites on translin. 
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Thanks to this computational analysis, we were able to identify four adjacent binding sites for 
individual ribonucleotide bases on each translin monomer: the first one is mainly formed by Arg-86, 
the second one is delimited by His-90, Arg-21, and Glu-89, and the third and fourth sites are less 
distinct, as they are globally delimited by His-88, Asp 136, and Arg 92 (Fig.14 B–D and G).  
Moreover, computer simulation predicted that the RNA would fold into a 5’-3’ “M” 
conformation, in which the central part would form a stem loop structure whereas each of the 
external bars of the M (ascending and descending, respectively) might interact with the four-
nucleotide binding site present on each translin monomer (fig. 14A). To test the prediction made by 
in silico 3D modeling that the G196A SNP impairs binding of the BDNF oligo to the translin/trax 
complex, our collaborators at Johns Hopkins performed gel-shift competition assays with a wildtype 
human BDNF oligo spanning nucleotides 176–199 and the G196A version of the same segment. Since 
the docking simulation also predicts that G178 binds to the highly selective site 2 on the other 
translin monomer, we also examined the impact of mutating this G residue, as well as its neighbor 
G177 (Fig. 15A). While 10 nM of wild type or G177U BDNF RNA was sufficient to displace about 85% 
of a labeled rat protamine-2 oligo probe containing the translin binding site, the mutated G196A or 
G178U oligos were able to displace only 50% of the protamine-2 probe, as would be expected if 
these oligos have lower affinity for the complex (Fig. 15A, and B). In agreement with the model, 
mutating both these key G residues, G178 and G196, almost completely abolished the ability of this 









Fig. 15. G178 and G196 mediate binding to translin. (A) Stem-loop structure and the nucleotides (in gray) interacting with 
translin in the oligo used for these experiments. (B) In competition gel-shift assays, significant loss in inhibitory potency is 
produced by the G178U and G196A substitutions. The double mutation G178U/G196A markedly decreases its ability to 
compete with the WT Prm-2 probe. The G177U mutant does not differ from WT, and the inhibitory activity of the  
177U/G196A double mutant equals that of G196A mutant. 
  ANALYSIS OF THE MOLECULAR MECHANISMS OF BDNF MRNA  




In contrast, mutating G177 and G196 did not decrease its inhibitory activity below of that of 
the single G196A mutation (Fig. 15 B and C). Taken together, these competition data strongly support 
the in  silico modeling that predicts G178 and G196 to be the crucial residues for binding of BDNF 
mRNA to translin. These encouraging results prompted us to investigate if the G residues in position 
178 and 196 actually represent the critical residues bound by translin. We therefore tested this 
prediction transfecting  primary rat hippocampal neurons with the human BDNF-GFP chimeras 
containing either the normal G196 allele (Val) or the mutated G196A (Met) version. In addition, we 
tested whether mutations at G177 and G178 residues would exert similar effects on BDNF mRNA 
targeting as they do on binding to the translin complex. As predicted, we found that dendritic  the 
G196A form of human BDNF transcripts (hCDS Met-GFP) was markedly reduced compared with the 
normal allele (P <0.001, Fig. 16B). Consistent with the competition assays, G178U, as well as 
combined mutation of both G178 and G196, also decreased CDS dendritic localization. Of note, 
G196A, G178U, and G196A/G178U showed decreases of similar magnitude (≈30% decrease), 
suggesting that changing either of these key G residues is sufficient to achieve the maximal possible 
impairment of the translin-mediated dendritic targeting of the CDS-GFP construct (Fig. 16 A and B; P 
< 0.001). In contrast, G177U, which does not impair binding to translin, also did not affect targeting 
of the human BDNF CDS (Fig. 16B). Of note, si-translin has little further inhibitory effect on targeting 
of the G196A construct (hCDS Met-GFP), even though it strongly inhibits either rat or human wild-










Fig.16. Impact of human G196A mutation on BDNF mRNA targeting. (A) In situ hybridization on hippocampal neurons 
transfected with human BDNF CDS-GFP with mutations at G177,G178 and G196. Arrows show the MDDL.(Scale bar, 10 µm.) 
(B) hCDS-G178U-, hCDS-G196A-, and hCDS-G178U/G196AGFP mRNAs show lower RDF values than hCDS-G196-GFP (***, P < 
0.001), hCDS-G177U had no effect (NS). (C) Translin silencing impairs dendritic targeting of human BDNF CDS mRNA (***, P 
< 0.001) but has a smaller effect on hCDS Met-GFP (phi symbol, P< 0.05 vs. hCDS Met-GFP without siRNA). Error bars, SEM. 
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The marked difference in dendritic targeting noted between G196 (Val) and G196A (Met) BDNF 
constructs was not due to their effects on the degree of arborization of transfected neurons, because 
we did not find any difference in the total length of processes of the in situ positive neurons 24 h 
posttransfection with mutant or normal human BDNF constructs (hCDS Val- GFP 186.35±2.05 mm; 
hCDS Met-GFP 184±6.65 µm). As a final demonstration of the importance of translin binding for the 
correct BDNF mRNA sorting in dendrites, we investigated the impact of the G196A mutation in a 
knock in animal model carrying this SNP on both BDNF alleles (Chen et al, 2006). BDNF mRNA is 
targeted to distal dendrites of hippocampal neurons upon stimulation with the proepileptic drug 
pilocarpine (fig. 17), in agreement with previous studies done in rats (Tongiorgi et al, 2004). Although 
Val/Val and Met/Met mice showed comparable seizure activity in response to pilocarpine, dendritic 
targeting of BDNF mRNA in hippocampal neurons was abolished in G196A (Met/Met) mice (fig. 17).  
 
Fig. 17. In situ hybridization for BDNF mRNA on  
hippocampal sections from wt (Val/Val) and 
Met/Met knock-in mice. In saline-treated mice, 
BDNF mRNA is confined to the cell body layers of 
CA1 (Left) and CA3 (Right) in both wt and Met/Met 
mice (Upper). Upon pilocarpine treatment for 3 h 
(PILO), BDNF mRNA labeling is  pparent in dendritic 
regions (stratum radiatum) of CA1 and CA3 
neurons in Val/Val mice, but not in Met/Met 













  ANALYSIS OF THE MOLECULAR MECHANISMS OF BDNF MRNA  




Thus, these findings indicate that the inhibitory effect of G196A on dendritic targeting is not 
limited to the truncated CDS transcript but also applies to endogenous, full-length BDNF mRNA. 
These important results shed new insights on the physiological implications of this simple but 
deleterious mutation in human beings affected by obsessive compulsive disorders. It has been 
proposed that the Val66Met mutation impairs the correct intracellular sorting and secretion of BDNF 
protein, leading to the phenotypic characters and memory deficits (Bath & Lee, 2006; Chen et al, 
2006; Pezawas et al, 2004). Thanks to these results we provide further evidence that there is an 
upstream deficit at the level of dendritic BDNF mRNA targeting that might account for a reduced 
distal BDNF protein availability related to the reduction in the complexity of the dendritic arbor 
induced by this mutation. The work presented here has recently been published in PNAS (“Dendritic 
trafficking of BDNF mRNA is mediated by translin and blocked by the G196A (Val66Met) mutation” 
C. Chiaruttini*, A. Vicario*, Z. Li, G. Baj, P. Braiuca, Y. Wu, F. S. Lee, L. Gardossi, J. M. Baraban and E. 
Tongiorgi, PNAS (2009). *CC and AV are equally contributing as first author) 
 
8.2.2 The 3’UTRs contain inducible signals mediating BDNF mRNA 
activity dependent targeting 
Given the unexpected finding that the coding region of BDNF contains a constitutive dendritic 
targeting element and none of the 5’UTRs responds to extracellular stimulation, we hypothesized 
that the two different 3’UTRs of BDNF may contain the activity dependent signals that mediate the 
KCl- and neurotrophin- dependent BDNF mRNA translocation in dendrites. A recent work  highlighted 
that the long 3’UTR but not the short 3’UTR, is involved in mediating BDNF mRNA dendritic sorting 
and translation  in resting neurons, but did not investigate the effect of neuronal activity with respect 
to its localization (An et al, 2008). To study more in detail the role of 3’UTRs, primary rat hippocampal 
neurons were transfected with the GFP-3’UTR short or long chimaeras, and 24h later neurons were 
stimulated for 3h with either 10mM KCl or 50ng/mL of NT-3 or BDNF. Afterwards, neurons were 
subjected to standard ISH using a DIG-labeled GFP antisense probe, and the localization of the mRNA 
in positive transfected cells was measured (fig 18). To rule out any unspecific staining, control ISHs 
using either GFP sense probes on transfected cells or either antisense probes on non transfected 
neurons have been performed (fig.18D, right panel).  In resting neurons, the short 3’UTR was mainly 
confined in the proximal dendritic compartment (MDDL 41.56±0.82µm) in accordance with a 
previous study  by An et al. (2008) and similarly to the GFP reporter alone (MDDL 40.34±1.72µm), 
whose localization is not influenced by neuronal depolarization (MDDL 40.36±1.87µm). However, the 
short 3’UTR was found to promote a significant increase in reporter mRNA localization in distal 
  ANALYSIS OF THE MOLECULAR MECHANISMS OF BDNF MRNA  




dendrites either after high potassium depolarization (MDDL 80.57±1.94µm, P<0.001 respect to GFP-
3’UTR short) or treatment with NT-3 (MDDL 69.14±1.61µm, P<0.001 respect to GFP-3’UTR short) but 





























Fig.18. Activity dependent localization of BDNF 3’UTRs. A, D) In situ hybridization on hippocampal neurons transfected with 
either GFP-3’UTR short or long. Panel D, right side, control in situ hybridizations using GFP sense probe on transfected cells 
(upper picture) and GFP antisense probe on non transfected cells (lower picture). Arrows indicate MDDL.(Scale bar 10µm) 
B)10MmKCl and 50ng/mL NT-3 induce a significant increase in mean 3’UTR short MDDL (respectively 80.57±1.94µm and  
69.14±1.61µm,  ***P<0.001 respect to GFP-3’UTR short). C,F) densitometric analysis of neurons transfected with GFP-
3’UTR short (C) or long (F) treated with different agonists. Increased signals along dendrites have been detected in both 
GFP- 3’UTR short and long transfected neurons after KCl/ NT-3 and KCl/BDNF application respectively (***, P<0.001 respect 
to GFP). Data are in accordance with the mean MDDL observed in each case .  
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 The broad Trk tyrosine kinase inhibitor K252a abolished the GFP-3’UTRsh reporter dendritic 
localization in response to NT-3 application (Fig.18B). Similarly, also KCl-induced translocation was 
significantly impaired, therefore indicating that a NT-3- dependent component plays a significant role 
during neuronal depolarization (fig.18B). However, the BDNF-sensitive region remained still 
unknown, since the short 3’UTR delivery in dendrites was unaffected by this neurotrophin. These 
initial results prompted us to investigate the regulation of long 3’UTR dendritic targeting. In resting 
conditions, the localization of the GFP-3’UTR long chimaera did not differ significantly from the GFP 
reporter alone (MDDL 43.14±1.36µm). However, depolarization induced a strong increase in 
dendritic localization of this construct mRNA (MDDL 62.44±1.44µm, P<0.001 respect to GFP-3’UTR 
long) (fig. 18D, E  and F). Furthermore, we found that with 50ng/mL BDNF the dendritic localization 
of the 3’UTR long reached distances from the soma comparable to those seen after high potassium 
depolarization (MDDL 61.38±1.92µm). Accordingly, K252a application significantly abolished both 
BDNF and KCL dependent mRNA targeting, suggesting that BDNF signaling may largely account for 
the effect of KCl depolarization on BDNF 3’UTR long mRNA localization (fig.18E). Surprisingly, even if 
the 3’UTR long does contain the nucleotide sequence of 3’UTR short, it did not result sensitive to NT-
3 signaling, arguing for a different mechanism of control of neurotrophin-dependent subcellular 
localization for these two variants. The same data have been quantified through a densitometric 
analysis of in situ signal throughout the entire dendritic length of positive neurons, leading to results 
comparable to those obtained with MDDL measurements (fig. 18C and F).  
Taken together, these data provide strong evidence that the inducible signals responsible for 
the activity dependent localization of BDNF mRNA lie at the level of the two 3’UTR regions. These 
signals are modulated by neuronal depolarization (KCl) for both regions but are specifically regulated 
by NT-3 for 3’UTR short and BDNF for 3’UTR long. To confirm these in vitro data accounting for an 
active role of 3’UTR short in mediating BDNF mRNA sorting, we took advance of a transgenic mouse 
model lacking of a functional  long 3’UTR (Gorski et al, 2003). As shown in figure 19, in both wild type 
and BDNF
klox 
mice, BDNF mRNA is confined in the proximal dendritic compartment of CA1 and CA3 
neurons in resting conditions and dendritic staining in resting BDNF
klox
  mice was reduced with 
respect to wt animals as described previously (An et al, 2008). On the basis of similar findings, An and 
coworkers concluded that only the long 3’UTR results necessary for BDNF mRNA targeting into 
dendrites (An et al, 2008). However, after treatment with the proepileptic drug pilocarpine for 3h, a 
dramatic accumulation of dendritic BDNF transcripts was observed  in wt as well as BDNF
klox 
animals, 
confirming our finding that under also BDNF mRNA with a short 3’UTR can be transported in 
dendrites after stimulation (see paragraph 8.2.1) (fig 19, right panel). 
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Fig.19. BDNF 3’UTR short is targeted in dendrites. Left panel , proximal BDNF mRNA localization in control conditions in wild 
type (wt) and transgenic mouse (Klox). A dramatic increase of dendritic BDNF messenger content has been observed after 3 
hours of pilocarpine treatment (300mg/kg) in both wildtype and klox animals, confirming the previous in vitro data 




  neurons a punctuate distribution of BDNF messenger was observed, 
whilst a more uniform one was seen in wild-type animals. These differences may be due to the fact 
that the long 3’UTR is lacking from distal compartments  of BDNF
klox
 neurons and therefore the 
staining for BDNF mRNA is generally weaker. 
 
8.2.3 The short and long 3’UTRs require a different but partially 
overlapping set of RNA binding proteins for their inducible localization 
Given that the two 3’UTR forms responded to different stimuli, we searched for putative RNA 
binding proteins that could account for this differential regulation. To this aim, we carried an 
exhaustive  bioinformatic analysis out on both sequences using clustalW and bioedit softwares. We 
took in consideration only the most conserved sites on BDNF mRNA among different species (Rno, 
Hsa,  Ptr, Mml, Oga, Cpo, Ocu, Sar, Eeu, Cfa, Fca, Eca, Bta, Dno, Laf, Ete, Mdo, Oan, Aca, Gga, Xtr) 
because they might be more indicative for a conserved biological function. As illustrated in figure 20, 
the short 3’UTR (1-321) displays two different conserved sites for ELAV proteins (the 5’ most is 
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3’UTR short ELAV rich region 
MID 3’UTR long 
END 3’UTR long 






Fig.20 Putative binding sites for known RNA binding proteins on rat  BDNF 3’UTR mRNA following bioinformatic analysis. 
Only conserved sites among species are shown. 
 
Of note, the short 3’UTR is highly conserved among species, suggesting its critical role in 
regulating BDNF protein expression. On the other side, even if the long 3’UTR is less conserved, we 
have identified three conserved “hot spots”  (red lines) containing several candidate recognition 
sequences for RBPs. The first conserved sequence presents many clustered binding sites for ELAV1 
(HuR) and has been named “ELAV rich region”. A nearby second conserved sequence of the 3’UTR 
long is characterized by a G-quartet like structure, known to be recognized by FMRP. Finally, a third 
region at the end of the long 3’UTR encodes a pattern of cis-elements similar to the one found in the 
short 3’UTR (i.e. CPEs and ELAV recognition sites). In this study we did not analyze the potential 
effect of miRNAs on BDNF expression, since it was beyond the principal aim of this project and a 
recent study already addressed this issue (Mellios et al, 2008).  
To test the effective contribution of these proteins with respect to BDNF mRNA targeting, we 
looked at any alteration in 3’UTR short or long dendritic localization in presence of siRNAs made 
against each of these RNA binding proteins. Starting from the short 3’UTR, we cotransfected primary 
neurons with GFP-3’UTR short together with siRNA cocktails against each CPEB protein (siRNA 
specific for CPEB-1, -2, -3 and -4) or ELAVs separately (siRNAs specific for ELAV-1, -2, -3, and -4). 
Analysis of siRNA efficacy showed a high degree of reduction in the relative proteins and a high 
specificity for all siRNA cocktails used (see Fig. 21 for silencing efficacy and Fig. 22 for specificity). 
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Fig.21. Analysis of efficacy and specificity of siRNA-mediated knockdown of the RBPs considered in the present study. PC12 
rat pheochromocytoma cells were silenced for 36 hours with with 19nM of each siRNA mixture. Protein extract s were then 
subjected to standard western blot with specific antibodies (see materials and methods). 
 
To rule out any possible siRNA-induced off target effect among homologous members of the 
CPEB and ELAV family, we performed a series of RT-PCR reactions. The results obtained demonstrate 
that each siRNA cocktail specifically targets only the desired isoform and not the other ones (fig 22).  
 
 
Fig. 22. Representative PCRs of the silencing effect among CPEB (left) and ELAV (right) family members. No off target effects 
were observed during silencing of each specific isoform. CPEB3 displayed a very faint mRNA expression in primary neurons 
but a significant one in rat brain. 
 
As reported in figure 23, panel A, activity-dependent localization of  the GFP reporter requires 
the activation of both CPEB-1 and -2 , but not CPEB-3 or -4 (CPEB1 siRNA KCL MDDL 37.16±1.12 µm, 
CPEB2 siRNA KCL MDDL 37.48±1.63 µm, ****P<0.001 respect to KCl no siRNA; CPEB1 siRNA NT-3  
MDDL 37.69±1.09 µm, CPEB2 siRNA NT-3 MDDL 38.96±1.18 µm , ### P<0.001 respect to NT-3 no 
siRNA). A control, luciferase-specific siRNA has no effect on BDNF mRNA targeting. To further confirm 
the role of CPEBs, we introduced  point mutations to disrupt the CPEB binding site on the short 3’UTR 
(UUUUAUCGAUCG, fig 23B). This mutated chimaeric mRNA completely lost its ability to travel in 
distal dendrites, confirming the fundamental role of CPEB1 and 2 during activity-dependent mRNA 
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sorting processes. However, it is unclear if CPEB 2 can bind directly to the mRNA since UUUUAU is 
the consensus sequence for CPEB1, and a specific CPEB2 recognition site has not been described 
yet(Huang et al, 2006). When analyzing the ELAV family, we found that both ELAV-2 and -4 are 
required for the correct 3’UTR short KCL- and NT-3-dependent localization (ELAV2 siRNA KCL MDDL 
43.57±1.99 µm, ELAV4 siRNA NT-3 MDDL 41.32±1.39 µm, ***P<0.001 respect to KCl no siRNA; ELAV2 
siRNA NT-3 MDDL 42.53±1.28 µm, ELAV4 siRNA NT-3 MDDL 41.48±1.14µm, ***P<0.001 respect to 
NT-3 no siRNA) (fig 22C). The other two family members, ELAV-1 and -3, did not result involved in 
BDNF subcellular localization. Involvement of ELAV-2 and-4 proteins is confirmed by the fact that 
disruption of either the 5’ or 3’ ELAV binding sites (AUUUAUAGCGCG) severely impairs the correct 
BDNF 3’UTR dendritic targeting. It is conceivable that ELAV-2 and -4 may bind separately to the two 
























Fig. 23. CPEB and ELAV proteins are involved in 3’short activity dependent targeting. A) silencing of CPEB 1 and 2 selectively 
abolishes KCl and NT-3 induced 3’UTR short localization, whilst CPEB-3 and -4 do not (***, P<0.001 respect to ctrl no 
siRNA+KCl, ###, P<0.001 respect to ctrl no siRNA +NT-3). B) A similar impairment in mRNA transport has been registered 
after selective mutation of the CPE binding site (***, P<0.001 respect to 3’sh wt+KCl, ###, P<0.001 respect to 3’sh wt +NT-3. 
C) knock down of either ELAV-2 or -4, but not ELAV-1 or -3, abrogates activity induced sorting of the short 3’UTR. The same 
effect is mimicked by point mutations on both ELAV recognition sites on BDNF 3’UTR short (D) (***, P<0.001 respect to ctrl 
no siRNA+KCl, ###, P<0.001 respect to ctrl no siRNA +NT-3). 
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The lack of dendritic localization of the 3’UTR mutants is related to a deficit in transcript 
transport and not to a decreased stability or expression, since the relative RNA levels of these 
mutants are comparable to the parental unmutated GFP and wild-type GFP 3’UTR short mRNAs (fig 
24). In summary, these results clearly demonstrate that KCl and NT-3 are able to induce distal 
dendritic localization of BDNF 3’UTR short through a complex mechanism that requires the 















Fig.24. 3’UTR segments display a similar stability. Upper panel, representative common RT-PCRs for each construct, 
displaying a similar stability when normalized and quantified respect to the housekeeping gene GAPDH (lower panel). 
 
After having identified some of the key proteins mediating 3’UTR short dendritic localization, 
we decided to determine which RBPs are responsible for the KCl- and BDNF-dependent sorting of the 
long 3’UTR isoform. We cotransfetced primary neurons with the GFP-3’UTR long chimaera together 
with siRNAs specifically directed against CPEB and ELAV. We found that dendritic targeting the long 
3’UTR requires only CPEB1 but not CPEB2, CPEB3 or CPEB4 (KCl MDDL 48.84±1.15µm, *** P<0.001 
respect to KCl no siRNA, BDNF MDDL 49.17±1.55 µm,### P<0.001 respect to BDNF no siRNA) (fig 25 A). 
This finding suggest that CPEB2 is specifically required in the context of the short 3’UTR and 
might potentially confer the responsiveness to NT-3 that characterizes the short but not the long 
3’UTR. On the other side, with ELAVs silencing the situation appears more complicated. Indeed, we 
surprisingly found that ELAV-1, -3 and -4 downregulation promotes a global increase in 3’UTR long 
targeting even in resting conditions, in particular with siRNAs targeting ELAV1 (ctrl MDDL 59.90±1.31 
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µm, φφφ P<0.001 respect to ctrl no siRNA; KCl MDDL 81.40±1.64 µm, *** P<0.001 respect to KCl no 
siRNA; BDNFMDDL 78.36±2.13 µm, ### P<0.001 respect to BDNF no siRNA). A similar increase in 
dendritic targeting of the 3’UTR long targeting found in resting conditions also when siRNAs against 
the proteins of the Fragile-X proteins (FXRPs) family FMRP1 and FXR2 (Fig 25C). Interestingly, activity- 


















Fig. 25 RNA binding proteins involved in the activity dependent sorting of BDNF 3’UTR long. A) siRNAs against CPEB family 
members show the importance of CPEB1, but not the other isoforms, in mediating KCL and BDNF induced localization. B) 
siRNA mediated knock down of all ELAV proteins induces either a basal or stimulus depend increase in the mRNA dendritic 
transport, with the strongest effect seen  in absence of ELAV1. C) Similarly, silencing of either FMRP or FXR2P promotes a 
basal, but not activity induced enhancement of 3’long accumulation in distal dendrites. siRNAs against hnRNPA2, translin or 
control luciferase don’t induce any significant alteration in BDNF 3’long subcellular localization. D) GFP-3’UTR END displays 
a constitutive  dendritic targeting respect to the full length sequence, and is moreover augmented after KCL or BDNF 
application, suggesting for the presence of an active DTE. E) The middle fragment (GFP-3’MID) does not contain any obvious 
DTE nor responds to stimulation (left), but it rather blocks the constitutive targeting of the CDS either in control conditions 
or after KCl application. This inhibitory activity is instead relieved only with BDNF treatment, implying the existence of a 
true retention signal whose activity is limited in presence of BDNF. (φφφP<0.001***P<0.001, 
###
P<0.001). 
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Additionally, we tested the role of other two RNA binding proteins, translin and hnRNPA2/B1. 
The former was used as an internal control since this protein is not involved in the sorting of 3’UTR 
long. The latter was tested since we found a putative A2RE11 recognition element in the terminal 
part of the 3’UTR long. However, we did not observe any significant alteration in the extent of BDNF 
mRNA targeting after hnRNPA2/B1 silencing (Fig 25C).  The finding of an increased basal but not 
activity-dependent BDNF mRNA targeting in absence of FXRP proteins was confirmed in vivo  in both 
FXR2P and FMR1 knockout mouse models sacrificed 3h after injection with pilocarpine (fig 26).   
Fig 26. Enhanced basal BDNF mRNA localization in CA1 and cortical neurons of FMR1 KO mice. Upper panel, increased basal 
dendritic BDNF mRNA localization in FMR1 KO (TG) CA1 neurons with respect to wt ones. After 3 hours of pilocarpine 
treatment a similar extent of BDNF mRNA dendritic sorting was observed. A similar enhanced basal targeting  has been 
observed in layer V cortical neurons. Scale bar, 10µm. 
In conclusion, we found a specific set of RBPs able to exert a retention activity under resting 
conditions to confine BDNF mRNA with the long 3’UTR in the somato-proximal dendritic 
compartment . Of note, these “inhibitory” proteins display clustered recognition sites in the central 
region of the 3’UTR long that are very well conserved throughout the evolution (nts 890-1510, see 
figure 20). In summary, we found that CPEB-1, but not -2, promotes BDNF 3’UTR long sorting in 
dendrites during neuronal activity and we discovered that the FXRP family is able to block the basal 
dendritic targeting of BDNF transcript and that the and all four members of  ELAV protein are able to 
control both basal and activity-induced BDNF mRNA dendritic trafficking.  
On the basis of these unexpected but exciting results, we speculated that the central region of 
the 3’UTR long might actually represent a retention signal, able to counteract the constitutive 
dendritic targeting signal in the coding region of BDNF mRNA mediated by translin. On the other side, 
if this hypothesis were true, deletion of this region or expression of the terminal 3’UTR tail would 
display an increased dendritic targeting. To test this hypothesis, we cloned and transfected in 
primary neurons a construct expressing GFP in fusion with terminal 3’UTR long nucleotides (2339-
2790, named GFP-3’UTR END). We found an increased basal targeting with respect to the full length 
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3’UTR long (MDDL 63.96±1.93 µm, φφφP<0.001 respect to ctrl 3’UTR long), comparably to what 
observed for ELAV1 siRNA (fig.25C). At the same time, both KCl and BDNF induced a small but 
significant increase in transport with respect to 3’UTR long (3’UTR END KCL MDDL 73.41±2.61 µm, 
***P<0.001 respect to KCl 3’UTR long; 3’UTR END BDNF MDDL 75.79±1.88µm, ###P<0.001 respect to 
BDNF 3’UTR long). Taken together, these results strongly suggest that the terminal sequence of BDNF 
3’UTR long contains a constitutively active dendritic targeting element whose function can be 
further modulated by neuronal activity (KCL and BDNF). In addition we found evidence suggesting  
the presence of an upstream retention element since the full length 3’UTR long is not targeted in 
dendrites under resting conditions. These speculations prompted us to generate a second chimaera, 
encompassing nts 849-1533 of BDNF 3’UTR long in fusion with the GFP reported (GFP-3’UTR MID). 
However, to really understand if the MID region actually represents a retention element, it was 
necessary to determine if the MID region can counteract the constitutive dendritic targeting signal  of 
the coding region. To this end, we analyzed the subcellular localization of a CDS-GFP-3’UTR MID 
chimaera in comparison to CDS-GFP known to be constitutively targeted in dendrites (fig 25E). We 
found that the 3’UTR MID fragments per se does not respond to any stimulus nor contain any DTE, 
but in the context of the coding region it does block the spontaneous dendritic localization mediated 
by translin (GFP-3’UTR MID ctrl MDDL 39.65±0.91 µm vs. CDS-GFP ctrl MDDL  57.25±2.06 µm, 
***P<0.001). Notably, this retention is not relieved by stimulation with 10mM KCl (GFP-3’UTR-MID 
KCl MDDL 45.17±1,28µm, 
φφφ
P<0.001 respect to KCl GFP-CDS) but only by BDNF (GFP-3’UTR-MID 
BDNF MDDL 61.85±1.63µm). In summary, these findings demonstrate that the region spanning 
nucleotides 849-1533 of 3’UTR long contains a retention signal able to override both constitutive 
signals, one located the terminal part of the 3’UTR long and one in the CDS. This retention signal is 
specifically relieved by BDNF and may account for the proximal BDNF mRNA localization seen under  
basal physiological conditions and may be missing in FMR1 and FXR2P knock out models causing an 
exaggerated dendritic accumulation of BDNF mRNA at rest. 
 
8.3 The short and long 3’UTR display a differential translatability that 
may account for a distinct biological function 
During the first part of this study, we found a different combination of stimuli and RBPs that 
drive a different response and subcellular localization of short and long 3’UTRs. Therefore, we 
continued our study searching for a physiological significance of this phenomenon. In a recent work, 
it has been demonstrated that in BDNF
klox
 mice, lacking of a functional long 3’UTR, there is a selective 
depletion of dendritic BDNF in hippocampal neurons, accompanied by a deficit in distal CA1 synapses 
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LTP, reduced spine head diameter and increased spine density (An et al, 2008). In light of these 
findings, we speculated that these variants may not only be regulated at the level of mRNA 
localization, but also from a translational point of view. In fact, it was already known that the short 
variant is more polyadenylated and potentially more translatable than the long one (Timmusk et al, 
1994). Accordingly, we found that the long 3’UTR has a non canonical polyadenylation signal 
(AAUUAA) that may hypothetically confer a very low polyadenylation efficacy. By performing a 
standard polyadenylation assay (PAT) on hippocampal neuronal cultures, we confirmed this 











Fig.27. Increased poly(A) tail length of short 3’UTR respect to the long isoform. A) Upper panel, representative PAT assay for 
3’UTR short tail, showing a long A tail also in resting conditions, slightly increased after KCL treatment. siRNA targeting 
CPEB1, but not 2, severely interferes with the normal polyadenylation process, as quantified in the lower panel. B) PAT 
assay on the long 3’UTR confirms a shorter adenosine tail respect to BDNF UTRsh, that is strictly dependent on CPEB1 and 
requires the activation of CPEB2 as well.  
Surprisingly, we found that KCl-induced depolarization increases the poly(A) tail length of the 
short 3’UTR but not of the long 3’UTR and that both 3’UTRs require CPEB1 for the correct poly(A) 
extension, whilst CPEB2 seems to have a minor role (fig. 27B). On the basis of these results, we 
expected the 3’UTR short to be more easily translatable than the long 3’UTR, since the translation 
efficiency is directly related to poly(A) tail extension (Huang et al, 2003). To test this prediction, we 
analysed the translatability in SK-N-BE neuroblastoma cells of  the same constructs used for the 
subcellular localization studies in relation to the downstream 3’UTR sequence (fig.28).  
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Fig. 28. In vitro translatability of GFP-3’UTR chimaeras variants in BE cells. Upper panel, representative WBs for each 
construct, showing the relative GFP expression and tubulin intensity as normalizing control. Lower panel., densitometric 
quantification  of the bands. GFP expression for each construct was internally normalized to the relative tubulin levels. 
Results are represented as % of expression respect to GFP. *P<0.05 respect to GFP, paired t-Test) 
In the presence of the short 3’UTR sequence the GFP reporter showed 142% higher protein 
levels with respect to GFP alone (*, p<0.05) and mutation of the CPE or upstream ELAV binding sites 
severely impaired translation of the reporter (58% and 4% respectively, *P<0.05 respect to GFP). The 
relative levels of RNA, evaluated trough semi-quantitative RT-PCR, were constant among constructs, 
therefore any difference was imputable to a pure translational effect (see fig.24). In the same 
experiment, we also confirmed the poor translatability of the full length long 3’UTR (27% of GFP 
alone). However, when only the isolated terminal fragment was considered, we found a striking 
increase in translatability (+218%; *p<0.05). The intermediate region of the 3’UTR long had a 
comparable expression with respect to GFP, meaning that it does not contain any enhancing nor 
inhibitory element active on translation at least under control conditions. We then proceeded to 
analyze separately the behavior of 3’UTR short and relative mutants in different experimental 
conditions (fig.29). We started analyzing a set of possible stimuli able to promote an increase of GFP 
expression driven by 3’UTR short. We tested either 50mMKCl or 50ng/ml NT-3, since they induce 
mRNA transport, as well as 50ng/ml BDNF, BDNF paired to glutamate and glutamate alone. 
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Fig.29. effect of 3’UTR short on GFP expression in BE cells. A) wild type 3’UTR short enhances reporter translation after KCL, 
BDNF and glutamate stimulation. NT-3 showed the greatest effect almost doubling the GFP expression (*P<0.05 respect to 
wt ctrl). B) CPE binding site mutation causes a marked decrease of reporter translation even in basal conditions. Any applied 
stimulus is able to restore the expression to basal levels (*P<0.05 respect to CPEmut ctrl).C) ELAVup mutation showed the 
highest repression, being only partially relieved after NT-3 and glutamate application(*P<0.05 respect to ELAVup mut 
ctrl).D) ELAVdw mutation blocked the KCl, BDNF and NT-3 increase of reporter translation, that was instead significantly 
impaired during glutamate mediated responses (*P<0.05 respect to ELAVdw mut ctrl). GFP expression for each construct in 
any condition was internally normalized to the relative tubulin levels and subsequently to ctrl GFP-3’UTR short wt. Results 
in stimulated conditions are represented as % of expression respect to their relative basal state ( *P<0.05, paired t-Test) 
The glutamate stimulus was chosen since CPEB, a putative interactor of 3’UTR short, has been 
previously described to be activated by glutamate signaling trough NMADR and Aurora Kinase 
activation. As compared to the basal expression, KCl, BDNF, 20µM glutamate and glutamate+BDNF 
were able at the same extent to enhance GFP expression under the control of 3’UTR short 
(respectively +49%, +53%, +64% and +49%, *P<0.05 respect to 3’UTR short GFP control). Notably, NT-
3 had the greatest effect, almost doubling the GFP expression (fig.29A). In order to unravel the 
possible mechanism/s responsible for this enhancement in GFP translation, we analyzed whether 
mutation of specific RNA binding protein sites would have any effect. As shown in fig.29B, mutation 
of CPE binding site had a dramatic effect on 3’UTR short mediated expression (-63% in control 
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conditions respect to GFP-3’UTR short). However, all stimuli considered here were still able to 
enhance, even if at a lesser extent, GFP translation comparably to the basal 3’UTR short. We 
concluded that CPEB is required for the basal 3’UTRsh driven expression, but is only partially involved 
in KCl, BDNF, NT3 and glutamate responses, and  among these stimuli is more important in mediating 
NT-3-dependent responses (-5% vs. +114% for CPEmut and 3’sh wt respectively). However, whether 
this is a direct effect of CPEB1 or 2 or is a secondary effect generated by the lack of interaction with 
other proteins is still unclear. The construct bearing the most disrupting mutation is the one affecting 
the upstream ELAV binding site (-78% respect to 3’UTR short wt) that resulted  unable to respond to 
BDNF or KCl, and responded only partially to  NT-3 and glutamate (fig 29C). We concluded that KCl-
and BDNF-induced responses are dependent on the binding of the ELAV proteins to the upstream 
ELAV binding site. On the other hand, the partial response observed in absence of the CPEB binding 
site might be related to a lack of interaction with an ELAV partner. Accordingly, a residual NT-3 and 
glutamate response (+41% and +26% respect to basal ELAVup mutant) may be accounted by the 
reduced, but sill significant activity of CPEB proteins.  Additionally, since ELAVs seem to be involved in 
repression of miRNA activity (Bhattacharyya et al, 2006), this strong repression might be related to 
the constitutive activity of miRNAs, since in a bioinformatic study we recently found a very close and 
conserved miRNA-381 target site. Finally, mutation of the downstream ELAV binding site does not 
alter significantly the basal GFP expression levels, but it blocks the activity dependent activation of 
translation, similarly to the CPE mutation. This would further posit for an interaction between CPEB 
and ELAV family members during activity-dependent activation of BDNF mRNA translation. 
Surprisingly, mutation of the downstream ELAV site had deleterious effects on glutamate mediated 
responses, suggesting that this site is not involved in basal 3’UTRsh driven expression but is essential 
during glutamate stimulation (fig.29D). A possible interpretation is that in absence of the stabilizing 
activity of ELAVs the mRNA becomes degraded during glutamate excitation, or in alternative, that 
ELAV proteins may operate by repressing any inhibitory mechanism that would otherwise impede 
mRNA translation.  
In  conclusion, the greatest increase in BDNF protein expression depends on NT-3-driven 
activation of 3’UTR short, that is almost entirely mediated by CPEB1 and by binding of one ELAV 
isoform to the upstream recognition site. The latter has also revealed to be essential for the KCl- and 
BDNF-mediated responses, whilst the downstream ELAV binding site resulted to be involved not in 
basal, but in activation of translation induced by glutamate, since its disruption led to fatal decrease 
of reporter translatability. In this intricate scenario, it appears that CPEB and ELAVs are differentially 
able to respond to distinct agonists, but these proteins are influencing each other.  
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In the next series of experiments we analyzed the translational effect of the long 3’UTR and 
relative fragments (MID and END) in BE cells to. As reported in figure 30, after transfection of full 
length 3’UTR long we applied a similar set of agonists: 50mM KCl, 50ng/mL BDNF, or NT-3, 20µM Glu, 
Glu+BDNF, 50µMDHPG and 30µM NMDA+DHPG. DHPG was used since it is a well known activator of 
mGluR1 receptors, whose signaling leads to a concomitant  activation of FMRP. This stimulation 
paradigm might therefore help us to elucidate any effect on BDNF mRNA translatability potentially 

















Fig.30. 3’UTR long effect on GFP expression in BE cells. A)BDNF, but not significantly KCL nor NT-3 slightly enhanced the 
3’UTR long mediated GFP expression (**P<0.01). Glutamate (glu), glu+BDNF, DHPG and DHPG+NMDA increasingly 
depressed the reporter expression in a significant manner respect to control conditions (*P<0.05; **P<0.01). B) GFP-3’long 
MID showed an increased basal expression respect to wild type, full length (FL) 3’UTR long. Almost all the stimuli applied 
depressed the translation efficiency of GFP, possibly via an mGluR and NMDAR dependent mechanism (P<0.05 respect to 
ctrl GFP-3’long MID. C)The terminal 3’UTR long fragment induced an enhanced GFP expression in resting conditions and 
after KCl or BDNF application. The translation levels were restored to the full length dependent ones after NT-3, glu, 
glu+BDNF and DHPG+NMDA (*P<0.05). GFP expression for each construct in any condition was internally normalized to the 
relative tubulin levels and subsequently to ctrl GFP-3’UTR full length. Results in stimulated conditions are represented as % 
of expression respect to their relative basal state ( *P<0.05;**P<0.01, paired t-Test). 
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The pairing of NMDA and DHPG was tested to prove potential responses mediated by CPEB 
(via NMDAR AuroraA CPEB) or FMRP (via DHPG). Interestingly, we found a small but significant 
increase in 3’long dependent GFP expression only with BDNF treatment (+14% respect to ctrl GFP-
3’long**P<0.01) and we found a surprising decrease with either Glu, Glu+BDNF, DHPG and 
DHPG+NMDA (respectively -12%, -24%,-65% and -88% respect to the control, *P<0.05;**P<0.01) 
(fig.30A). These results suggest that BDNF is not only able to promote specifically the dendritic 
transport of the long 3’UTR form, but also its translation through a positive feedback loop. Moreover, 
the depression seen after glutamate application may be indicative of an mGluR activation rather than 
AMPARs or NMDARs, a result confirmed by the specific action of DHPG that in turn led to a 
significant overall decrease of reporter expression. Interestingly, the strongest effect seen with 
concomitant DHPG and NMDA application does not reflect any activation of CPEBs, but could be 
rather informative of an ongoing process of NMDAR and mGLUR-mediated LTD, that in turn would 
lead to a severe decrease in BDNF expression. Regarding the expression of the MID region of 3’UTR 
long, we confirmed its increased expression with respect to the full length 3’UTR (FL 3’UTR), but after 
stimulus application we found a global decrease of GFP expression comparable to the levels 
observed with the full 3’UTR long, regardless the stimulus used (fig. 30B). Of note, the MID 3’UTR 
long is also repressed by DHPG and DHPG+NMDA application (respectively -58%and -68% respect to 
ctrl GFP-3’long MID, *P<0.05), suggesting that this decrease may be an FMRP-dependent mechanism 
that acts specifically on this region, since the terminal 3’long fragment is not sensitive to DHPG 
(fig.30C). On the other side, we noticed that the MID 3’UTR long fragment conferred an enhanced 
reporter translation in both basal (+56% respect to control GFP-3’long), and either KCl or BDNF 
application (respectively +62% and +44%  compared to control GFP-3’long), mirroring the BDNF and 
KCl responses observed in the context of the full length 3’UTR long. However, we are not able to find 
an exhaustive explanation about the apparent inhibitory role played by NT-3 on MID and END 3’long 
dependent-GFP expression, since this neurotrophin does not repress the full length 3’UTR long 
mediated translation (fig. 30A). 
Finally, we proceeded through immunohistochemistry analysis on brain sections of wildtype 
and BDNF
Klox
 mice,  searching for possible differences in BDNF expression after 3h of strong electrical 
activity induced by the proepileptic drug pilocarpine. As reported in fig. 31, both in wt and BDNF
klox
  
hippocampal neurons we detected a clear signal in dendrites, especially in CA1 region. These results 
strongly suggest that the short 3’UTR is also locally translated in dendrites, and that in absence of the 
long isoform the 3’UTR short may account for the localization of BDNF protein in distal dendrites. 
These results are in contrast with the observations of An and coworkers that were limited to animals 
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under resting conditions (2008), but are in accordance with the ability of the 3’UTR short to be 
localized in dendrites and locally translated. 
 
Fig.31. BDNF immunohistochemistry on wt and Klox brain slices shows a comparable localization of the protein. Left panel, 
BDNF staining in dendrites in control conditions. A strong dendritic labeling has been detected in both wt and klox animals, 
even if less uniform in CA1 region of Klox neurons. On the other hand, a stronger signal has been detected in  dentate 
granule (dg) cells of transgenic animals (arrow, middle  panel). Right panel, BDNF immunostaining after 6 hours of 
pilocarpine treatment. There is no obvious increase in dendritic BDNF content in both wt and klox CA1 neurons, both 
showing an evident vacuolization as consequence of epileptic seizures. Respect to resting conditions, there is a dramatic 
upregulation of BDNF expression in DG granule cells and stratum molecular (arrowheads) in either wt and klox neurons. 
Lower panel, negative control staining with only secondary HRP-conjugated antibody. Scale bar, 20µm 
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9.1 Main findings 
In this study we investigated the molecular mechanisms regulating BDNF mRNA subcellular 
localization and its translation into protein. We analysed the role of the 5’UTRs, the coding region 
and the two 3’ untranslated regions (3’UTR short and long) and found a different set of proteins 
controlling mRNA dendritic sorting and, for the 3’UTRs,  translation as well. The main findings can be 
summarized as follows: 
1) We identified potassium-induced depolarization, BDNF and NT-3 as the three main stimuli 
able to induce endogenous BDNF mRNA sorting in neuronal dendrites in vitro.  
2) We were able to demonstrate in vitro that none of the 5’UTR sequences considered (exon 1, 
2B and 2C, 4 and 6) contains inducible dendritic targeting elements, but rather that the somatic 
isoforms (those containing exon 1 and 4) encode some still unidentified retention signals preventing 
their delivery in dendrites.   
3) Surprisingly, we found that the driving force mediating constitutive BDNF mRNA targeting, 
in absence of its 3’UTRs, is mediated by a targeting element localized in the coding region and thanks 
to a detailed bioinformatic, biochemical and mutational/functional analysis we identified translin 
(also known as TB-RBP) as the interacting partner with BDNF mRNA at this site. Notably, we found 
that only two conserved guanosines (G178 and G196, human BDNF numeration) are necessary for a 
correct protein:RNA interaction. Mutation of either G causes a severe deficit in binding of translin to 
BDNF mRNA and a blockade of BDNF mRNA dendritic localization in vitro of the same magnitude as 
that observed in presence of translin targeting siRNAs.  
4) We found that a common human single nucleotide polymorphism of BDNF gene, associated 
with eating and neuropsychiatric disorders (G196A or Val66Met), overlaps with one G of the translin 
binding site. This SNP had deleterious effects on both in vitro and in vivo BDNF transcript localization, 
in addition to a previously reported impaired activity-dependent secretion of BDNFMet (Chen et al, 
2004; Egan et al, 2003). The novelty of our findings resides on the fact that besides an improper 
BDNF protein secretion there is a much more severe depletion of the dendritic fraction of BDNF 
mRNA that in normal conditions might potentially modulate and strengthen the force of the 
synapses experiencing long term plasticity. 
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5) We found that both short and long 3’UTR regions promote dendritic targeting of a GFP 
reporter mRNA in response to KCl and selectively to NT-3 (short 3’UTR) or BDNF (long 3’UTR). The 
latter findings are quite exciting since to date they represent the first description of one mRNA with 
two 3’UTR variants whose localization is selectively regulated by different sets of stimuli, with strong 
implications on the local modulation of synaptic plasticity.  
6) Thanks to an exhaustive bioinformatic analysis and siRNA-based approach, we have 
identified two distinct sets of RNA binding proteins regulating BDNF 3’UTR short and long dendritic 
transport. In particular, we demonstrated that CPEB-1 and -2, together with ELAV-2 and -4 are 
essential for the NT-3- and KCL-dependent delivery of short 3’UTR splice variants in dendrites. On the 
other side, the long 3’UTR requires the activation of only CPEB1 for its localization and surprisingly, it 
contains inhibitory signals mediated by ELAVs (in particular ELAV1) and FXR proteins that modulate 
its basal and activity dependent sorting.  
 
In light of these unexpected findings, we hypothesized that the long 3’UTR contains at least 
two separates sets of signals, one positively and one negatively regulating dendritic targeting. 
Therefore, analyzing the subcellular localization of the last conserved 500 nts of BDNF 3’UTR long, we 
found both a basal and stimulus dependent enrichment of this mRNA in dendrites, posing for the 
identification of a “permissive” DTE. These observations closely mirror the effects induced by the 
absence of either FXRs or ELAV1, that were expected to recognize as very conserved region in the 
middle of 3’UTR long (nts 849-1533). After isolating this fragment, hosting a retention signal, we 
demonstrated not only that it does not respond to any stimulus, but also it inhibits the constitutive 
dendritic localization of the CDS. Moreover, this retention is not relieved by KCl, but only by BDNF, 
therefore validating our hypothesis about the presence of two different sets of signals at the level of 
long 3’UTR. In front of these results, we reasoned whether the different stimulus dependent 
localization of these two 3’UTR variants may also be linked to a different translatability.  
 
7) Using the very same constructs used for the localization studies, we  found that the short 
3’UTR positively influences the translatability of a GFP reporter that is further enhanced by different 
stimuli including NT-3. Furthermore, the high translational competence of the short 3’UTR has been 
validated in vivo, where we were able to detect strong labeling for BDNF protein in dendrites of 
neurons of a transgenic mouse lacking a of functional long 3’UTR. Additionally, thanks to a fine 
mutational analysis, we demonstrated that CPEB and ELAV proteins were actively involved in this 
process.  
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8) We also found that the 3’UTR long confers a very poor translatability to the GFP reporter, 
possibly because of a constitutively poorly active polyadenylation signal and the additional inhibitory 
effect of internal translation repressor sequences. A detailed analysis of the terminal 500 
nuicleotides of 3’UTR long sequence (END fragment) allowed us to conclude that it contains signals 
that positively modulates translation. We concluded that in the context of a full length 3’UTR long, 
there are at least one inhibitory element accounting for a poor translatability of the 3’UTR long under 
basal conditions. 
 
9.2 Both 3’UTR short and long contain  inducible, activity-dependent 
localization signals. 
This study unravels the dynamics of activity dependent regulation of BDNF mRNA sorting in 
dendrites. Notably, we found that NT-3 and BDNF mutually control the subcellular localization of 
3’UTR short and long respectively, and both of them respond to high potassium-induced 
depolarization. Even though the long 3’UTR does contain the nucleotide sequence of the short 3’UTR, 
its localization is not influenced at all by NT-3 signaling. This specificity may be accounted for an NT-3 
sensitive element directly or indirectly interacting with the short 3’UTR (potentially CPEB2), whose 
access to the mRNA in the context of the long 3’UTR is not anymore allowed. As reported in figures 
32 and 33  showing the secondary structure of the native 3’UTR short and long respectively, the CPE 
site at nts 93-98 (Fig. 32; red square) is no more accessible in the context of long 3’UTR folding. Up to 
date it is unknown if CPEB2 is influencing BDNF mRNA metabolism through direct mRNA contact or 
through an interaction with CPEB1. Nevertheless, due to the buried corresponding site in 3’UTR long, 
it is conceivable that CPEB1/2 are no more able to contact this sequence inside the long 3’UTR. 
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Fig.32. Secondary structure prediction of short 3’UTR (Mfold algorithm). Red square, CPE binding site; green circles, ELAV 




To further confirm the involvement of CPEBs in NT-3-mediated signaling, a recent work by 
Kundel and coworkers reported the that CPEB-1 mediates the NT-3-dependent beta-catenin mRNA 
translation in developing hippocampal neurons (Kundel et al, 2009). As reported by Huang and 
coworkers, CPEB-2, -3 and -4 seem to bind to a completely different sequence than the canonical CPE 
and may be regulated by p70S6 kinase rather than AuroraA (Huang et al, 2006). Since the latter 
specifically activates CPEB1 after NMDAR activation, one can hypothesize that KCl stimulation 
promotes both pre-synaptic neurotransmitter release (e.g. glutamate) leading to post-synaptic 
CPEB1 activation, and post-synaptic neurotrophin exocytosis (e.g. NT-3), promoting TrK-dependent 
p70S6K and CPEB2 activation. In this way, CPEB1 and 2 may respectively act as pre- and post-synaptic 
coincidence detectors modulating the localization and possibly the expression of such an important 
plasticity mediator like BDNF. 
Interestingly, we found that the two ELAV binding sites on short 3’UTR (green circles, nts 4-9 
and 148-153) are quite close in terms of secondary structure. This further corroborates the idea of a 
potential interaction between these two sites that would further explain why the absence of either 
ELAV-2 or ELAV-4 leads to a severe disruption of 3’UTR short targeting in dendrites. It has been 
reported in many cases that ELAVs are able to form omo- or hetero-dimers (Gao & Keene, 1996; 
Kasashima et al, 2002), and these reciprocal protein-protein interactions positively modulate their 
RNA binding activity. In this way, ELAV2-4  dimerization may allow the formation of RNA transporting 
granules able to interact with the cytoskeleton for transport and with the translational machinery as 
well, as suggested by Antic and colleagues (Antic & Keene, 1998; Gao & Keene, 1996).  
  ANALYSIS OF THE MOLECULAR MECHANISMS OF BDNF MRNA  




Additionally, we found two other conserved sites in the 3’UTR short sequence, namely a nanos 
response element (NRE) and a CUG rich region, that represent respectively, one potential target for 
pumilio, a translational regulator (Wickens et al, 2002), or for CUG-binding protein, known to 
regulate splicing, deadenylation, mRNA stability and translation (Ladd et al, 2001; Moraes et al, 2006; 
Mori et al, 2008; Paillard et al, 2003; Philips et al, 1998; Savkur et al, 2001; Timchenko et al, 1999). 
Despite the high conservation of those sequences, we did not included pumilio and CUGBPs in the 
present study, since there are no reports assessing their involvement in mRNA regulation of 
transport. 
On the other side, by looking at the long 3’UTR, the situation is much more complex, also by 
virtue of the length and complexity of this untranslated region (fig.32). Our observations about the 
subcellular localization of 3’long led to the identification of only one protein, among the ones 
considered, ablke to drive its activity dependent localization. One highly conserved CPEB1 binding 
site is contained in the terminal part of 3’UTR long, in close proximity to several AU-rich stretches 
that can be recognized by ELAV proteins. This region revealed to contain a constitutively active DTE 
mediated by CPEB1, but at the same time we found that this very same region harbors the the 
binding sites for ELAV proteins that inhibit dendritic sorting of this mRNA (see fig25). This dual role of 
the terminal regione of the 3’UTR long may be explained hypothesizing that in the context of a full 
length 3’UTR, the ELAVs binding to the terminal segment may cooperate and interact with  the two 
AUUUAU sequences in the short 3’UTR, therefore strengthening their inhibitory effect. 
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Fig.33. Secondary structure prediction of long 3’UTR (Mfold algorithm). Red circle, short 3’UTR domain (Red square, CPE 
binding site; green circles, ELAV binding sites); yellow box, ELAV1 binding sites clusters; green box, mid 3’UTR region, purple 
circle, FMRP binding site; blue “C”, terminal END region. Of note, the domains containing targeting elements (END) and 
retention signals (MID) are spatially segregated and are conserved in 3’long structures with different free energy contents 
(not shown). For comparison, see fig.20. 
 
This model would be in accordance to what has been observed either after siRNA induced 
ELAVs silencing and after isolation of the terminal segment, that lacks of all the upstream regulatory 
sequences. Moreover, An and colleagues reported that a chimaera consisting of the GFP reporter 
followed by the long 3’UTR except the short sequence displays an enhanced dendritic localization 
than the full length 3’UTR (An et al, 2008). On the other side, we identified a previously unknown 
retention signal localized in the middle of the long 3’UTRs, that is able to overcome the constitutive 
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sorting signal mediated by translin at the level of the CDS. These findings are in accordance with an 
increased BDNF mRNA basal content in dendrites of FMR1 and FXR2 KO animals in resting conditions 
and this might also account for an increased susceptibility to epileptic seizures seen in these animals 
(El Idrissi et al, 2005). Moreover, a very recent study, Sharma and colleagues reported an 
exaggerated mTOR and PI3K activation in FMR1 KO mice (Sharma et al, 2010) that would therefore 
explain the PI3K-dependent accumulation of BDNF mRNA in dendrites observed by Tongiorgi and 
coworkers (Righi et al, 2000).  From this scenario, it clearly emerges that the long 3’UTR is controlled 
by a set of inhibitory signals and proteins that prevent its basal dendritic sorting, thus also 
contributing to the proximal localization observed for the endogenous transcript. On the other side, 
the strategy controlling the dynamics of short 3’UTR localization seems to rely on the activation of 
dormant targeting elements and proteins.  
Interestingly, a similar organization of targeting elements has been observed in another 
dendritically localized transcript, namely CaMKIIα mRNA. In fact, it has been reported the presence 
of a translin binding site at the level of the coding region that is necessary for its correct sorting in 
dendrites (Severt et al, 1999), exactly as for BDNF mRNA. Moreover, Mori and colleagues identified 
two opposing signals at the level of CaMKIIα 3’UTR: a DTE in the first 28-56 nts of 3’UTR, promoting 
RNA  sorting (also known as the CNDLE sequence, see par.2.2.1), that is overridden by a downstream 
retention signal whose inhibition is relieved after KCl-induced depolarization (Mori et al, 2000). This 
behavior strongly remembers our findings about a bipartite signal in BDNF 3’UTR long: an active DTE, 
most likely mediated by CPEB1, and an upstream retention signal normally blocking mRNA sorting, 
but relieved after BDNF (but not KCl) application, mediated by several RNA-binding proteins of the 
ELAV and FXRP families. Moreover, in a separate work, Huang and coworkers identified in CaMKII-
alpha mRNA two CPE elements facilitating mRNA transport and translational activation  (Huang et al, 
2002). Through a bioinformatic analysis, we also found two AU-rich regions, many ELAV binding sites  
and a G-quartet-like structure in BDNF mRNA similarly to CaMKII-alpha (for comparison, 
see(Dictenberg et al, 2008). Finally, Also CaMKII-alpha may express a short or a long 3’UTR, with the 
latter being much more abundant than the former.  
 
This striking parallelism between BDNF and CaMKIIα targeting elements, their distribution, the 
RNA binding proteins involved and their activity-depend sorting further supports the “RNA operon 
theory” (Keene & Tenenbaum, 2002), by which common signals and RNA binding proteins are shared 
by different mRNAs with common functions (e.g. synaptic plasticity and potentiation) therefore 
jointly coordinating their post-transcriptional outcome. Hence, it is tempting to speculate that these 
transcripts which are both involved in the induction and maintenance of synaptic plasticity, and 
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therefore functionally related, might share similar pathways of dendritic trafficking and local 
translation at synapses, in order to maximize the efficiency of neuronal response  during plasticity 
related events. 
 
9.3 Towards a model of BDNF mRNA dendritic targeting mechanism 
This study provides compelling evidence that the BDNF coding region common to all BDNF 
splice variants is sufficient to direct constitutive targeting of BDNF mRNAs to the distal dendritic 
compartment. Characterization of this signal has demonstrated that it: (i) can be overridden by the 
5’UTRs of BDNF mRNA isoforms (exon 1 and 4) that are retained in the cell body and proximal 
dendrites, (ii) is mediated by translin, and (iii) is blocked by a retention signal mediated by a complex 
of ELAV and FXRP proteins that likely binds to conserved sequences in the central regions of the 
3’UTRlong; iv) we also found that the targeting of full length BDNF mRNA is induced by KCl 
depolarization, BDNF and NT3 and that the inducible targeting signals that respond to these stimuli 
are encoded by the both 3’UTRs. Interestingly, the 3’UTR short responds to KCl and NT3 while the 
3’UTR long to KCl and BDNF; v) the short 3’UTR contains inducible dendritic targeting signals that 
respond to KCl and NT-3 via CPEB1 and 2 while the the 3’UTR long contains signals that respond to 
KCl and BDNF for and via CPEB1. The long 3’UTR contains additional retention signals that are 
relieved only upon stimulation with BDNF and are mediated by  FXR and ELAV proteins that might 
cooperate with the constitutive signals in the CDS mediated by the translin/trax complex. 
 
From these results it is possible to conclude that dendritic trafficking of BDNF transcripts 
displays two key features: activity-dependence and transcript selectivity. Although we showed that 
3’UTR plays a critical role in mediating activity-dependent trafficking of BDNF transcripts, this 
segment is unlikely to mediate transcript selectivity because both the short and long forms of the 
3’UTR are contained in BDNF transcripts that are retained in the soma/proximal dendrites, as well as 
those targeted to distal dendrites. Our results indicate that transcript selectivity is mediated by a 
constitutively active dendritic targeting element (DTE) located in the CDS that can be overridden by 
signals located in the 5’UTR of transcripts that are retained in the soma/proximal dendrites, but not 
by those targeted to distal dendrites (Fig. 34). The ability of si-translin to block activity-dependent 
targeting of both the truncated CDS-GFP construct and endogenous, full-length transcripts, but not 
the isolated 3‘ UTR, indicates that both a translin-dependent DTE in the CDS and a translin-
independent DTE in the 3’UTR are required to mediate activity-dependent trafficking of full-length 
BDNF transcripts. Further confirmation of this model is provided by our finding that the G196A SNP, 
  ANALYSIS OF THE MOLECULAR MECHANISMS OF BDNF MRNA  




which by definition acts selectively on the CDS DTE, blocks pilocarpine-induced dendritic trafficking of 





Fig.34 Proposed model of BDNF mRNAs sorting mechanisms. Multiple 5’UTR sequences with either inhibitory or permissive 
targeting properties determine transcript-selective sorting. Translocation to dendrites is mediated by constitutive dendritic 
targeting signals in the CDS that require binding of the translin/trax complex at the G178-G196 residues. The 3’UTR 
region(s) contain inducible dendritic targeting signals that respond to KCl, BDNF and NT-3 via CPEB1 and 2  for the short 
3’UTR and via CPEB1 for the 3’UTR long. The long 3’UTR contains additional retention signals that are relieved only upon 
stimulation with BDNF and are mediated by  FXR and ELAV proteins that might cooperate with the constitutive signals in the 
CDS mediated by the translin/trax complex. 
 
9.4 Short vs. long BDNF 3’UTR: in search for different functions  
In a recent work, it has been reported that the long 3’UTR is targeted in dendrites and there it 
locally regulates BDNF mRNA translation in vitro. On the other side, the short isoform seems not to 
play any significant role (An et al, 2008). Our results are partially in accordance, but the main findings 
presented here are based on the analysis of 3’UTRs localization in presence of different stimuli 
known to mediate BDNF mRNA somatic export. Moreover, our in vitro data accounting for an active 
role played also by the short 3’UTR are strongly corroborated by in vivo evidences showing that (i) in 
mice lacking of a functional long 3’UTR there is still a significant sorting of BDNF mRNA after 
pilocarpine-induced seizures and (ii) comparable levels of dendritic BDNF protein between BDNF
Klox
 
and wt animals at 2 months of age. Additional in vitro data demonstrate the positive translational 
control exerted by the  short 3’UTR respect to the long that, similarly to the regulation of its 
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subcellular localization, is controlled by a set of inhibitory signals that repress its translation in resting 
conditions. 
The same authors, despite normal levels of total BDNF in brain, reported a selective 
impairment of LTP, but not brief high frequency stimulation (1X100Hz, 1s) in apical dendrites of CA1 
BDNF
klox
 neurons, accompanied by an increased spine density and decreased spine head diameter, 
consistent with a local regulatory effect. This phenotype, reminding the one observed in immature 
spines, was accounted to a decreased spine pruning, as a consequence of a selective dendritic 
depletion of BDNF protein. Of note, those differences have been reported only in adult (8-10 weeks) 
but not juvenile (P21) mice. These abnormalities, together with a significant decrease in activity-
regulated exocytosis of BDNF, are consistent with spine network remodeling exerted by 3’UTR long 
driven-BDNF expression in the adult. In front of the normal electrophysiological and neuroanatomical 
phenotype seen in young animals, we reasoned whether the short 3’UTR may vicariate or at least 
compensate the absence of the long isoform during early life stages. From a developmental point of 
view, several reports on alternative polyadenylation site selection stated a preferential usage of long 
3’UTRs vs short ones as development and differentiation progresses (Ji & Tian, 2009; Liu et al, 2007; 
Sandberg et al, 2008; Wood et al, 2008). This progressive lengthening of 3’UTRs is in accordance with 
a much more complex network of mRNA regulation, since the number of potential miRNA target 
sites is increased respect to short 3’UTRs, often accompanied with an increased AU rich content 
leading to instability and increased efficacy of miRNA targeting (Grimson et al, 2007; Ji & Tian, 2009; 
Long et al, 2007). Moreover, it is conceivable that sequence lengthening may lead to the introduction 
of other types of cis-elements that cooperate to finely regulated developmental and differentiation 
programs. With respect to these observations, and consistent with an abnormal phenotype seen in 
adult BDNF
klox
 mice, our findings stating (i) short 3’UTR localization in dendrites of BDNF
klox
 mice, (ii) 
increased translatability conferred by the short variant respect to the long 3’UTR , (iii) increased 
number of cis-acting elements, potential miRNA binding sites and AU rich regions in the latter, 
strongly support the idea that the short 3’UTR may exert a leading role in controlling BDNF 
expression in early development, whilst the long 3’UTR gets involved later as development and 
differentiation proceed. In fact, spine pruning and shaping is a finely regulated step that coincides  
with maturation of the neuronal network. On the other side, a strong BDNF expression in early stages 
driven by the short 3’UTR would support neuronal survival and spine formation, that would 
eventually be reinforced or removed during maturation as long 3’UTR usage becomes more 
important. We therefore strongly believe that the biological meaning of the presence of a short and 
long 3’UTR is not confined to a mere difference in their subcellular localization (soma vs. dendrites), 
but rather on a exclusive role in modulating neuronal survival and network formation depending on 
  ANALYSIS OF THE MOLECULAR MECHANISMS OF BDNF MRNA  




the developmental stage. To test our hypothesis, we are currently looking at potential differences 
between 3’UTR short vs. long usage at different stages (P10, P21 and P60). Hence, we expect an 
increased abundance of 3’short in P10 and P21 mice and an opposing predominance of 3’UTR long in 
the adult (P60). 
 
It is known since a long time that during development the relative levels of each neurotrophin 
and respective Trk receptor may vary. In particular, the earliest neurotrophin receptor to be 
expressed during brain development is that for neurotrophin-3, followed by a later expression of 
TrkB (Bernd, 2008). The reciprocal interplay between neurotrophins has been investigated, 
particularly concerining BDNF and NT-3, both in vitro and in vivo systems (Lindholm et al, 1994; 
McAllister et al, 1997; Patz & Wahle, 2006). Both BDNF and NT-3 have been shown to play important 
but somehow counteracting effects during development, as opposing effects in regulating cortical 
dendritic growth (McAllister et al, 1997). Moreover, NT-3 mRNA levels, detected prenatally in visual 
cortex, dramatically decreases at later stages of development, with an opposing trend for BDNF 
mRNA (Lein & Shatz, 2000; Patz & Wahle, 2006). This evidence is further supported in rat cerebellar 
neurons, were an up-regulation of BDNF expression in vitro is accompanied by a significant decrease 
of NT-3 expression (Condorelli et al, 1998). Moreover, it has been reported that acute NT-3 
administration leads to increased BDNF secretion in hippocampal neurons (Canossa et al, 1997; 
Kruttgen et al, 1998). In light of this large body of evidence and supported by our in vitro data, we 
propose a model whereby earlier expression of NT-3 might promote both 3’UTR short-containing 
splice variants localization in distal dendrites and their local translation into protein. At the same 
time, NT-3 signaling may promote de novo synthesized BDNF secretion, that in turn may lead to both 
pre- and post-synaptic TrkB activation. As reported in fig.29, 3’UTR driven expression is strongly 
upregulated by NT-3, but also significantly by BDNF itself. Therefore, as long as NT-3 expression is 
maintained, it might sustain BDNF targeting, translation and exocytosis through a positive feedback 
loop that would locally potentiate BDNF action promoting neuronal survival and spine formation. 
Accordingly, when NT-3 levels decrease during development, the local production of BDNF may in 
turn promote dendritic targeting of the long isoform, its local translation into protein (see fig.30) and 
exocytosis. Therefore, accordingly to An and colleagues, only at later stages the local 3’UTR long-
dependent production of BDNF would then promote spine pruning and a fine neuronal network 
remodeling, ongoing with development and differentiation.  
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9.5 Implications for neuropsychiatric and developmental diseases  
Our finding that the G196A SNP blocks dendritic trafficking of BDNF mRNA implies that 
phenotypic changes induced by this mutation, such as reduced hippocampal dendritic complexity 
and volume, as well as memory deficits (Bath & Lee, 2006; Pezawas et al, 2004), and susceptibility to 
mood disorders (Krishnan et al, 2007) may be due to this effect. This finding links defects in dendritic 
trafficking with defective neuronal development resulting in susceptibility to eating and mood 
disorders, and reduced memory performance. Recent studies have suggested that this SNP may also 
impair BDNF protein sorting by disrupting its interaction with sortilin, a vesicular membrane protein 
implicated in protein trafficking (Chen et al, 2005). Thus, conceivably, the G196A SNP interferes with 
BDNF processing by disrupting trafficking of both BDNF mRNA and protein through distinct 
mechanisms. 
 
It is also noteworthy that translin deletion in mice impairs performance in several behavioral 
paradigms used to assess learning, memory, and anxiety (Stein et al, 2006). However, it is important 
to emphasize that this deficit in subcellular BDNF mRNA sorting may not account completely for the 
biological deficits produced by this mutation. On the other hand, it has been found that klox mice 
lacking BDNF transcripts with the long 3’UTR show deficits in dendritic localization of BDNF mRNA 
under resting conditions and a marked impairment in long-term synaptic potentiation and Morris 
water maze performance of these mutant mice (An et al., 2008). However, the lack of deficits in 
dendritic arborisation in BDNF
klox
 mice argues that the phenotype of these mice  is not as severe as 
that of G196A mice. The reason for this milder phenotype is clearly explained by our compelling 
demonstration that the 3’UTR short isoform may largely vicariate the 3’UTR long in producing BDNF 
protein in dendrites. This compensatory mechanism may operate particularly during early 
development when the 3’UTR shor tisoform is predominant with respect to the long variant.    
 
In conclusion, these findings indicate that further studies are warranted to assess the role that 
dendritic trafficking of BDNF mRNA plays in the pathophysiology of neuropsychiatric disorders.    
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